pyrophosphate profile

Diphosphates: Inorganic salts of phosphoric acid that contain two phosphate groups. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Pathways (42,211)

pyrophosphate is involved in 42211 pathway(s), involving a total of 412772 unique proteins and 760529 unique compounds

ID Source	ID
PubMed CID	644102
CHEBI ID	18361
MeSH ID	M0569649

Synonym
diphosphates
pyrophosphat
CHEBI:18361
diphosphat
diphosphate(4-)
14000-31-8
[o3popo3](4-)
mu-oxido-bis(trioxidophosphate)(4-)
pyrophosphate ion
p2o7(4-)
mu-oxo-hexaoxodiphosphate
pyrophosphate(4-) ion
pyrophosphate(4-)
pyrometaphosphate
pyrophosphate (p2o74-)
diphosphate (p2o74-)
diphosphoric acid, ion(4-)
phosphate (p2o74-)
diphosphate
DF048DC2-F386-4F01-8876-FD4CD8DE4A9F
2O1C
phosphonato phosphate
bdbm50278316
x3ssv2v6l3 ,
unii-x3ssv2v6l3
3C14
diphospate
XPPKVPWEQAFLFU-UHFFFAOYSA-J
DTXSID4074514
Q290828
pyrophosphate anion
(phosphonatooxy)phosphonate

Excerpt	Reference
"Pyrophosphate (PPi) is a potent inhibitor of ectopic mineralization but its role during aortic valve calcification is not known."	( Bertacco, E; Buso, G; Causin, V; D'Andrea, S; Faggin, E; Gerosa, G; Iop, L; Pauletto, P; Puato, M; Rattazzi, M, 2014)
"Pyrophosphate was found to be a potent inhibitor of malic enzyme activity, with a Ki of 0.036 mM."	( Levin, DB; Oresnik, IJ; Rydzak, T; Sparling, R; Taillefer, M, 2015)
"Pyrophosphate is a potent mitogen, capable of stimulating proliferation in multiple cell types, and a critical participant in bone mineralization. "	( Engqvist, H; Engstrand, T; Karlsson-Ott, M; Lind, T; Lu, X; Melhus, H; Pujari-Palmer, M; Pujari-Palmer, S, 2016)
"Pyrophosphate is an ideal example of a factor that, dependent upon environment, has the capacity to inhibit or enhance mineralization."	( Franceschi, RT; Hatch, NE, 2009)
"Pyrophosphate is an established inhibitor of hydroxyapatite deposition and crystal growth, yet when hydrolyzed into phosphate, it becomes a substrate for hydroxyapatite deposition. "	( Franceschi, RT; Hatch, NE; Li, Y, 2009)
"Pyrophosphate (PPi) is a potent inhibitor of vascular calcification and may be deficient in renal failure. "	( McIntyre, CW; O'Neill, WC; Sigrist, MK, 2010)
"Pyrophosphate (PPi) is a biologically important target. "	( Chen, WH; Pang, Y; Xing, Y, 2011)
"Pyrophosphate (PPi) is a known inhibitor of hydroxyapatite formation and has been shown to inhibit medial vascular calcification in vitamin D-toxic rats. "	( Khawandi, W; Lomashvili, KA; O'Neill, WC, 2005)
"Pyrophosphate is a potent inhibitor of medial vascular calcification where its level is controlled by hydrolysis via a tissue-nonspecific alkaline phosphatase (TNAP). "	( Garg, P; Lomashvili, KA; Millan, JL; Narisawa, S; O'Neill, WC, 2008)
"Pyrophosphate is a noncompetitive inhibitor (Ki = 0.07 mM) of rho poly(C)-dependent ATPase, an activity that is required for rho-mediated termination."	( Guterman, SK; Kent, RB, 1982)
"Pyrophosphate arthropathy is an age-related disease rarely seen in those under 45 years of age. "	( Dieppe, PA; Doherty, M, 1984)
"Pyrophosphate arthropathy is a clinical syndrome that is recognized as a consequence of calcification of aging tissues. "	( Handy, JR, 1996)
"This pyrophosphate was shown to be an intermediate in the joining reaction because of the fact that coupling with A-A-A-A-A-A to give the decanucleotide could be performed in the absence of ATP."	( Ikehara, M; Nishikawa, S; Ohtsuka, E; Sugiura, M, 1976)

Excerpt	Reference
"Pyrophosphate (PYP) imaging has a high diagnostic accuracy for transthyretin cardiac amyloidosis (ATTR-CA). "	( Asif, T; Gupta, A; Malhotra, S; Murthi, M; Singh, V; Soman, P, 2023)
"Pyrophosphate arthropathy has a wide spectrum of clinical symptoms and is a common cause of synovitis in the elderly. "	( Bjelle, A, 1979)
"Pyrophosphate (PYP) imaging has a high diagnostic accuracy for transthyretin cardiac amyloidosis (ATTR-CA). "	( Asif, T; Gupta, A; Malhotra, S; Murthi, M; Singh, V; Soman, P, 2023)
"The pyrophosphate bridge has hydrogen bonds to the side chains of arginine-47 and -369 and to main chain nitrogen atoms from the amino ends of two alpha-helices."	( Eklund, H; Jones, TA; Samama, JP, 1984)
"Pyrophosphate arthropathy has a wide spectrum of clinical symptoms and is a common cause of synovitis in the elderly. "	( Bjelle, A, 1979)

Excerpt	Reference
"Pyrophosphate ions activate the steady-state rate of oxidation of propionaldehyde by sheep liver cytosolic aldehyde dehydrogenase at alkaline pH values. "	( Blackwell, LF; Buckley, PD; Hill, JP; Motion, RL, 1991)
"Pyrophosphate promotes liberation of two releasable nucleotide molecules, decreasing the affinity of the enzyme to AD(T)P."	( Murataliev, MB, 1987)

Excerpt	Reference
"Pyrophosphate treatment also separated the basal lamina from the plasma membrane."	( Fleischer, S; Saito, A; Seiler, S, 1984)
"Pyrophosphate (pH 9) treatment solubilized the fibrillar content, yielding ghosts that were empty except for cores."	( Alexson, SE; Fujiki, Y; Lazarow, PB; Shio, H, 1985)
"Treatment with pyrophosphate inhibited vascular calcification in progeroid mice."	( Acín-Pérez, R; Andrés, V; Enriquez, JA; López-Otín, C; Osorio, FG; Rivera-Torres, J; Villa-Bellosta, R, 2013)

Class	Description
diphosphate ion
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathway	Proteins	Compounds
Alanine Metabolism	5	13
Selenoamino Acid Metabolism	12	26
Histidine Metabolism	17	35
Nicotinate and Nicotinamide Metabolism	14	34
Pyrimidine Metabolism	23	53
Urea Cycle	13	25
Aspartate Metabolism	14	30
Glycine and Serine Metabolism	24	52
Arginine and Proline Metabolism	20	47
Pantothenate and CoA Biosynthesis	6	19
Glutamate Metabolism	22	44
Purine Metabolism	37	66
Cysteine Metabolism	9	23
Oxidation of Branched-Chain Fatty Acids	11	22
Fatty Acid Metabolism	14	41
Tryptophan Metabolism	18	55
Pyruvate Metabolism	21	39
Propanoate Metabolism	18	37
Amino Sugar Metabolism	17	31
Ammonia Recycling	12	27
Betaine Metabolism	8	18
Biotin Metabolism	4	7
Butyrate Metabolism	7	18
Methionine Metabolism	16	37
Sulfate/Sulfite Metabolism	6	20
Ethanol Degradation	7	16
Galactose Metabolism	12	34
Fructose and Mannose Degradation	18	30
Steroid Biosynthesis	21	42
Nucleotide Sugars Metabolism	8	17
Phenylacetate Metabolism	3	8
Riboflavin Metabolism	5	15
Spermidine and Spermine Biosynthesis	6	14
Bile Acid Biosynthesis	17	61
Ubiquinone Biosynthesis	5	18
Phytanic Acid Peroxisomal Oxidation	6	20
Phenylalanine and Tyrosine Metabolism	11	21
Inositol Metabolism	22	26
Lactose Synthesis	10	15
Primary Hyperoxaluria Type I	5	13
Pyruvate Carboxylase Deficiency	5	13
4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	22	44
Homocarnosinosis	22	44
Hyperinsulinism-Hyperammonemia Syndrome	22	44
Adenosine Deaminase Deficiency	37	66
Adenylosuccinate Lyase Deficiency	37	66
Gout or Kelley-Seegmiller Syndrome	37	66
Lesch-Nyhan Syndrome (LNS)	37	66
Molybdenum Cofactor Deficiency	37	66
Xanthine Dehydrogenase Deficiency (Xanthinuria)	37	66
Purine Nucleoside Phosphorylase Deficiency	37	66
AICA-Ribosiduria	37	66
Prolidase Deficiency (PD)	20	47
Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	20	47
Hyperprolinemia Type II	20	47
Hyperprolinemia Type I	20	47
Prolinemia Type II	20	47
Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	20	47
Ornithine Aminotransferase Deficiency (OAT Deficiency)	20	47
Biotinidase Deficiency	4	7
Canavan Disease	14	30
Hypoacetylaspartia	14	30
Smith-Lemli-Opitz Syndrome (SLOS)	21	42
CHILD Syndrome	21	42
Desmosterolosis	21	42
Chondrodysplasia Punctata II, X-Linked Dominant (CDPX2)	21	42
Lysosomal Acid Lipase Deficiency (Wolman Disease)	21	42
Cystathionine beta-Synthase Deficiency	16	37
Hypermethioninemia	16	37
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	16	37
Glycine N-Methyltransferase Deficiency	16	37
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	16	37
Methionine Adenosyltransferase Deficiency	16	37
Ethylmalonic Encephalopathy	14	41
Glutaric Aciduria Type I	14	41
Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD Deficiency)	14	41
Histidinemia	17	35
Lactic Acidemia	5	13
Leigh Syndrome	21	39
Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	21	39
Pyruvate Dehydrogenase Complex Deficiency	21	39
Phenylketonuria	11	21
Tyrosinemia Type 2 (or Richner-Hanhart Syndrome)	11	21
Tyrosinemia Type 3 (TYRO3)	11	21
Refsum Disease	6	20
Sialuria or French Type Sialuria	17	31
Salla Disease/Infantile Sialic Acid Storage Disease	17	31
Ibandronate Action Pathway	21	43
Simvastatin Action Pathway	21	43
Pravastatin Action Pathway	21	43
Rosuvastatin Action Pathway	21	43
Alendronate Action Pathway	21	43
Starch and Sucrose Metabolism	16	26
Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	8	18
Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	8	23
Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	10	25
Argininemia	13	25
Argininosuccinic Aciduria	13	25
Citrullinemia Type I	13	25
Ornithine Transcarbamylase Deficiency (OTC Deficiency)	13	25
beta-Ureidopropionase Deficiency	23	53
UMP Synthase Deficiency (Orotic Aciduria)	23	53
Dihydropyrimidinase Deficiency	23	53
MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	23	53
Carbamoyl Phosphate Synthetase Deficiency	13	25
Congenital Bile Acid Synthesis Defect Type II	17	61
Congenital Bile Acid Synthesis Defect Type III	17	61
Familial Hypercholanemia (FHCA)	17	61
Zellweger Syndrome	17	61
Cerebrotendinous Xanthomatosis (CTX)	17	61
Dimethylglycine Dehydrogenase Deficiency	24	52
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	24	52
Sarcosinemia	24	52
Galactosemia	12	34
Malonic Aciduria	18	37
Methylmalonic Aciduria Due to Cobalamin-Related Disorders	18	37
Non-Ketotic Hyperglycinemia	24	52
2-Hydroxyglutric Aciduria (D and L Form)	22	44
Tay-Sachs Disease	17	31
Hypercholesterolemia	21	42
Azathioprine Action Pathway	47	82
Mercaptopurine Action Pathway	47	80
Lovastatin Action Pathway	21	43
Zoledronate Action Pathway	21	43
Cerivastatin Action Pathway	21	43
Risedronate Action Pathway	21	43
Pamidronate Action Pathway	21	43
Fluvastatin Action Pathway	21	43
Atorvastatin Action Pathway	21	43
Clomocycline Action Pathway	1	4
Azithromycin Action Pathway	1	4
Clarithromycin Action Pathway	1	4
Clindamycin Action Pathway	1	4
Erythromycin Action Pathway	1	4
Roxithromycin Action Pathway	1	4
Telithromycin Action Pathway	1	4
Amikacin Action Pathway	1	4
Gentamicin Action Pathway	1	4
Kanamycin Action Pathway	1	4
Neomycin Action Pathway	1	4
Netilmicin Action Pathway	1	4
Spectinomycin Action Pathway	1	4
Streptomycin Action Pathway	1	4
Demeclocycline Action Pathway	1	4
Doxycycline Action Pathway	1	4
Minocycline Action Pathway	1	4
Oxytetracycline Action Pathway	1	4
Tetracycline Action Pathway	1	4
Lymecycline Action Pathway	1	4
Thioguanine Action Pathway	47	81
Disulfiram Action Pathway	23	66
Dopamine Activation of Neurological Reward System	4	4
Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	8	7
Corticotropin Activation of Cortisol Production	6	6
Excitatory Neural Signalling Through 5-HTR 7 and Serotonin	8	7
Excitatory Neural Signalling Through 5-HTR 6 and Serotonin	8	7
Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	37	9
Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	38	9
Vasopressin Regulation of Water Homeostasis	8	6
Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	11	6
Intracellular Signalling Through Histamine H2 Receptor and Histamine	9	7
Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	11	6
Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	6	6
Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	8	7
Hyperglycinemia, Non-Ketotic	24	52
Galactosemia II (GALK)	8	17
Galactosemia III	8	17
beta-Mercaptolactate-Cysteine Disulfiduria	9	23
Malonyl-CoA Decarboxylase Deficiency	18	37
Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency	20	47
Hyperornithinemia with Gyrate Atrophy (HOGA)	20	47
Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]	20	47
L-Arginine:Glycine Amidinotransferase Deficiency	20	47
Cholesteryl Ester Storage Disease	21	42
Hyper-IgD Syndrome	21	42
Mevalonic Aciduria	21	42
Wolman Disease	21	42
Xanthinuria Type I	37	66
Xanthinuria Type II	37	66
Sulfite Oxidase Deficiency	6	20
G(M2)-Gangliosidosis: Variant B, Tay-Sachs Disease	17	31
Adenine Phosphoribosyltransferase Deficiency (APRT)	37	66
Mitochondrial DNA Depletion Syndrome-3	37	66
Myoadenylate Deaminase Deficiency	37	66
Carnitine Palmitoyl Transferase Deficiency I	14	41
Long Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)	14	41
Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD)	14	41
Carnitine Palmitoyl Transferase Deficiency II	14	41
Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)	14	41
Trifunctional Protein Deficiency	14	41
Glycogen Synthetase Deficiency	16	26
Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis	16	26
Glycogenosis, Type IV. Amylopectinosis, Anderson Disease	16	26
Glycogenosis, Type VI. Hers Disease	16	26
Mucopolysaccharidosis VII. Sly Syndrome	16	26
Sucrase-Isomaltase Deficiency	16	26
Primary Hyperoxaluria II, PH2	21	39
Pyruvate Kinase Deficiency	21	39
Fructosuria	18	30
Multiple Carboxylase Deficiency, Neonatal or Early Onset Form	4	7
Succinic Semialdehyde Dehydrogenase Deficiency	22	44
Short-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (SCHAD)	8	18
Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type	16	37
Congenital Disorder of Glycosylation CDG-IId	10	15
GLUT-1 Deficiency Syndrome	10	15
Mercaptopurine Metabolism Pathway	15	24
Valproic Acid Metabolism Pathway	11	32
Thioguanine Metabolism Pathway	1	4
Lamivudine Metabolism Pathway	18	16
Tobramycin Action Pathway	1	4
Tigecycline Action Pathway	1	4
Arbekacin Action Pathway	1	4
Paromomycin Action Pathway	1	4
27-Hydroxylase Deficiency	17	61
3-Phosphoglycerate Dehydrogenase Deficiency	24	52
Cystinosis, Ocular Nonnephropathic	9	23
Fructose Intolerance, Hereditary	18	30
Rolitetracycline Action Pathway	0	3
Methacycline Action Pathway	0	3
Lincomycin Action Pathway	0	3
Chloramphenicol Action Pathway	0	3
Troleandomycin Action Pathway	0	3
Josamycin Action Pathway	0	3
Abacavir Action Pathway	0	5
Delavirdine Action Pathway	0	3
Didanosine Action Pathway	0	5
Efavirenz Action Pathway	0	3
Emtricitabine Action Pathway	0	3
Lamivudine Action Pathway	0	5
Nevirapine Action Pathway	0	3
Rilpivirine Action Pathway	0	3
Stavudine Action Pathway	0	3
Zalcitabine Action Pathway	0	5
Zidovudine Action Pathway	0	5
Fatty Acid Oxidation	7	9
Biosynthesis of Siderophore Group Nonribosomal Peptides	18	21
Lipoic Acid Metabolism	3	10
Arginine Metabolism	28	48
tRNA Charging	52	27
Cysteine Biosynthesis	13	29
tRNA Charging 2	22	25
Histidine Biosynthesis	8	21
Asparagine Biosynthesis	6	12
phospholipid biosynthesis (CL(17:0cycw7c/18:1(9Z)/19:0cycv8c/17:0cycw7c))	8	14
Mannose Metabolism	9	13
NAD Biosynthesis	5	20
NAD Salvage	6	20
Lipopolysaccharide Biosynthesis	41	53
Quorum Sensing	10	20
S-Adenosyl-L-Methionine Biosynthesis	8	17
Galactose Degradation/Leloir Pathway	13	18
Amino Sugar and Nucleotide Sugar Metabolism I	17	33
Amino Sugar and Nucleotide Sugar Metabolism II	22	31
Amino Sugar and Nucleotide Sugar Metabolism III	23	40
Peptidoglycan Biosynthesis I	30	36
Folate Biosynthesis	11	26
Purine Nucleotides De Novo Biosynthesis	29	45
Sulfur Metabolism	28	33
Sulfur Metabolism (Butanesulfonate)	28	34
Sulfur Metabolism (Propanesulfonate)	28	34
Sulfur Metabolism (Ethanesulfonate)	28	34
Sulfur Metabolism (Isethionate)	28	34
Sulfur Metabolism (Methanesulfonate)	28	34
Colanic Acid Building Blocks Biosynthesis	17	23
Secondary Metabolites: Methylerythritol Phosphate and Polyisoprenoid Biosynthesis	11	21
Secondary Metabolites: Enterobacterial Common Antigen Biosynthesis	9	17
Secondary Metabolites: Trehalose Biosynthesis and Metabolism	10	12
Secondary Metabolites: Isoprenoid Biosynthesis (Nonmevalonate Pathway)	8	18
Secondary Metabolites: Ubiquinol Biosynthesis	9	22
Secondary Metabolites: Histidine Biosynthesis	8	20
phospholipid biosynthesis I (CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) )	13	24
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/18:1(9Z)/19:0cycv8c))	13	21
phospholipid biosynthesis (CL(18:1/18:1/18:1/18:1))	12	22
phospholipid biosynthesis CL(14:0/15:0cyclo/14:0/17:0cycw7c)	11	18
phospholipid biosynthesis (CL(14:0/15:0cyclo/17:0cycw7c/14:0)	13	18
phospholipid biosynthesis CL(14:0/16:0/14:0/14:0)	13	20
phospholipid biosynthesis CL(14:0/16:0/14:0/16:0)	11	20
Phospholipid Biosynthesis CL(14:0/16:0/14:0/18:1(9Z))	12	20
phospholipid biosynthesis CL(14:0/16:0/14:0/19:0cycv8c)	13	19
phospholipid biosynthesis CL(14:0/16:0/16:1(9Z)/14:0)	13	20
phospholipid biosynthesis CL(14:0/16:0/18:1(9Z)/14:0)	13	21
phospholipid biosynthesis CL(14:0/16:0/19:0cycv8c/14:0)	13	19
phospholipid biosynthesis CL(14:0/16:1(9Z)/14:0/16:1(9Z))	13	21
phospholipid biosynthesis CL(14:0/16:1(9Z)/14:0/18:1(9Z))	13	21
phospholipid biosynthesis CL(14:0/16:1(9Z)/14:0/19:0cycv8c)	13	19
phospholipid biosynthesis CL(14:0/16:1(9Z)/18:1(9Z)/14:0)	13	21
phospholipid biosynthesis CL(14:0/16:1(9Z)/19:0cycv8c/14:0)	13	19
phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/14:0)	13	21
phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/17:0cycw7c)	11	18
phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/18:1(9Z))	13	21
phospholipid biosynthesis CL(14:0/18:1(9Z)/14:0/19:0cycv8c)	13	19
phospholipid biosynthesis CL(14:0/18:1(9Z)/17:0cycw7c/14:0)	13	19
phospholipid biosynthesis CL(14:0/18:1(9Z)/19:0cycv8c/14:0)	13	19
phospholipid biosynthesis CL(14:0/19:0cycv8c/14:0/17:0cycw7c)	13	19
phospholipid biosynthesis CL(14:0/19:0cycv8c/14:0/19:0cycv8c)	13	19
phospholipid biosynthesis CL(14:0/19:0cycv8c/17:0cycw7c/14:0)	13	19
phospholipid biosynthesis CL(15:0cyclo/14:0/14:0/17:0cycw7c)	13	19
phospholipid biosynthesis CL(15:0cyclo/14:0/16:1(9Z)/16:1(9Z))	13	21
phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/14:0)	11	17
phospholipid biosynthesis CL(15:0cyclo/14:0/17:0cycw7c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/14:0/18:1(9Z)/18:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/14:0/19:0cycv8c/19:0cycv8c)	13	18
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/16:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/14:0/19:0cycv8c)	11	17
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/16:1(9Z))	13	22
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/15:0cyclo/18:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/15:0cyclo/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/14:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/17:0cycw7c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/16:1(9Z))	13	23
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/18:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:0/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/14:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/16:0)	11	21
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/17:0cycw7c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/18:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/16:1(9Z)/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/16:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/18:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/17:0cycw7c/19:0cycv8c)	11	17
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/14:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/16:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/17:0cycw7c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/18:1(9Z))	11	23
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/18:1(9Z)/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/14:0)	11	17
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/15:0cyclo)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/16:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/18:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/15:0cyclo/19:0cycv8c/19:0cycv8c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/14:0/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/14:0)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/16:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/16:0/15:0cyclo/19:0cycv8c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/16:0)	11	21
phospholipid biosynthesis CL(15:0cyclo/16:0/17:0cycw7c/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/16:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/17:0cycw7c)	11	19
phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/16:0/16:0/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:0)	11	21
phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis CL(15:0cyclo/16:0/16:1(9Z)/16:1(9Z))	13	23
phospholipid biosynthesis CL(15:0cyclo/16:0/17:0cycw7c/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/16:0/17:0cycw7c/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/16:0)	11	23
phospholipid biosynthesis CL(15:0cyclo/16:0/18:1(9Z)/18:1(9Z))	11	20
phospholipid biosynthesis (CL(15:0cyclo/16:0/19:0cycv8c/15:0cyclo))	11	18
phospholipid biosynthesis CL(15:0cyclo/16:0/19:0cycv8c/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/16:0/19:0cycv8c/19:0cycv8c)	10	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/14:0/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/14:0/16:1(9Z))	13	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/14:0)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/16:1(9Z))	13	23
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/15:0cyclo/19:0cycv8c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:0/16:0)	11	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:0/16:1(9Z))	11	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/14:0)	13	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/15:0cyclo)	13	23
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/16:0)	13	23
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/16:1(9Z))	13	24
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/17:0cycw7c)	11	19
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/18:1(9Z))	13	22
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/16:1(9Z)/19:0cycv8c)	13	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/17:0cycw7c/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/17:0cycw7c/16:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/17:0cycw7c/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/18:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/18:1(9Z)/16:1(9Z))	13	23
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/18:1(9Z)/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/19:0cycv8c/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/19:0cycv8c/16:1(9Z))	13	21
phospholipid biosynthesis CL(15:0cyclo/16:1(9Z)/19:0cycv8c/19:0cycv8c)	10	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/14:0/14:0)	13	19
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/14:0/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/15:0cyclo/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:0/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:0/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:1(9Z)/16:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/16:1(9Z)/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/14:0)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/15:0cyclo)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c)/16:0)	11	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/16:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/18:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/17:0cycw7c/19:0cycv8c)	11	17
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/18:1(9Z)/17:0cycw7c)	11	20
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/18:1(9Z)/18:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/17:0cycw7c/19:0cycv8c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/14:0/15:0cyclo)	11	19
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/14:0/18:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/15:0cyclo/14:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/15:0cyclo/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/15:0cyclo/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/15:0cyclo/19:0cycv8c)	11	19
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/16:0/16:0)	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/16:0/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/16:1(9Z)/16:1(9Z))	13	22
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/16:1(9Z)/18:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/17:0cycw7c/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/17:0cycw7c/17:0cycw7c)	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/17:0cycw7c/18:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/14:0)	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/16:0)	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/16:1(9Z))	11	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/17:0cycw7c)	11	18
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/18:1(9Z))	11	19
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/18:1(9Z)/19:0cycv8c)	13	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/19:0cycv8c/15:0cyclo)	11	19
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/19:0cycv8c/18:1(9Z))	13	20
phospholipid biosynthesis CL(15:0cyclo/18:1(9Z)/19:0cycv8c/19:0cycv8c)	8	15
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/14:0/15:0cyclo)	11	17
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/14:0/19:0cycv8c)	13	20
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/15:0cyclo/14:0)	11	17
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/19:0cycv8c/15:0cyclo))	11	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/15:0cyclo/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/15:0cyclo/19:0cycv8c)	11	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:0/16:0)	11	19
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:0/19:0cycv8c)	10	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:1(9Z)/16:1(9Z))	13	21
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/16:1(9Z)/19:0cycv8c)	10	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/17:0cycw7c/15:0cyclo)	11	17
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/19:0cycv8c/16:0))	11	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/17:0cycw7c/17:0cycw7c)	11	17
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/18:1(9Z)/18:1(9Z))	13	20
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/18:1(9Z)/19:0cycv8c)	11	20
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/14:0)	11	17
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/15:0cyclo)	11	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/16:0)	10	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/16:1(9Z))	10	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/18:1(9Z))	11	18
phospholipid biosynthesis CL(15:0cyclo/19:0cycv8c/19:0cycv8c/19:0cycv8c)	10	18
phospholipid biosynthesis CL(16:0/14:0/14:0/14:0)	13	20
phospholipid biosynthesis CL(16:0/14:0/14:0/16:0)	13	21
phospholipid biosynthesis CL(16:0/14:0/14:0/16:1(9Z))	13	21
phospholipid biosynthesis CL(16:0/14:0/14:0/18:1(9Z))	13	21
phospholipid biosynthesis CL(16:0/14:0/14:0/19:0cycv8c)	13	19
phospholipid biosynthesis CL(16:0/14:0/16:0/14:0)	13	22
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/19:0cycv8c/17:0cycw7c))	11	18
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/14:0/14:0))	11	18
phospholipid biosynthesis (CL(18:1(9Z)/18:1(9Z)/19:0cycv8c/16:1(9Z))	11	18
phospholipid biosynthesis CL(16:0/14:0/16:1(9Z)/14:0)	13	20
phospholipid biosynthesis CL(16:0/14:0/16:1(9Z)/16:1(9Z))	11	20
phospholipid biosynthesis CL(16:0/14:0/17:0cycw7c/17:0cycw7c)	11	18
phospholipid biosynthesis CL(16:0/14:0/18:1(9Z)/14:0)	11	20
phospholipid biosynthesis CL(16:0/14:0/18:1(9Z)/18:1(9Z))	11	20
phospholipid biosynthesis CL(16:0/14:0/19:0cycv8c/14:0)	13	19
phospholipid biosynthesis CL(16:0/14:0/19:0cycv8c/19:0cycv8c)	10	18
phospholipid biosynthesis CL(16:0/15:0cyclo/14:0/15:0cyclo)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/14:0)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/16:1(9Z))	11	20
phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/17:0cycw7c)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/18:1(9Z))	11	21
phospholipid biosynthesis CL(16:0/15:0cyclo/15:0cyclo/19:0cycv8c)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/16:0)	11	21
phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/16:1(9Z))	11	21
phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/17:0cycw7c)	11	19
phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/18:1(9Z))	11	20
phospholipid biosynthesis CL(16:0/15:0cyclo/16:0/19:0cycv8c)	11	19
phospholipid biosynthesis CL(16:0/15:0cyclo/16:1(9Z)/15:0cyclo)	11	21
phospholipid biosynthesis CL(16:0/15:0cyclo/16:1(9Z)/16:0)	11	21
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/14:0/18:1(9Z)))	11	19
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/14:0/19:0cycv8c))	11	17
phospholipid biosynthesis CL(16:0/15:0cyclo/16:1(9Z)/16:1(9Z))	13	23
phospholipid biosynthesis CL(16:0/15:0cyclo/17:0cycw7c/15:0cyclo)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/17:0cycw7c/16:0)	11	19
phospholipid biosynthesis CL(16:0/15:0cyclo/17:0cycw7c/17:0cycw7c)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/18:1(9Z)/15:0cyclo)	11	20
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/17:0cycw7c/17:0cycw7c))	11	16
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/17:0cycw7c/18:1(9Z)))	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/18:1(9Z)/16:0)	11	21
phospholipid biosynthesis CL(16:0/15:0cyclo/18:1(9Z)/18:1(9Z))	11	21
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/18:1(9Z)/14:0))	11	17
phospholipid biosynthesis CL(16:0/15:0cyclo/19:0cycv8c/15:0cyclo)	11	18
phospholipid biosynthesis CL(16:0/15:0cyclo/19:0cycv8c/16:0)	11	19
phospholipid biosynthesis CL(16:0/15:0cyclo/19:0cycv8c/19:0cycv8c)	10	18
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/18:1(9Z)/17:0cycw7c))	11	18
phospholipid biosynthesis (CL(18:1(9Z)/19:0cycv8c/19:0cycv8c/14:0))	11	17
phospholipid biosynthesis CL(16:0/16:0/14:0/14:0)	11	21
phospholipid biosynthesis (CL(19:0cycv8c/14:0/14:0/17:0cycw7c))	9	15
phospholipid biosynthesis CL(16:0/16:0/14:0/16:1(9Z))	11	21
phospholipid biosynthesis (CL(19:0cycv8c/14:0/14:0/19:0cycv8c))	9	15
phospholipid biosynthesis CL(16:0/16:0/14:0/17:0cycw7c)	11	19
phospholipid biosynthesis CL(16:0/16:0/14:0/18:1(9Z))	11	21
phospholipid biosynthesis CL(16:0/16:0/14:0/19:0cycv8c)	11	19
phospholipid biosynthesis CL(16:0/16:0/16:0/17:0cycw7c)	11	19

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, dATP pyrophosphohydrolase	Escherichia coli	Ki	19.0000	19.0000	19.0000	19.0000	AID977610
Chain A, Adenylate cyclase type 5	Canis lupus familiaris (dog)	Ki	300.0000	300.0000	300.0000	300.0000	AID977610
Chain B, Adenylate cyclase type 2	Rattus norvegicus (Norway rat)	Ki	300.0000	300.0000	300.0000	300.0000	AID977610
Carbonic anhydrase 1	Homo sapiens (human)	Ki	25,800.0000	0.0000	1.3726	10.0000	AID1803484
Carbonic anhydrase 2	Homo sapiens (human)	Ki	48,500.0000	0.0000	0.7236	9.9200	AID1803485
Carbonic anhydrase	Methanosarcina thermophila	Ki	7,300.0000	0.0600	0.9714	8.5000	AID1803493
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
one-carbon metabolic process	Carbonic anhydrase 1	Homo sapiens (human)
morphogenesis of an epithelium	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of synaptic transmission, GABAergic	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of cellular pH reduction	Carbonic anhydrase 2	Homo sapiens (human)
angiotensin-activated signaling pathway	Carbonic anhydrase 2	Homo sapiens (human)
regulation of monoatomic anion transport	Carbonic anhydrase 2	Homo sapiens (human)
secretion	Carbonic anhydrase 2	Homo sapiens (human)
regulation of intracellular pH	Carbonic anhydrase 2	Homo sapiens (human)
neuron cellular homeostasis	Carbonic anhydrase 2	Homo sapiens (human)
positive regulation of dipeptide transmembrane transport	Carbonic anhydrase 2	Homo sapiens (human)
regulation of chloride transport	Carbonic anhydrase 2	Homo sapiens (human)
carbon dioxide transport	Carbonic anhydrase 2	Homo sapiens (human)
one-carbon metabolic process	Carbonic anhydrase 2	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
arylesterase activity	Carbonic anhydrase 1	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 1	Homo sapiens (human)
protein binding	Carbonic anhydrase 1	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 1	Homo sapiens (human)
hydro-lyase activity	Carbonic anhydrase 1	Homo sapiens (human)
cyanamide hydratase activity	Carbonic anhydrase 1	Homo sapiens (human)
arylesterase activity	Carbonic anhydrase 2	Homo sapiens (human)
carbonate dehydratase activity	Carbonic anhydrase 2	Homo sapiens (human)
protein binding	Carbonic anhydrase 2	Homo sapiens (human)
zinc ion binding	Carbonic anhydrase 2	Homo sapiens (human)
cyanamide hydratase activity	Carbonic anhydrase 2	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
cytosol	Carbonic anhydrase 1	Homo sapiens (human)
extracellular exosome	Carbonic anhydrase 1	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 2	Homo sapiens (human)
cytosol	Carbonic anhydrase 2	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 2	Homo sapiens (human)
myelin sheath	Carbonic anhydrase 2	Homo sapiens (human)
apical part of cell	Carbonic anhydrase 2	Homo sapiens (human)
extracellular exosome	Carbonic anhydrase 2	Homo sapiens (human)
cytoplasm	Carbonic anhydrase 2	Homo sapiens (human)
plasma membrane	Carbonic anhydrase 2	Homo sapiens (human)
apical part of cell	Carbonic anhydrase 2	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Assay ID	Title	Year	Journal	Article
AID1803254	CA Inhibition Assay from Article 10.3109/14756366.2011.649268: \\Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.\\	2013	Journal of enzyme inhibition and medicinal chemistry, Apr, Volume: 28, Issue:2	Inhibition of the alpha- and beta-carbonic anhydrases from the gastric pathogen Helycobacter pylori with anions.
AID1803491	ChEMBL_158311 (CHEMBL763368) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1803484	ChEMBL_158304 (CHEMBL763189) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1803485	ChEMBL_158305 (CHEMBL763190) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1803486	ChEMBL_158306 (CHEMBL763191) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1803493	ChEMBL_158313 (CHEMBL763370) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID1803487	ChEMBL_158307 (CHEMBL763192) from Article 10.1016/j.bmc.2016.05.029: \\Anion inhibition profiles of a-, u00DF- and u00BF-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.\\	2016	Bioorganic & medicinal chemistry, 08-15, Volume: 24, Issue:16	Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae.
AID977610	Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB	2009	Biochemistry, Apr-21, Volume: 48, Issue:15	Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
AID977610	Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB	2007	Structure (London, England : 1993), Aug, Volume: 15, Issue:8	Structure and function of the E. coli dihydroneopterin triphosphate pyrophosphatase: a Nudix enzyme involved in folate biosynthesis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	3751 (58.71)	18.7374
1990's	595 (9.31)	18.2507
2000's	778 (12.18)	29.6817
2010's	890 (13.93)	24.3611
2020's	375 (5.87)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	183 (2.71%)	5.53%
Reviews	337 (5.00%)	6.00%
Case Studies	286 (4.24%)	4.05%
Observational	3 (0.04%)	0.25%
Other	5,934 (88.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Trials	Classes	Roles
bromide	[no description available]	medium	11	0	halide anion; monoatomic bromine
chlorine	[no description available]	medium	56	0	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
chlorine	[no description available]	medium	56	4	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
hydrogen carbonate	[no description available]	medium	22	0	carbon oxoanion	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
nitrates	[no description available]	medium	22	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species
nitrates	[no description available]	medium	22	3	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species
nitrites	[no description available]	medium	5	0	monovalent inorganic anion; nitrogen oxoanion; reactive nitrogen species	human metabolite
cyanides	[no description available]	medium	34	0	pseudohalide anion	EC 1.9.3.1 (cytochrome c oxidase) inhibitor
sulfamic acid	[no description available]	medium	3	0	sulfamic acids
benzenearsonic acid	[no description available]	medium	2	0	arsonic acids; organoarsonic acid
thiocyanate	[no description available]	medium	3	0	pseudohalide anion; sulfur molecular entity	human metabolite
carbonates	[no description available]	medium	21	0	carbon oxoanion
fluorides	[no description available]	medium	144	0	halide anion; monoatomic fluorine
fluorides	[no description available]	medium	144	20	halide anion; monoatomic fluorine
iodine	[no description available]	medium	5	0	halide anion; monoatomic iodine	human metabolite
azides	[no description available]	medium	28	0	pseudohalide anion	mitochondrial respiratory-chain inhibitor
benzeneboronic acid	[no description available]	medium	3	0	boronic acids
sulfamide	[no description available]	medium	2	0	sulfamides
hydrogen sulfite	[no description available]	medium	4	0	sulfur oxoanion	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
perchlorate	[no description available]	medium	2	0	chlorine oxoanion; monovalent inorganic anion
perrhenate	[no description available]	medium	2	0	monovalent inorganic anion; rhenium oxoanion
tetraborate	[no description available]	medium	2	0
hydrobromic acid	[no description available]	medium	2	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
hydrochloric acid	[no description available]	medium	7	0	chlorine molecular entity; gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
hydrogen sulfide	[no description available]	medium	3	0	gas molecular entity; hydracid; mononuclear parent hydride; sulfur hydride	Escherichia coli metabolite; genotoxin; metabolite; signalling molecule; toxin; vasodilator agent
cyanic acid	[no description available]	medium	1	0	one-carbon compound; pseudohalogen oxoacid
carbonic acid	[no description available]	medium	1	0	carbon oxoacid; chalcocarbonic acid	mouse metabolite
hydrogen cyanide	[no description available]	medium	3	0	hydracid; one-carbon compound	Escherichia coli metabolite; human metabolite; poison
thiocyanic acid	[no description available]	medium	1	0	hydracid; one-carbon compound; organosulfur compound	Escherichia coli metabolite
diphosphoric acid	[no description available]	medium	604	0	acyclic phosphorus acid anhydride; phosphorus oxoacid	Escherichia coli metabolite
diphosphoric acid	[no description available]	medium	604	6	acyclic phosphorus acid anhydride; phosphorus oxoacid	Escherichia coli metabolite
selenic acid	[no description available]	medium	1	0	selenium oxoacid
sulfurous acid	[no description available]	medium	1	0	sulfur oxoacid
sulfuric acid	[no description available]	medium	3	0	sulfur oxoacid	catalyst
acetazolamide	[no description available]	medium	3	0	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
acetazolamide	[no description available]	medium	3	1	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
ditiocarb	[no description available]	medium	1	0	dithiocarbamic acids	chelator; copper chelator
hydrofluoric acid	[no description available]	medium	2	0	hydrogen halide; mononuclear parent hydride	NMR chemical shift reference compound
perchloric acid	[no description available]	medium	2	0	chlorine oxoacid
nitrous acid	[no description available]	medium	2	0	nitrogen oxoacid
fluorosulfonic acid	[no description available]	medium	1	0	sulfur oxoacid	NMR solvent
hydroiodic acid	[no description available]	medium	1	0	gas molecular entity; hydrogen halide; mononuclear parent hydride	mouse metabolite
trithiocarbonic acid	[no description available]	medium	1	0	chalcocarbonic acid; one-carbon compound; thiocarbonyl compound
selenocyanic acid	[no description available]	medium	1	0	organic radical
emtricitabine	[no description available]	medium	7	1	monothioacetal; nucleoside analogue; organofluorine compound; pyrimidone	antiviral drug; HIV-1 reverse transcriptase inhibitor
tenofovir	[no description available]	medium	11	2	nucleoside analogue; phosphonic acids	antiviral drug; drug metabolite; HIV-1 reverse transcriptase inhibitor
alanine	[no description available]	medium	28	1	alanine zwitterion; alanine; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid	EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor; fundamental metabolite
gs-7340	[no description available]	medium	1	1	6-aminopurines; ether; isopropyl ester; L-alanine derivative; phosphoramidate ester	antiviral drug; HIV-1 reverse transcriptase inhibitor; prodrug
biotin	[no description available]	medium	4	0	biotins; vitamin B7	coenzyme; cofactor; Escherichia coli metabolite; fundamental metabolite; human metabolite; mouse metabolite; nutraceutical; prosthetic group; Saccharomyces cerevisiae metabolite
phytic acid	[no description available]	medium	26	1	inositol phosphate
cytidine	[no description available]	medium	7	1	cytidines	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
cytidine diphosphate choline	[no description available]	medium	3	1	nucleotide-(amino alcohol)s; phosphocholines	human metabolite; mouse metabolite; neuroprotective agent; psychotropic drug; Saccharomyces cerevisiae metabolite
methamphetamine	[no description available]	medium	1	1	amphetamines; secondary amine	central nervous system stimulant; environmental contaminant; neurotoxin; psychotropic drug; xenobiotic
technetium	[no description available]	medium	1,111	15	manganese group element atom
guanosine triphosphate	[no description available]	medium	87	0	guanosine 5'-phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
inosine triphosphate	[no description available]	medium	4	0	inosine phosphate; purine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
technetium tc 99m pyrophosphate	[no description available]	medium	686	9
durapatite	[no description available]	medium	55	3
citric acid, anhydrous	[no description available]	medium	66	10	tricarboxylic acid	antimicrobial agent; chelator; food acidity regulator; fundamental metabolite
ferric pyrophosphate	[no description available]	medium	85	37	iron coordination entity
sodium pyrophosphate	[no description available]	medium	174	16	inorganic sodium salt	chelator; food emulsifier; food thickening agent
alpha-aminopyridine	[no description available]	medium	1	0
dabrafenib	[no description available]	medium	1	0	1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide	anticoronaviral agent; antineoplastic agent; B-Raf inhibitor
abemaciclib	[no description available]	medium	1	0
cerium	[no description available]	medium	3	0	f-block element atom; lanthanoid atom
ceric oxide	[no description available]	medium	2	0	cerium molecular entity; metal oxide
erythritol	[no description available]	medium	8	0	butane-1,2,3,4-tetrol	antioxidant; human metabolite; plant metabolite
2-c-methylerythritol 4-phosphate	[no description available]	medium	5	0	tetritol phosphate	Escherichia coli metabolite
3,3',5,5'-tetramethylbenzidine	[no description available]	medium	3	0
molybdenum	[no description available]	medium	29	0	chromium group element atom	micronutrient
molybdate ion	[no description available]	medium	4	0	divalent inorganic anion; molybdenum oxoanion	Escherichia coli metabolite
pyruvic acid	[no description available]	medium	13	0	2-oxo monocarboxylic acid	cofactor; fundamental metabolite
astaxanthine	[no description available]	medium	1	0	carotenol; carotenone	animal metabolite; anticoagulant; antioxidant; food colouring; plant metabolite
copper gluconate	[no description available]	medium	20	0	organic molecular entity
gluconic acid	[no description available]	medium	4	0	gluconic acid	chelator; Penicillium metabolite
fumarates	[no description available]	medium	5	0	butenedioate; C4-dicarboxylate	human metabolite; metabolite; Saccharomyces cerevisiae metabolite
1,2-oleoylphosphatidylcholine	[no description available]	medium	3	0	phosphatidylcholine(1+)
lysine	[no description available]	medium	58	0	aspartate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; lysine; organic molecular entity; proteinogenic amino acid	algal metabolite; anticonvulsant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
glycerol	[no description available]	medium	74	0	alditol; triol	algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent
phosphatidylcholines	[no description available]	medium	12	0	1,2-diacyl-sn-glycero-3-phosphocholine
arabinofuranosylcytosine triphosphate	[no description available]	medium	3	0
cytarabine	[no description available]	medium	2	1	beta-D-arabinoside; monosaccharide derivative; pyrimidine nucleoside	antimetabolite; antineoplastic agent; antiviral agent; immunosuppressive agent
superphosphate	[no description available]	medium	76	0
2-naphthol orange	[no description available]	medium	1	0
peroxymonosulfate	[no description available]	medium	2	0	sulfur oxide; sulfur oxoanion
lead	[no description available]	medium	17	1	carbon group element atom; elemental lead; metal atom	neurotoxin
isoleucine	[no description available]	medium	47	0	aspartate family amino acid; isoleucine; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
leucine	[no description available]	medium	55	0	amino acid zwitterion; L-alpha-amino acid; leucine; proteinogenic amino acid; pyruvate family amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
adenosine	[no description available]	medium	59	0	adenosines; purines D-ribonucleoside	analgesic; anti-arrhythmia drug; fundamental metabolite; human metabolite; vasodilator agent
valine	[no description available]	medium	38	0	L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; pyruvate family amino acid; valine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
2-methylisoborneol	[no description available]	medium	2	0
2-methyl-5,6-cyclopentapyrimidine	[no description available]	medium	2	0
ubiquinone	[no description available]	medium	14	0
drimenol	[no description available]	medium	1	0	homoallylic alcohol; octahydronaphthalenes; primary alcohol; sesquiterpenoid
aspartic acid	[no description available]	medium	26	0	aspartate family amino acid; aspartic acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; mouse metabolite; neurotransmitter
sesquiterpenes	[no description available]	medium	55	0
ferrous sulfate	[no description available]	medium	24	10	iron molecular entity; metal sulfate	reducing agent
acid phosphatase	[no description available]	medium	32	0
uridine diphosphate	[no description available]	medium	16	0	pyrimidine ribonucleoside 5'-diphosphate; uridine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
uridine	[no description available]	medium	23	0	uridines	drug metabolite; fundamental metabolite; human metabolite
squalene	[no description available]	medium	36	0	triterpene	human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
anticodon	[no description available]	medium	5	0
lignin	[no description available]	medium	5	0
mocetinostat	[no description available]	medium	5	0	aminopyrimidine; benzamides; pyridines; secondary amino compound; secondary carboxamide; substituted aniline	antineoplastic agent; apoptosis inducer; autophagy inducer; cardioprotective agent; EC 3.5.1.98 (histone deacetylase) inhibitor; hepatotoxic agent
heme	[no description available]	medium	7	0
nad	[no description available]	medium	93	0	organophosphate oxoanion	cofactor; human metabolite; hydrogen acceptor; Saccharomyces cerevisiae metabolite
phosphorus	[no description available]	medium	96	2	monoatomic phosphorus; nonmetal atom; pnictogen	macronutrient
tryptophan	[no description available]	medium	53	0	erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid zwitterion; L-alpha-amino acid; proteinogenic amino acid; tryptophan zwitterion; tryptophan	antidepressant; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
nitrogenase	[no description available]	medium	1	0
cysteine	[no description available]	medium	35	0	cysteinium	fundamental metabolite
adenosine monophosphate	[no description available]	medium	165	0	adenosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	adenosine A1 receptor agonist; cofactor; EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.11 (fructose-bisphosphatase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
adenine	[no description available]	medium	77	1	6-aminopurines; purine nucleobase	Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
thiamine pyrophosphate	[no description available]	medium	33	0	organic chloride salt; vitamin B1
thiamine	[no description available]	medium	38	0	primary alcohol; vitamin B1	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
iridium	[no description available]	medium	1	0	cobalt group element atom; platinum group metal atom
triazoles	[no description available]	medium	6	0	1,2,3-triazole
hydroxymethanediphosphonic acid	[no description available]	medium	3	0	1,1-bis(phosphonic acid)
anserine	[no description available]	medium	2	0	beta-alanine derivative; dipeptide; zwitterion	animal metabolite; mouse metabolite
natriuretic peptide, brain	[no description available]	medium	1	0	polypeptide
dicyandiamido	[no description available]	medium	2	0	guanidines; nitrile	curing agent; explosive; fertilizer; flame retardant; nitrification inhibitor
calcium sulfate dihydrate	[no description available]	medium	4	0	calcium salt; hydrate
calcium sulfate	[no description available]	medium	5	0	calcium salt; inorganic calcium salt
ammonium hydroxide	[no description available]	medium	23	0	azane; gas molecular entity; mononuclear parent hydride	EC 3.5.1.4 (amidase) inhibitor; metabolite; mouse metabolite; neurotoxin; NMR chemical shift reference compound; nucleophilic reagent; refrigerant
nitrous oxide	[no description available]	medium	2	0	gas molecular entity; nitrogen oxide	analgesic; bacterial metabolite; food packaging gas; food propellant; general anaesthetic; greenhouse gas; inhalation anaesthetic; NMDA receptor antagonist; raising agent; refrigerant; vasodilator agent
methane	[no description available]	medium	17	0	alkane; gas molecular entity; mononuclear parent hydride; one-carbon compound	bacterial metabolite; fossil fuel; greenhouse gas
ribose	[no description available]	medium	58	1	D-ribose; ribopyranose
bmn 673	[no description available]	medium	1	1
beta-escin	[no description available]	medium	2	0
mevalonic acid	[no description available]	medium	60	0	3,5-dihydroxy-3-methylpentanoic acid
phosphomevalonic acid	[no description available]	medium	1	0	monoalkyl phosphate
teixobactin	[no description available]	medium	1	0	cyclodepsipeptide; macrocycle; peptide antibiotic	antibacterial agent
goethite	[no description available]	medium	2	0
histidine	[no description available]	medium	44	0	amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
minocycline	[no description available]	medium	1	0
phenylalanine	[no description available]	medium	60	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid	algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
pyrethrins	[no description available]	medium	1	0
uridine triphosphate	[no description available]	medium	10	0	pyrimidine ribonucleoside 5'-triphosphate; uridine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
triphosphoric acid	[no description available]	medium	63	2	acyclic phosphorus acid anhydride; phosphorus oxoacid
uracil	[no description available]	medium	21	0	pyrimidine nucleobase; pyrimidone	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; prodrug; Saccharomyces cerevisiae metabolite
interleukin-8	[no description available]	medium	2	0
pyridoxal	[no description available]	medium	2	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
geranylgeranyl pyrophosphate	[no description available]	medium	13	0	geranylgeranyl diphosphate	mouse metabolite
gemcitabine	[no description available]	medium	2	0	organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; environmental contaminant; immunosuppressive agent; photosensitizing agent; prodrug; radiosensitizing agent; xenobiotic
muramidase	[no description available]	medium	7	0
cytidine diphosphate	[no description available]	medium	4	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite
acetylgalactosamine	[no description available]	medium	1	0	N-acetyl-D-hexosamine; N-acetylgalactosamine	Escherichia coli metabolite; human metabolite; mouse metabolite
tenofovir diphosphate	[no description available]	medium	3	0
tafamidis	[no description available]	medium	4	0	1,3-benzoxazoles; dichlorobenzene; monocarboxylic acid	central nervous system drug
ubiquinone q1	[no description available]	medium	1	0	ubiquinones
menaquinone 6	[no description available]	medium	1	0
isopentenol	[no description available]	medium	2	0	enol
limonene	[no description available]	medium	3	0	cycloalkene; p-menthadiene	human metabolite
n-pentanol	[no description available]	medium	4	0	pentanol; short-chain primary fatty alcohol	human metabolite; plant metabolite
inositol	[no description available]	medium	27	0	cyclitol; hexol
germacrene d	[no description available]	medium	1	0
isophthalate	[no description available]	medium	1	0	dicarboxylic acid dianion
coenzyme a	[no description available]	medium	28	0	adenosine 3',5'-bisphosphate	coenzyme; Escherichia coli metabolite; mouse metabolite
acetyl coenzyme a	[no description available]	medium	9	0	acyl-CoA	acyl donor; coenzyme; effector; fundamental metabolite
sulfur	[no description available]	medium	25	0	chalcogen; nonmetal atom	macronutrient
phthalic acid	[no description available]	medium	1	0	benzenedicarboxylic acid	human xenobiotic metabolite
succinic acid	[no description available]	medium	5	0	alpha,omega-dicarboxylic acid; C4-dicarboxylic acid	anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent
succinyl-coenzyme a	[no description available]	medium	1	0	omega-carboxyacyl-CoA	Escherichia coli metabolite; inhibitor; mouse metabolite
succinyl phosphate	[no description available]	medium	1	0
elaiophylin	[no description available]	medium	1	0	lactol; macrodiolide; monosaccharide derivative	antifungal agent; autophagy inhibitor; bacterial metabolite
thymidine	[no description available]	medium	29	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
fe(iii)-edta	[no description available]	medium	5	2	iron coordination entity
limestone	[no description available]	medium	17	4	calcium salt; carbonate salt; inorganic calcium salt; one-carbon compound	antacid; fertilizer; food colouring; food firming agent
edetic acid	[no description available]	medium	142	2	ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid	anticoagulant; antidote; chelator; copper chelator; geroprotector
carbamyl phosphate	[no description available]	medium	5	0	acyl monophosphate; one-carbon compound	Escherichia coli metabolite; mouse metabolite
adenosine diphosphate	[no description available]	medium	186	0	adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite; human metabolite
acetyl phosphate	[no description available]	medium	4	0	acyl monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
phosphoribosyl pyrophosphate	[no description available]	medium	26	0	5-O-phosphono-D-ribofuranosyl diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
nadp	[no description available]	medium	75	0
levonorgestrel	[no description available]	medium	1	1	17beta-hydroxy steroid; 3-oxo-Delta(4) steroid; terminal acetylenic compound	contraceptive drug; female contraceptive drug; progestin; synthetic oral contraceptive
3,3-dimethylallyl pyrophosphate	[no description available]	medium	16	0	prenol phosphate	epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
isopentenyl pyrophosphate	[no description available]	medium	36	0	prenol phosphate	antigen; antioxidant; epitope; Escherichia coli metabolite; mouse metabolite; phosphoantigen
linalool	[no description available]	medium	4	0	monoterpenoid; tertiary alcohol	antimicrobial agent; fragrance; plant metabolite; volatile oil component
aspirin	[no description available]	medium	2	0	benzoic acids; phenyl acetates; salicylates	anticoagulant; antipyretic; cyclooxygenase 1 inhibitor; cyclooxygenase 2 inhibitor; drug allergen; EC 1.1.1.188 (prostaglandin-F synthase) inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug; plant activator; platelet aggregation inhibitor; prostaglandin antagonist; teratogenic agent
arachidonic acid	[no description available]	medium	4	0	icosa-5,8,11,14-tetraenoic acid; long-chain fatty acid; omega-6 fatty acid	Daphnia galeata metabolite; EC 3.1.1.1 (carboxylesterase) inhibitor; human metabolite; mouse metabolite
camphor, (+-)-isomer	[no description available]	medium	2	0	bornane monoterpenoid; cyclic monoterpene ketone	plant metabolite
isoborneol	[no description available]	medium	1	0	borneol
thromboxanes	[no description available]	medium	1	0
guanosine tetraphosphate	[no description available]	medium	4	0	guanosine bisphosphate	Escherichia coli metabolite; mouse metabolite
arginine	[no description available]	medium	38	3	arginine; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	biomarker; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical
inosine diphosphate	[no description available]	medium	2	0	inosine phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite
cadmium	[no description available]	medium	19	0	cadmium molecular entity; zinc group element atom
calcium pyrophosphate	[no description available]	medium	214	1	calcium phosphate
molnupiravir	[no description available]	medium	1	0	isopropyl ester; ketoxime; nucleoside analogue	anticoronaviral agent; antiviral drug; prodrug
drimane	[no description available]	medium	1	0	sesquiterpene; terpenoid fundamental parent
farnesyl pyrophosphate	[no description available]	medium	44	0	farnesyl diphosphate	Escherichia coli metabolite; mouse metabolite
antrocin	[no description available]	medium	1	0
piperazine	[no description available]	medium	1	0	azacycloalkane; piperazines; saturated organic heteromonocyclic parent	anthelminthic drug
zoledronic acid	[no description available]	medium	13	0	1,1-bis(phosphonic acid); imidazoles	bone density conservation agent
arsenopyrite	[no description available]	medium	1	0
arsenic	[no description available]	medium	28	0	metalloid atom; pnictogen	micronutrient
chloramphenicol	[no description available]	medium	12	0	C-nitro compound; carboxamide; diol; organochlorine compound	antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor
bismuth oxybromide	[no description available]	medium	1	0
technetium tc 99m medronate	[no description available]	medium	44	2
gold	[no description available]	medium	18	0	copper group element atom; elemental gold
sq 109	[no description available]	medium	1	0
citrate phosphate dextrose	[no description available]	medium	1	0
geranyl pyrophosphate	[no description available]	medium	81	0	polyprenyl diphosphate	Escherichia coli metabolite; mouse metabolite
phosphohistidine	[no description available]	medium	1	0
ticagrelor	[no description available]	medium	1	0	aryl sulfide; hydroxyether; organofluorine compound; secondary amino compound; triazolopyrimidines	P2Y12 receptor antagonist; platelet aggregation inhibitor
methylthio-adp	[no description available]	medium	1	0
cubebol	[no description available]	medium	1	0	carbotricyclic compound; sesquiterpenoid; tertiary alcohol
beta-lapachone	[no description available]	medium	1	0	benzochromenone; orthoquinones	anti-inflammatory agent; antineoplastic agent; plant metabolite
naphthoquinones	[no description available]	medium	12	0
platinum	[no description available]	medium	5	0	elemental platinum; nickel group element atom; platinum group metal atom
guanosine	[no description available]	medium	15	0	guanosines; purines D-ribonucleoside	fundamental metabolite
guanosine diphosphate	[no description available]	medium	12	0	guanosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	Escherichia coli metabolite; mouse metabolite; uncoupling protein inhibitor
carbamates	[no description available]	medium	18	0	amino-acid anion
formycin diphosphate	[no description available]	medium	1	0
diazomethane	[no description available]	medium	1	0	diazo compound	alkylating agent; antineoplastic agent; carcinogenic agent; poison
jasmonic acid	[no description available]	medium	1	0	oxo monocarboxylic acid	jasmonates; plant metabolite
coronatine	[no description available]	medium	1	0	N-acyl-amino acid
cyclopentane	[no description available]	medium	5	0	cycloalkane; cyclopentanes; volatile organic compound	non-polar solvent
isoprene	[no description available]	medium	6	0	alkadiene; hemiterpene; volatile organic compound	plant metabolite
ozone	[no description available]	medium	3	0	elemental molecule; gas molecular entity; reactive oxygen species; triatomic oxygen	antiseptic drug; disinfectant; electrophilic reagent; greenhouse gas; mutagen; oxidising agent; tracer
pentane	[no description available]	medium	4	0	alkane; volatile organic compound	non-polar solvent; refrigerant
undecaprenol	[no description available]	medium	1	0	long-chain primary fatty alcohol; undecaprenols
2-(5-bromo-2-pyridylazo)-5-(n-n-propyl-n-3-sulfopropylamino)phenol	[no description available]	medium	1	0
deuterium	[no description available]	medium	10	0	dihydrogen
hydrogen	[no description available]	medium	23	0	elemental hydrogen; elemental molecule; gas molecular entity	antioxidant; electron donor; food packaging gas; fuel; human metabolite
terephthalic acid	[no description available]	medium	1	0	benzenedicarboxylic acid
linalyl pyrophosphate	[no description available]	medium	2	0	monoterpenyl phosphate
chloroprene	[no description available]	medium	3	0	chloroolefin
hydroxide ion	[no description available]	medium	3	0	oxygen hydride	mouse metabolite
stilbenes	[no description available]	medium	42	4	stilbene
oxi 4503	[no description available]	medium	38	4
cellulose	[no description available]	medium	22	1	glycoside
serine	[no description available]	medium	23	0	L-alpha-amino acid; proteinogenic amino acid; serine family amino acid; serine zwitterion; serine	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
levamisole	[no description available]	medium	8	0	6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole	antinematodal drug; antirheumatic drug; EC 3.1.3.1 (alkaline phosphatase) inhibitor; immunological adjuvant; immunomodulator
apyrase	[no description available]	medium	11	0
arl-67156	[no description available]	medium	1	0
phencyclidine	[no description available]	medium	4	0	benzenes; piperidines	anaesthetic; neurotoxin; NMDA receptor antagonist; psychotropic drug
manganese	[no description available]	medium	148	0	elemental manganese; manganese group element atom	Escherichia coli metabolite; micronutrient
zeolites	[no description available]	medium	4	0
dolomite	[no description available]	medium	1	0
ascorbic acid	[no description available]	medium	43	5	ascorbic acid; vitamin C	coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent
formamidine	[no description available]	medium	1	0	carboxamidine; formamidines; one-carbon compound	EC 1.14.13.39 (nitric oxide synthase) inhibitor
tellurium	[no description available]	medium	2	0	chalcogen; metalloid atom
tobramycin	[no description available]	medium	2	0	amino cyclitol glycoside	antibacterial agent; antimicrobial agent; toxin
hydroxyl radical	[no description available]	medium	8	0	oxygen hydride; oxygen radical; reactive oxygen species
pyrimidine	[no description available]	medium	8	0	diazine; pyrimidines	Daphnia magna metabolite
sodium thiosulfate	[no description available]	medium	2	0	inorganic sodium salt	antidote to cyanide poisoning; antifungal drug; nephroprotective agent
cardiovascular agents	[no description available]	medium	2	0
thiosulfates	[no description available]	medium	5	0	divalent inorganic anion; sulfur oxide; sulfur oxoanion	human metabolite
resiquimod	[no description available]	medium	1	0	imidazoquinoline
bromohydrin pyrophosphate	[no description available]	medium	28	1	alkyl diphosphate; organobromine compound	phosphoantigen
iodixanol	[no description available]	medium	3	0	organoiodine compound	radioopaque medium
nsc 600032	[no description available]	medium	3	1
inositol 2-monophosphate	[no description available]	medium	1	0
sodium nitrite	[no description available]	medium	1	0	inorganic sodium salt; nitrite salt	antidote to cyanide poisoning; antihypertensive agent; antimicrobial food preservative; food antioxidant; poison
transferrin	[no description available]	medium	26	3
laccase	[no description available]	medium	3	0
1-palmitoyl-2-oleoylglycero-3-phosphoglycerol	[no description available]	medium	2	0	phosphatidylglycerol
dimethyl sulfoxide	[no description available]	medium	14	0	sulfoxide; volatile organic compound	alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger
uridine diphosphate n-acetylmuramic acid	[no description available]	medium	4	0	UDP-N-acetylmuramate(3-)
1-palmitoyl-2-oleoylphosphatidylethanolamine	[no description available]	medium	2	0	(18R,21S)-24-amino-21-hydroxy-21-oxido-15-oxo-16,20,22-trioxa-21lambdalambda(5)-phosphatetracosan-18-yl icosanoate; phosphatidylethanolamine
farnesal	[no description available]	medium	1	0	farnesal; polyprenal
farnesol	[no description available]	medium	30	0	farnesol	plant metabolite
methanol	[no description available]	medium	20	0	alkyl alcohol; one-carbon compound; primary alcohol; volatile organic compound	amphiprotic solvent; Escherichia coli metabolite; fuel; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
fructose-1-phosphate	[no description available]	medium	2	0	D-fructose 1-phosphate
malic acid	[no description available]	medium	3	0	2-hydroxydicarboxylic acid; C4-dicarboxylic acid	food acidity regulator; fundamental metabolite
urea	[no description available]	medium	48	0	isourea; monocarboxylic acid amide; one-carbon compound	Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
thiamine monophosphate	[no description available]	medium	6	0	organic chloride salt; vitamin B1
combretastatin	[no description available]	medium	4	0
ferrous fumarate	[no description available]	medium	8	6	dicarboxylic acid
antimony	[no description available]	medium	2	0	metalloid atom; pnictogen
fluorine	[no description available]	medium	28	1	diatomic fluorine; gas molecular entity	NMR chemical shift reference compound
caseins	[no description available]	medium	16	0
pantetheine	[no description available]	medium	4	0	pantetheines; thiol	human metabolite; metabolite; mouse metabolite
sodium hydroxide	[no description available]	medium	7	0	alkali metal hydroxide
piperidines	[no description available]	medium	3	0
phosphoenolpyruvate	[no description available]	medium	19	0	carboxyalkyl phosphate; monocarboxylic acid	fundamental metabolite
vitamin b 6	[no description available]	medium	1	0
silver	[no description available]	medium	10	0	copper group element atom; elemental silver	Escherichia coli metabolite
deoxyguanosine	[no description available]	medium	2	0	purine 2'-deoxyribonucleoside; purines 2'-deoxy-D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
deoxyguanosine triphosphate	[no description available]	medium	6	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
s-adenosylmethionine	[no description available]	medium	12	0	organic cation; sulfonium compound	coenzyme; cofactor; human metabolite; micronutrient; Mycoplasma genitalium metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
anthranilic acid	[no description available]	medium	2	0	aminobenzoic acid	human metabolite; mouse metabolite
sodium fluoride	[no description available]	medium	113	43	fluoride salt	mutagen
tetracycline	[no description available]	medium	14	0
beta-glycerophosphoric acid	[no description available]	medium	5	0	glycerol monophosphate	Escherichia coli metabolite; plant metabolite
inositol 3-phosphate	[no description available]	medium	1	0
inositol 1-phosphate	[no description available]	medium	2	0
warfarin	[no description available]	medium	7	0	benzenes; hydroxycoumarin; methyl ketone
citronellol	[no description available]	medium	1	0	monoterpenoid	plant metabolite
geraniol	[no description available]	medium	10	0	3,7-dimethylocta-2,6-dien-1-ol; monoterpenoid; primary alcohol	allergen; fragrance; plant metabolite; volatile oil component
alendronate	[no description available]	medium	3	0	1,1-bis(phosphonic acid); primary amino compound	bone density conservation agent; EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
pamidronate	[no description available]	medium	6	0	phosphonoacetic acid
imidodiphosphonic acid	[no description available]	medium	6	0
etidronate	[no description available]	medium	41	1	1,1-bis(phosphonic acid)	antineoplastic agent; bone density conservation agent; chelator
aluminum	[no description available]	medium	21	0	boron group element atom; elemental aluminium; metal atom
lysophosphatidic acid	[no description available]	medium	12	0	1-acyl-sn-glycerol 3-phosphate
tricalcium phosphate	[no description available]	medium	144	4	calcium phosphate
luminol	[no description available]	medium	3	0
ergosterol	[no description available]	medium	2	0	3beta-hydroxy-Delta(5)-steroid; 3beta-sterol; ergostanoid; phytosterols	fungal metabolite; Saccharomyces cerevisiae metabolite
1,2-dipalmitoylphosphatidylcholine	[no description available]	medium	4	0
bacteriochlorophylls	[no description available]	medium	2	0
manganese dioxide	[no description available]	medium	2	0	manganese molecular entity; metal oxide
inositol 1,4,5-trisphosphate	[no description available]	medium	6	0	myo-inositol trisphosphate	mouse metabolite
inositol 4,5-bisphosphate	[no description available]	medium	1	0	myo-inositol bisphosphate
2,2'-dipicolylamine	[no description available]	medium	7	0
adenosine diphosphate ribose	[no description available]	medium	9	0	ADP-sugar	Escherichia coli metabolite; mouse metabolite
5'-thioadenosine	[no description available]	medium	1	0
phosphatidylinositol 4-phosphate	[no description available]	medium	1	0
2-naphthol	[no description available]	medium	6	0	naphthol	antinematodal drug; genotoxin; human urinary metabolite; human xenobiotic metabolite; mouse metabolite; radical scavenger
tyrosine	[no description available]	medium	35	0	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
sucrose	[no description available]	medium	30	1	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
glycidyl nitrate	[no description available]	medium	6	0
pyridine	[no description available]	medium	8	0	azaarene; mancude organic heteromonocyclic parent; monocyclic heteroarene; pyridines	environmental contaminant; NMR chemical shift reference compound
guanidine	[no description available]	medium	8	0	carboxamidine; guanidines; one-carbon compound
magnesium pyrophosphate	[no description available]	medium	57	0
dipicolinic acid	[no description available]	medium	3	0	pyridinedicarboxylic acid	bacterial metabolite
prenol	[no description available]	medium	2	0	alkenyl alcohol; prenols
oligonucleotides	[no description available]	medium	32	0
europium	[no description available]	medium	5	0	f-block element atom; lanthanoid atom
betulin	[no description available]	medium	1	0	diol; pentacyclic triterpenoid	analgesic; anti-inflammatory agent; antineoplastic agent; antiviral agent; metabolite
ferrous gluconate	[no description available]	medium	2	1
vancomycin	[no description available]	medium	3	0	glycopeptide	antibacterial drug; antimicrobial agent; bacterial metabolite
amorpha-4,11-diene	[no description available]	medium	2	0	octahydronaphthalenes; sesquiterpene
sodium acetate, anhydrous	[no description available]	medium	2	0	organic sodium salt	NMR chemical shift reference compound
trans-2,3',4,5'-tetrahydroxystilbene	[no description available]	medium	1	0	stilbenoid
firefly luciferin	[no description available]	medium	12	0	1,3-thiazolemonocarboxylic acid; benzothiazoles; imidothioate	luciferin
kaolinite	[no description available]	medium	2	0	aluminosilicate mineral; mixture	antidiarrhoeal drug; excipient
niacinamide	[no description available]	medium	18	1	pyridine alkaloid; pyridinecarboxamide; vitamin B3	anti-inflammatory agent; antioxidant; cofactor; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; EC 3.5.1.98 (histone deacetylase) inhibitor; Escherichia coli metabolite; geroprotector; human urinary metabolite; metabolite; mouse metabolite; neuroprotective agent; Saccharomyces cerevisiae metabolite; Sir2 inhibitor
1-anilino-8-naphthalenesulfonate	[no description available]	medium	6	0	aminonaphthalene; naphthalenesulfonic acid	fluorescent probe
n-isopropylacrylamide	[no description available]	medium	1	0
diacetylfluorescein	[no description available]	medium	1	0
erythrosine	[no description available]	medium	6	0
Trp-Trp	[no description available]	medium	1	0	dipeptide	Mycoplasma genitalium metabolite
acridine orange	[no description available]	medium	5	0	aminoacridines; aromatic amine; tertiary amino compound	fluorochrome; histological dye
cobalt	[no description available]	medium	42	0	cobalt group element atom; metal allergen	micronutrient
thrombin aptamer	[no description available]	medium	2	0
trehalose	[no description available]	medium	2	0	trehalose	Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
benzoxazoles	[no description available]	medium	3	0	1,3-benzoxazoles; mancude organic heterobicyclic parent
abscisic acid	[no description available]	medium	7	0	2-trans-abscisic acid
ferric hydroxide	[no description available]	medium	1	0
fructose-6-phosphate	[no description available]	medium	17	0	D-fructose 6-phosphate
fructose 2,6-diphosphate	[no description available]	medium	6	0	D-fructofuranose 2,6-bisphosphate	human metabolite; mouse metabolite
dimethyltin	[no description available]	medium	1	0	organotin compound
threonine	[no description available]	medium	16	0	amino acid zwitterion; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid; threonine	algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
gadolinium	[no description available]	medium	4	0	f-block element atom; lanthanoid atom
vanadates	[no description available]	medium	17	0	trivalent inorganic anion; vanadium oxoanion	EC 3.1.3.1 (alkaline phosphatase) inhibitor; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
alkenes	[no description available]	medium	24	0
metformin	[no description available]	medium	1	0	guanidines	environmental contaminant; geroprotector; hypoglycemic agent; xenobiotic
4,6-dinitro-o-cresol	[no description available]	medium	1	0	dinitrophenol acaricide; hydroxytoluene; nitrotoluene	dinitrophenol insecticide; fungicide; herbicide
sulfathiazole	[no description available]	medium	2	0	1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
fenton's reagent	[no description available]	medium	3	0
glucosamine	[no description available]	medium	15	0	D-glucosamine	Escherichia coli metabolite; geroprotector; mouse metabolite
lipid a	[no description available]	medium	11	0	dodecanoate ester; lipid A; tetradecanoate ester	Escherichia coli metabolite
pyrene	[no description available]	medium	3	0	ortho- and peri-fused polycyclic arene	fluorescent probe; persistent organic pollutant
gibberellins	[no description available]	medium	6	0
gibberellic acid	[no description available]	medium	2	0	C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound	mouse metabolite; plant metabolite
cellobiose	[no description available]	medium	1	0	cellobiose	epitope
glycogen	[no description available]	medium	9	1
salicylaldehyde	[no description available]	medium	2	0	hydroxybenzaldehyde	nematicide; plant metabolite
zingiberene	[no description available]	medium	2	0	cyclohexadiene; sesquiterpene
dihydroxyacetone	[no description available]	medium	2	0	ketotriose; primary alpha-hydroxy ketone	antifungal agent; Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
tetrapotassium pyrophosphate	[no description available]	medium	15	6
inosinic acid	[no description available]	medium	12	0	inosine phosphate; purine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
phosphoserine	[no description available]	medium	5	0	non-proteinogenic alpha-amino acid; O-phosphoamino acid; serine derivative	human metabolite
poloxalene	[no description available]	medium	1	0	epoxide
triclosan	[no description available]	medium	26	13	aromatic ether; dichlorobenzene; monochlorobenzenes; phenols	antibacterial agent; antimalarial; drug allergen; EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor; EC 1.5.1.3 (dihydrofolate reductase) inhibitor; fungicide; persistent organic pollutant; xenobiotic
naphthalene	[no description available]	medium	2	0	naphthalenes; ortho-fused bicyclic arene	apoptosis inhibitor; carcinogenic agent; environmental contaminant; mouse metabolite; plant metabolite; volatile oil component
phosphites	[no description available]	medium	2	0	phosphite ion; trivalent inorganic anion
aristolochene	[no description available]	medium	2	0	aristolochene
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene	[no description available]	medium	2	0	BODIPY compound
tagetitoxin	[no description available]	medium	2	0
lithium chloride	[no description available]	medium	2	0	inorganic chloride; lithium salt	antimanic drug; geroprotector
egtazic acid	[no description available]	medium	12	0	diether; tertiary amino compound; tetracarboxylic acid	chelator
polidocanol	[no description available]	medium	1	0	hydroxypolyether	hepatotoxic agent; nonionic surfactant; sclerotherapy agent
quinoline	[no description available]	medium	1	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; quinolines
flavone acetic acid	[no description available]	medium	1	0
vadimezan	[no description available]	medium	3	0	monocarboxylic acid; xanthones	antineoplastic agent
fosbretabulin	[no description available]	medium	10	1
ac 7700	[no description available]	medium	2	0
zd 6126	[no description available]	medium	3	0
thienopyrimidine	[no description available]	medium	1	0
benzene	[no description available]	medium	2	0	aromatic annulene; benzenes; volatile organic compound	carcinogenic agent; environmental contaminant; non-polar solvent
acetylcysteine	[no description available]	medium	1	1	acetylcysteine; L-cysteine derivative; N-acetyl-L-amino acid	antidote to paracetamol poisoning; antiinfective agent; antioxidant; antiviral drug; ferroptosis inhibitor; geroprotector; human metabolite; mucolytic; radical scavenger; vulnerary
carnosol	[no description available]	medium	1	1	diterpenoid
rutin	[no description available]	medium	1	1	disaccharide derivative; quercetin O-glucoside; rutinoside; tetrahydroxyflavone	antioxidant; metabolite
d-alpha tocopherol	[no description available]	medium	4	1	alpha-tocopherol	algal metabolite; antiatherogenic agent; anticoagulant; antioxidant; antiviral agent; EC 2.7.11.13 (protein kinase C) inhibitor; immunomodulator; micronutrient; nutraceutical; plant metabolite
dimethylhydrazines	[no description available]	medium	2	1
cadmium sulfide	[no description available]	medium	1	0	cadmium molecular entity
cysteamine	[no description available]	medium	1	0	amine; thiol	geroprotector; human metabolite; mouse metabolite; radiation protective agent
calcium phosphate, dibasic, dihydrate	[no description available]	medium	8	0	calcium salt; hydrate
adenosine phosphosulfate	[no description available]	medium	3	0	acyl monophosphate; acyl sulfate; adenosine 5'-phosphate	Escherichia coli metabolite; mouse metabolite
2,3-dimethoxy-1,4-naphthoquinone	[no description available]	medium	1	0	1,4-naphthoquinones
pyrroles	[no description available]	medium	13	0	pyrrole; secondary amine
atorvastatin	[no description available]	medium	1	0	aromatic amide; dihydroxy monocarboxylic acid; monofluorobenzenes; pyrroles; statin (synthetic)	environmental contaminant; xenobiotic
phosphoric acid, trisodium salt	[no description available]	medium	5	0	sodium phosphate
methionine	[no description available]	medium	37	0	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical
deferoxamine	[no description available]	medium	3	0	acyclic desferrioxamine	bacterial metabolite; ferroptosis inhibitor; iron chelator; siderophore
tartaric acid	[no description available]	medium	3	0	tartaric acid	Escherichia coli metabolite
chitosan	[no description available]	medium	6	0
sulfites	[no description available]	medium	14	0	divalent inorganic anion; sulfur oxide; sulfur oxoanion
xanthenes	[no description available]	medium	1	0	xanthene
cyclic adp-ribose	[no description available]	medium	3	0	cyclic purine nucleotide; nucleotide-sugar	metabolite; ryanodine receptor agonist
citrulline	[no description available]	medium	3	0	amino acid zwitterion; citrulline	Daphnia magna metabolite; EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; protective agent; Saccharomyces cerevisiae metabolite
ws 9659 a	[no description available]	medium	1	0
titanium	[no description available]	medium	2	0	titanium group element atom
titanium dioxide	[no description available]	medium	1	0	titanium oxides	food colouring
calcium bicarbonate	[no description available]	medium	1	0
anthracene	[no description available]	medium	3	0	acene; anthracenes; ortho-fused tricyclic hydrocarbon
asparagine	[no description available]	medium	9	0	amino acid zwitterion; asparagine; aspartate family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite
thulium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
sabinene	[no description available]	medium	3	0	thujene	plant metabolite
ovalbumin	[no description available]	medium	2	0
cadmium telluride	[no description available]	medium	1	0
citral	[no description available]	medium	1	0	enal; monoterpenoid; polyprenal	plant metabolite; volatile oil component
alpha-linolenic acid	[no description available]	medium	1	0	linolenic acid; omega-3 fatty acid	micronutrient; mouse metabolite; nutraceutical
perillaldehyde	[no description available]	medium	2	0	aldehyde; olefinic compound	human metabolite; mouse metabolite; volatile oil component
deoxycytidine	[no description available]	medium	3	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
choline	[no description available]	medium	12	0	cholines	allergen; Daphnia magna metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter; nutrient; plant metabolite; Saccharomyces cerevisiae metabolite
calyculin a	[no description available]	medium	2	0
oxazoles	[no description available]	medium	5	0	1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
dapi	[no description available]	medium	1	0	indoles	fluorochrome
glycine	[no description available]	medium	37	0	alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid	EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical
2'-deoxycytidine 5'-triphosphate	[no description available]	medium	7	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
hydrazine	[no description available]	medium	3	0	azane; hydrazines	EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
salicyl hydrazide	[no description available]	medium	1	0
palmitic acid	[no description available]	medium	2	0	long-chain fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor; plant metabolite
D-fructopyranose	[no description available]	medium	34	1	cyclic hemiketal; D-fructose; fructopyranose	sweetening agent
fructooligosaccharide	[no description available]	medium	1	0	oligosaccharide
2',3'-dideoxyuridine	[no description available]	medium	1	0	pyrimidine 2',3'-dideoxyribonucleoside
2',3'-didehydro-2',3'-dideoxyuridine	[no description available]	medium	1	0
6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione	[no description available]	medium	1	0	phthalazines
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid	[no description available]	medium	2	0
calcitriol	[no description available]	medium	2	0	D3 vitamins; hydroxycalciol; triol	antineoplastic agent; antipsoriatic; bone density conservation agent; calcium channel agonist; calcium channel modulator; hormone; human metabolite; immunomodulator; metabolite; mouse metabolite; nutraceutical
xylitol	[no description available]	medium	10	5
sorbitol	[no description available]	medium	5	1	glucitol	cathartic; Escherichia coli metabolite; food humectant; human metabolite; laxative; metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite; sweetening agent
sodium dodecyl sulfate	[no description available]	medium	24	0	organic sodium salt	detergent; protein denaturant
fluorophosphate	[no description available]	medium	21	10	fluorine molecular entity; phosphoric acid derivative
1,8-diazabicyclo(5.4.0)undec-7-ene	[no description available]	medium	1	0
oxathiaphospholane	[no description available]	medium	1	0
glucose-1-phosphate	[no description available]	medium	2	0	D-glucopyranose 1-phosphate
calyculin c	[no description available]	medium	1	0
lactic acid	[no description available]	medium	11	0	2-hydroxy monocarboxylic acid	algal metabolite; Daphnia magna metabolite
nitrogen dioxide	[no description available]	medium	1	0	nitrogen oxide
daptomycin	[no description available]	medium	1	0
beta-lactams	[no description available]	medium	1	0	beta-lactam antibiotic allergen; beta-lactam
ruthenium	[no description available]	medium	2	0	iron group element atom; platinum group metal atom
oxaloacetic acid	[no description available]	medium	2	0	C4-dicarboxylic acid; oxo dicarboxylic acid	geroprotector; metabolite
bismuth	[no description available]	medium	1	0	metal atom; pnictogen
potassium phosphate	[no description available]	medium	4	0	inorganic phosphate salt; inorganic potassium salt
hyaluronoglucosaminidase	[no description available]	medium	2	0
guanine	[no description available]	medium	32	0	2-aminopurines; oxopurine; purine nucleobase	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
8-hydroxy-2'-deoxyguanosine	[no description available]	medium	1	0	guanosines	biomarker
8-oxo-7,8-dihydrodeoxyguanine	[no description available]	medium	1	0
fluorexon	[no description available]	medium	2	0	xanthene dye	fluorochrome
berberine	[no description available]	medium	1	0	alkaloid antibiotic; berberine alkaloid; botanical anti-fungal agent; organic heteropentacyclic compound	antilipemic drug; antineoplastic agent; antioxidant; EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor; EC 1.1.1.21 (aldehyde reductase) inhibitor; EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor; EC 1.21.3.3 (reticuline oxidase) inhibitor; EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.11.10 (IkappaB kinase) inhibitor; EC 3.1.1.4 (phospholipase A2) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor; EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; geroprotector; hypoglycemic agent; metabolite; potassium channel blocker
sybr green i	[no description available]	medium	2	0	benzothiazolium ion; cyanine dye; quinolines; tertiary amine	fluorescent dye
trisodium 3-hydroxy-4-((2z)-2-(2-oxo-4-sulfonatonaphthalen-1-ylidene)hydrazinyl)naphthalene-2,7-disulfonate	[no description available]	medium	2	0
phosphorus radioisotopes	[no description available]	medium	109	0
guanosine monophosphate	[no description available]	medium	16	0	guanosine 5'-phosphate; purine ribonucleoside 5'-monophosphate	biomarker; Escherichia coli metabolite; metabolite; mouse metabolite
organophosphonates	[no description available]	medium	65	1	divalent inorganic anion; phosphite ion
elastin	[no description available]	medium	2	0	oligopeptide
alpha-chymotrypsin	[no description available]	medium	8	0
ectoine	[no description available]	medium	1	0	1,4,5,6-tetrahydropyrimidines; carboxamidine; monocarboxylic acid; zwitterion	osmolyte
cereulide	[no description available]	medium	1	0
calpain	[no description available]	medium	1	0
indium	[no description available]	medium	9	0	boron group element atom
gallium	[no description available]	medium	7	0	boron group element atom
glucose, (beta-d)-isomer	[no description available]	medium	2	0	D-glucopyranose	epitope; mouse metabolite
glucagon-like peptide 1	[no description available]	medium	1	0
oritavancin	[no description available]	medium	1	0	disaccharide derivative; glycopeptide; semisynthetic derivative	antibacterial drug; antimicrobial agent
benzofurans	[no description available]	medium	1	0
vorapaxar	[no description available]	medium	1	0	carbamate ester; lactone; naphthofuran; organofluorine compound; pyridines	cardiovascular drug; platelet aggregation inhibitor; protease-activated receptor-1 antagonist
tedizolid phosphate	[no description available]	medium	1	0	carbamate ester; organofluorine compound; oxazolidinone; phosphate monoester; pyridines; tetrazoles	antimicrobial agent; prodrug; protein synthesis inhibitor
tasimelteon	[no description available]	medium	1	0	1-benzofurans; cyclopropanes; monocarboxylic acid amide	melatonin receptor agonist
empagliflozin	[no description available]	medium	1	0	aromatic ether; C-glycosyl compound; monochlorobenzenes; tetrahydrofuryl ether	hypoglycemic agent; sodium-glucose transport protein subtype 2 inhibitor
ferric citrate	[no description available]	medium	4	1	iron chelate	anti-anaemic agent; nutraceutical
2,2'-(hydroxynitrosohydrazono)bis-ethanamine	[no description available]	medium	1	0
cyclic gmp	[no description available]	medium	13	0	3',5'-cyclic purine nucleotide; guanyl ribonucleotide	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
bradykinin	[no description available]	medium	1	0	oligopeptide	human blood serum metabolite; vasodilator agent
labdane	[no description available]	medium	2	0	diterpene; terpenoid fundamental parent
nimorazole	[no description available]	medium	1	0	C-nitro compound; imidazoles
carbogen	[no description available]	medium	1	0
vanadium	[no description available]	medium	8	0	elemental vanadium; vanadium group element atom	micronutrient
sulfadoxine	[no description available]	medium	1	1	pyrimidines; sulfonamide	antibacterial drug; antimalarial
amodiaquine	[no description available]	medium	1	1	aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug
pyrimethamine	[no description available]	medium	1	1	aminopyrimidine; monochlorobenzenes	antimalarial; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor
fanasil, pyrimethamine drug combination	[no description available]	medium	1	1
permanganate	[no description available]	medium	1	0	manganese oxoacid
tocopherols	[no description available]	medium	1	0
phytyl diphosphate	[no description available]	medium	5	0	(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate
phytol	[no description available]	medium	1	0
chlorophyll a	[no description available]	medium	13	0	chlorophyll; methyl ester	cofactor
4-anisidine	[no description available]	medium	1	0	methoxybenzenes; primary amino compound; substituted aniline	genotoxin; reagent
calcium citrate	[no description available]	medium	1	1	organic calcium salt	flavouring agent; food additive; food preservative; nutraceutical
hydroxylamine	[no description available]	medium	3	0	hydroxylamines	algal metabolite; bacterial xenobiotic metabolite; EC 1.1.3.13 (alcohol oxidase) inhibitor; EC 4.2.1.22 (cystathionine beta-synthase) inhibitor; EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor; nitric oxide donor; nucleophilic reagent
siderite	[no description available]	medium	1	0	carbonate mineral; carbonate salt; iron molecular entity; one-carbon compound
ferrihydrite	[no description available]	medium	1	0
isoniazid	[no description available]	medium	2	0	carbohydrazide	antitubercular agent; drug allergen
1,2-diaminobenzene	[no description available]	medium	1	0	phenylenediamine	hydrogen donor
artemisinin	[no description available]	medium	1	0	organic peroxide; sesquiterpene lactone	antimalarial; plant metabolite
chloroquine	[no description available]	medium	4	0	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
perylene	[no description available]	medium	2	0	ortho- and peri-fused polycyclic arene; perylenes
perylenediimide	[no description available]	medium	1	0	dicarboximide; organic heteropolycyclic compound	fluorochrome
vitamin k 1	[no description available]	medium	2	0	phylloquinones; vitamin K	cofactor; human metabolite; plant metabolite
plastoquinone	[no description available]	medium	1	0	plastoquinone
gamma-tocopherol	[no description available]	medium	1	0	tocopherol; vitamin E	algal metabolite; food antioxidant; plant metabolite
potassium chloride	[no description available]	medium	47	0	inorganic chloride; inorganic potassium salt; potassium salt	fertilizer
phenyl acetate	[no description available]	medium	58	0	benzenes; phenyl acetates
cocaine	[no description available]	medium	1	0	benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid	adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic
1,6-diaminohexane	[no description available]	medium	1	0	alkane-alpha,omega-diamine	human xenobiotic metabolite
sodium citrate, anhydrous	[no description available]	medium	8	1	organic sodium salt	anticoagulant; flavouring agent
sodium citrate, anhydrous	[no description available]	medium	8	0	organic sodium salt	anticoagulant; flavouring agent
3-mercaptopropionic acid	[no description available]	medium	1	0	mercaptopropanoic acid	algal metabolite
zirconium	[no description available]	medium	7	0	titanium group element atom
probenecid	[no description available]	medium	5	0	benzoic acids; sulfonamide	uricosuric drug
foscarnet	[no description available]	medium	14	0	carboxylic acid; one-carbon compound; phosphonic acids	antiviral drug; geroprotector; HIV-1 reverse transcriptase inhibitor; sodium-dependent Pi-transporter inhibitor
su 11248	[no description available]	medium	1	0	monocarboxylic acid amide; pyrroles	angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; immunomodulator; neuroprotective agent; vascular endothelial growth factor receptor antagonist
cytidine triphosphate	[no description available]	medium	12	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
4-aminophenylphosphate	[no description available]	medium	2	0
3'-deoxycytidine 5'-triphosphate	[no description available]	medium	2	0
samarium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
perillyl alcohol	[no description available]	medium	1	0	limonene monoterpenoid	plant metabolite; volatile oil component
pyropheophorbide a	[no description available]	medium	1	0
sodium bicarbonate	[no description available]	medium	13	5	one-carbon compound; organic sodium salt	antacid; food anticaking agent
salvinorin a	[no description available]	medium	1	0	organic heterotricyclic compound; organooxygen compound	metabolite; oneirogen
unguisin a	[no description available]	medium	1	0
1-butanol	[no description available]	medium	4	0	alkyl alcohol; primary alcohol; short-chain primary fatty alcohol	human metabolite; mouse metabolite; protic solvent
iron (3+) oxalate	[no description available]	medium	2	1
phytosterols	[no description available]	medium	1	0
colforsin	[no description available]	medium	3	0	acetate ester; cyclic ketone; labdane diterpenoid; organic heterotricyclic compound; tertiary alpha-hydroxy ketone; triol	adenylate cyclase agonist; anti-HIV agent; antihypertensive agent; plant metabolite; platelet aggregation inhibitor; protein kinase A agonist
fibrinogen	[no description available]	medium	7	0	iditol	fungal metabolite
toxopyrimidine	[no description available]	medium	3	0	aminopyrimidine; aromatic primary alcohol	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
aminoimidazole ribotide	[no description available]	medium	1	0	1-(phosphoribosyl)imidazole; aminoimidazole	bacterial metabolite
galactose-6-phosphate	[no description available]	medium	1	0	D-galactose 6-phosphate	metabolite
mannose-6-phosphate	[no description available]	medium	1	0	D-mannopyranose 6-phosphate
amiloride	[no description available]	medium	1	0	aromatic amine; guanidines; organochlorine compound; pyrazines	diuretic; sodium channel blocker
ethylmaleimide	[no description available]	medium	22	0	maleimides	anticoronaviral agent; EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor; EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor; EC 2.7.1.1 (hexokinase) inhibitor
phlorhizin	[no description available]	medium	3	0	aryl beta-D-glucoside; dihydrochalcones; monosaccharide derivative	antioxidant; plant metabolite
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid	[no description available]	medium	5	0
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid	[no description available]	medium	3	0	stilbenoid
zidovudine	[no description available]	medium	19	0	azide; pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
retinol	[no description available]	medium	8	1	retinol; vitamin A	human metabolite; mouse metabolite; plant metabolite
chlorophyllide a	[no description available]	medium	1	0
ammonium sulfate	[no description available]	medium	17	0	ammonium salt; inorganic sulfate salt	fertilizer
niclosamide	[no description available]	medium	1	0	benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide	anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor
copper sulfate	[no description available]	medium	2	0	metal sulfate	emetic; fertilizer; sensitiser
phenolphthalein	[no description available]	medium	1	0	phenols
phenolphthalein diphosphate	[no description available]	medium	1	0
iodine	[no description available]	medium	9	4	diatomic iodine	nutrient
aluminum oxide	[no description available]	medium	5	0
dialuminum magnesium tetraoxide	[no description available]	medium	1	0
2,3,4,6-tetrachlorophenol	[no description available]	medium	1	0	tetrachlorophenol	xenobiotic metabolite
n,n'-ethylenediamine disuccinic acid	[no description available]	medium	1	0
4-chlorophenol	[no description available]	medium	1	0	monochlorophenol
diadenosine triphosphate	[no description available]	medium	1	0	diadenosyl triphosphate	mouse metabolite
brefeldin a	[no description available]	medium	3	0	macrolide antibiotic	Penicillium metabolite
5'-adenylyl (beta,gamma-methylene)diphosphonate	[no description available]	medium	4	0	nucleoside triphosphate analogue
thapsigargin	[no description available]	medium	2	0	butyrate ester; organic heterotricyclic compound; sesquiterpene lactone	calcium channel blocker; EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
beta-ocimene	[no description available]	medium	1	0	beta-ocimene	plant metabolite
sodium selenite	[no description available]	medium	1	0	inorganic sodium salt; selenite salt	nutraceutical
sodium oxide	[no description available]	medium	1	0
potassium oxide	[no description available]	medium	1	0	metal oxide; potassium salt
myrcene	[no description available]	medium	1	0	monoterpene	anabolic agent; anti-inflammatory agent; flavouring agent; fragrance; plant metabolite; volatile oil component
phosphinothricin	[no description available]	medium	1	0	organic anion
tannins	[no description available]	medium	1	0
4-methyl-3-hydroxyanthranilic acid	[no description available]	medium	1	0	aminobenzoic acid; monohydroxybenzoic acid	bacterial metabolite
anthramycin	[no description available]	medium	1	0
alpha phellandrene	[no description available]	medium	1	0	cyclohexadiene; phellandrene	antimicrobial agent; plant metabolite; volatile oil component
dinoprostone	[no description available]	medium	4	0	prostaglandins E	human metabolite; mouse metabolite; oxytocic
dinoprost	[no description available]	medium	2	0	monocarboxylic acid; prostaglandins Falpha	human metabolite; mouse metabolite
isoxazoles	[no description available]	medium	2	0	isoxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
(3-mercaptopropyl)trimethoxysilane	[no description available]	medium	1	0
oseltamivir	[no description available]	medium	1	0	acetamides; amino acid ester; cyclohexenecarboxylate ester; primary amino compound	antiviral drug; EC 3.2.1.18 (exo-alpha-sialidase) inhibitor; environmental contaminant; prodrug; xenobiotic
pantothenic acid	[no description available]	medium	4	1	pantothenic acid; vitamin B5	antidote to curare poisoning; geroprotector; human blood serum metabolite
nickel	[no description available]	medium	8	0	metal allergen; nickel group element atom	epitope; micronutrient
1,7-phenanthroline	[no description available]	medium	18	0	phenanthroline
melatonin	[no description available]	medium	1	0	acetamides; tryptamines	anticonvulsant; central nervous system depressant; geroprotector; hormone; human metabolite; immunological adjuvant; mouse metabolite; radical scavenger
fluorescein	[no description available]	medium	1	0	2-benzofurans; gamma-lactone; organic heteropentacyclic compound; oxaspiro compound; polyphenol; xanthene dye	fluorescent dye; radioopaque medium
pd 98059	[no description available]	medium	1	0	aromatic amine; monomethoxyflavone	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
sb 203580	[no description available]	medium	1	0	imidazoles; monofluorobenzenes; pyridines; sulfoxide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector; Hsp90 inhibitor; neuroprotective agent
coumarin	[no description available]	medium	2	0	coumarins	fluorescent dye; human metabolite; plant metabolite
1-diphosphoinositol pentakisphosphate	[no description available]	medium	3	0
metaphosphoric acid	[no description available]	medium	1	0
3-phosphoglycerate	[no description available]	medium	2	0	monophosphoglyceric acid; tetronic acid derivative	algal metabolite; fundamental metabolite
acetone	[no description available]	medium	11	0	ketone body; methyl ketone; propanones; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; human metabolite; polar aprotic solvent
diisopropylamine	[no description available]	medium	1	0
acetylglucosamine	[no description available]	medium	6	0	N-acetyl-D-glucosamine	epitope
magnesium phosphate (2:3)	[no description available]	medium	3	0	inorganic magnesium salt
hypoxanthine	[no description available]	medium	4	0	nucleobase analogue; oxopurine; purine nucleobase	fundamental metabolite
bisphenol a-glycidyl methacrylate	[no description available]	medium	18	5	diarylmethane
phosphoric acid	[no description available]	medium	7	1	phosphoric acids	algal metabolite; fertilizer; human metabolite; NMR chemical shift reference compound; solvent
nsc 520594	[no description available]	medium	1	0
malachite green	[no description available]	medium	3	0	organic chloride salt	antibacterial agent; antifungal drug; carcinogenic agent; environmental contaminant; fluorochrome; histological dye; teratogenic agent
c.i. 42510	[no description available]	medium	4	0
glutamic acid	[no description available]	medium	4	0	glutamic acid; glutamine family amino acid; L-alpha-amino acid; proteinogenic amino acid	Escherichia coli metabolite; ferroptosis inducer; micronutrient; mouse metabolite; neurotransmitter; nutraceutical
pyridoxal phosphate	[no description available]	medium	16	0	methylpyridines; monohydroxypyridine; pyridinecarbaldehyde; vitamin B6 phosphate	coenzyme; cofactor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
transforming growth factor beta	[no description available]	medium	15	0
thymidine 5'-triphosphate	[no description available]	medium	10	0	pyrimidine 2'-deoxyribonucleoside 5'-triphosphate; thymidine phosphate	Escherichia coli metabolite; mouse metabolite
cyclen	[no description available]	medium	3	0	azacycloalkane; crown amine; saturated organic heteromonocyclic parent
orotidine	[no description available]	medium	2	0	nucleoside; pyrimidinemonocarboxylic acid; uridines	bacterial metabolite; fungal metabolite; plant metabolite
propadiene	[no description available]	medium	1	0	allenes
indolepropanol phosphate	[no description available]	medium	1	0	indoles; monoalkyl phosphate
rhodamine b	[no description available]	medium	1	0	organic chloride salt; xanthene dye	fluorescent probe; fluorochrome; histological dye
difructose anhydride iii	[no description available]	medium	1	1	sugar dianhydride
lithium	[no description available]	medium	13	0	alkali metal atom
octane	[no description available]	medium	1	0	alkane	xenobiotic
suramin	[no description available]	medium	1	0	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
beta-pinene	[no description available]	medium	1	0	pinene	plant metabolite
alpha-pinene	[no description available]	medium	1	0	pinene	plant metabolite
camphene	[no description available]	medium	1	0	carbobicyclic compound; monoterpene	fragrance; plant metabolite
bornyl pyrophosphate	[no description available]	medium	1	0	bornane monoterpenoid; monoterpenyl phosphate
flavin-adenine dinucleotide	[no description available]	medium	16	0	flavin adenine dinucleotide; vitamin B2	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; prosthetic group
flavin mononucleotide	[no description available]	medium	9	0
deuterium oxide	[no description available]	medium	1	0	deuterated compound; water	NMR solvent
gsk 1363089	[no description available]	medium	1	1	aromatic ether
dipyrromethene	[no description available]	medium	1	0	dipyrrins
boron	[no description available]	medium	1	0	boron group element atom; metalloid atom; nonmetal atom	micronutrient
porphobilinogen	[no description available]	medium	1	0	aralkylamino compound; dicarboxylic acid; pyrroles	Escherichia coli metabolite; metabolite; mouse metabolite
2-methylbutanoic acid	[no description available]	medium	1	0	methylbutyric acid	bacterial metabolite; human metabolite
2-methylvaleric acid	[no description available]	medium	1	0	branched-chain saturated fatty acid; methyl-branched fatty acid; monocarboxylic acid; short-chain fatty acid	flavouring agent; fragrance; plant metabolite
acetic acid	[no description available]	medium	4	0	monocarboxylic acid	antimicrobial food preservative; Daphnia magna metabolite; food acidity regulator; protic solvent
fructose-1,6-diphosphate	[no description available]	medium	16	0
sedoheptulose 7-phosphate	[no description available]	medium	1	0	ketoheptose phosphate; sedoheptulose derivative	Escherichia coli metabolite; human metabolite; mouse metabolite
glycylglycine	[no description available]	medium	1	0	dipeptide zwitterion; dipeptide	human metabolite
hypocrellin a	[no description available]	medium	1	0
phenol	[no description available]	medium	3	0	phenols	antiseptic drug; disinfectant; human xenobiotic metabolite; mouse metabolite
3-nitrotyrosine	[no description available]	medium	1	0	2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid
cyclohexyl methylphosphonofluoridate	[no description available]	medium	1	0
soman	[no description available]	medium	1	0	phosphonic ester
sarin	[no description available]	medium	3	0	fluorine molecular entity; phosphinic ester
eosine yellowish-(ys)	[no description available]	medium	1	0	organic sodium salt; organobromine compound	fluorochrome; histological dye
orotic acid	[no description available]	medium	23	0	pyrimidinemonocarboxylic acid	Escherichia coli metabolite; metabolite; mouse metabolite
imidazole	[no description available]	medium	4	0	imidazole
2,2'-dipyridyl	[no description available]	medium	5	0	bipyridine	chelator; ferroptosis inhibitor
1,10-phenanthroline	[no description available]	medium	2	0	phenanthroline	EC 2.7.1.1 (hexokinase) inhibitor; EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
methioninyl adenylate	[no description available]	medium	2	0
adenosine 5'-tetraphosphate	[no description available]	medium	1	0	adenosine 5'-phosphate; purine ribonucleoside 5'-tetraphosphate
zinc chloride	[no description available]	medium	7	4	inorganic chloride; zinc molecular entity	astringent; disinfectant; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; Lewis acid
nevirapine	[no description available]	medium	3	0	cyclopropanes; dipyridodiazepine	antiviral drug; HIV-1 reverse transcriptase inhibitor
pentetic acid	[no description available]	medium	22	0	pentacarboxylic acid	copper chelator
gamma-cyclodextrin	[no description available]	medium	1	0	cyclodextrin
palladium	[no description available]	medium	2	0	metal allergen; nickel group element atom; platinum group metal atom
naphthalimides	[no description available]	medium	3	0
bis(2-pyridyl)methylamine	[no description available]	medium	1	0
soblidotin	[no description available]	medium	1	0	tetrapeptide	antineoplastic agent; apoptosis inducer; microtubule-destabilising agent
sq-23377	[no description available]	medium	2	1	cyclic ether; enol; polyunsaturated fatty acid; very long-chain fatty acid	calcium ionophore; metabolite
sodium lactate	[no description available]	medium	2	0	lactate salt; organic sodium salt	food acidity regulator; food preservative
fluorodeoxyglucose f18	[no description available]	medium	1	0	2-deoxy-2-((18)F)fluoro-D-glucose; 2-deoxy-2-fluoro-aldehydo-D-glucose
calcium oxalate	[no description available]	medium	43	0	organic calcium salt
nicotinamide mononucleotide	[no description available]	medium	6	0	nicotinamide mononucleotide	Escherichia coli metabolite; mouse metabolite
clofarabine	[no description available]	medium	1	0	adenosines; organofluorine compound	antimetabolite; antineoplastic agent
farnesylacetic acid	[no description available]	medium	1	0
2-keto-3-deoxyoctonate	[no description available]	medium	1	0
silicon	[no description available]	medium	5	0	carbon group element atom; metalloid atom; nonmetal atom
catechol	[no description available]	medium	2	0	catechols	allelochemical; genotoxin; plant metabolite
lamivudine	[no description available]	medium	5	0	monothioacetal; nucleoside analogue; oxacycle; primary alcohol	allergen; anti-HBV agent; antiviral drug; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor; HIV-1 reverse transcriptase inhibitor; prodrug
selenium	[no description available]	medium	11	0	chalcogen; nonmetal atom	micronutrient
pyromorphite	[no description available]	medium	1	0
calcium lactate	[no description available]	medium	1	1
5-carboxytetramethylrhodamine succinimidyl ester	[no description available]	medium	1	0
methyl jasmonate	[no description available]	medium	2	0
2,6-bis(benzimidazol-2-yl)pyridine	[no description available]	medium	1	0	benzimidazoles
kainic acid	[no description available]	medium	1	0	dicarboxylic acid; L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid	antinematodal drug; excitatory amino acid agonist
domoic acid	[no description available]	medium	1	0	L-proline derivative; non-proteinogenic L-alpha-amino acid; pyrrolidinecarboxylic acid; tricarboxylic acid	algal metabolite; hapten; marine metabolite; neuromuscular agent; neurotoxin
furaldehyde	[no description available]	medium	1	0	aldehyde; furans	Maillard reaction product; metabolite
xylose	[no description available]	medium	4	0	D-xylose
thiazolyl blue	[no description available]	medium	1	0	organic bromide salt	colorimetric reagent; dye
thiazoles	[no description available]	medium	14	0	1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
benzoxazolone	[no description available]	medium	1	0	benzoxazole	allelochemical; phytoalexin
microcystin	[no description available]	medium	1	0	peptide
4-phenylbutyric acid	[no description available]	medium	1	0	monocarboxylic acid	antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor; prodrug
8-hydroxyguanosine	[no description available]	medium	1	0	purine nucleoside
nerolidol	[no description available]	medium	1	0	nerolidol
betadex	[no description available]	medium	1	0	cyclodextrin
adenosine 5'-o-(3-thiotriphosphate)	[no description available]	medium	5	0	nucleoside triphosphate analogue
tetrafluoroaluminate	[no description available]	medium	1	0
fluoranthene	[no description available]	medium	1	0	ortho- and peri-fused polycyclic arene
phenanthrene	[no description available]	medium	1	0	ortho-fused polycyclic arene; ortho-fused tricyclic hydrocarbon; phenanthrenes	environmental contaminant; mouse metabolite
phenanthrenes	[no description available]	medium	1	0
propidium	[no description available]	medium	1	0	phenanthridines; quaternary ammonium ion	fluorochrome; intercalator
4-aminobenzoic acid	[no description available]	medium	6	0	aminobenzoic acid; aromatic amino-acid zwitterion	allergen; Escherichia coli metabolite; plant metabolite
sulfamethoxazole	[no description available]	medium	1	0	isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic
propylparaben	[no description available]	medium	1	0	benzoate ester; paraben; phenols	antifungal agent; antimicrobial agent
lutetium	[no description available]	medium	1	0	d-block element atom; lanthanoid atom
acrylic acid	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid	metabolite
oxalates	[no description available]	medium	52	2
adenylyl imidodiphosphate	[no description available]	medium	26	0	adenosine 5'-phosphate
calixarenes	[no description available]	medium	3	0
calix(4)arene	[no description available]	medium	2	0
hepes	[no description available]	medium	1	0	HEPES; organosulfonic acid
verbenone	[no description available]	medium	1	0	carbobicyclic compound; cyclic ketone; enone
2'-deoxyadenosine triphosphate	[no description available]	medium	8	0	2'-deoxyadenosine 5'-phosphate; purine 2'-deoxyribonucleoside 5'-triphosphate	Escherichia coli metabolite; mouse metabolite
brine	[no description available]	medium	1	0
zidovudine triphosphate	[no description available]	medium	5	0
stavudine	[no description available]	medium	2	0	dihydrofuran; nucleoside analogue; organic molecular entity	antimetabolite; antiviral agent; EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
carbamide peroxide	[no description available]	medium	2	0	mixture	disinfectant; oxidising agent; reagent
n-vinyl-2-pyrrolidinone	[no description available]	medium	3	0	pyrrolidin-2-ones
bergaptol	[no description available]	medium	1	0	5-hydroxyfurocoumarin; psoralens
vpc32183	[no description available]	medium	1	0
dioctanoylphosphatidic acid	[no description available]	medium	1	0	1,2-diacyl-sn-glycerol 3-phosphate; octanoate ester
sodium sulfate	[no description available]	medium	2	0	inorganic sodium salt
inosine	[no description available]	medium	10	0	inosines; purines D-ribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
strontium	[no description available]	medium	18	0	alkaline earth metal atom
uridine diphosphate galactose	[no description available]	medium	3	0	UDP-D-galactose	mouse metabolite
isoascorbic acid	[no description available]	medium	1	0	ascorbic acid
phosphonoacetic acid	[no description available]	medium	11	0	monocarboxylic acid; phosphonic acids	antiviral agent; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor
galactose-1-phosphate	[no description available]	medium	1	0	alpha-D-hexose 1-phosphate; D-galactopyranose 1-phosphate	Escherichia coli metabolite; mouse metabolite
1h-tetrazole	[no description available]	medium	1	0	one-carbon compound; tetrazole
uridine diphosphate n-acetylglucosamine	[no description available]	medium	3	0
u 73122	[no description available]	medium	2	0	aromatic ether; aza-steroid; maleimides	EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
dimethylformamide	[no description available]	medium	3	0	formamides; volatile organic compound	geroprotector; hepatotoxic agent; polar aprotic solvent
tetrabutylammonium	[no description available]	medium	1	0	quaternary ammonium ion
silver nitrate	[no description available]	medium	1	0	inorganic nitrate salt; silver salt	astringent
methoxyfenozide	[no description available]	medium	2	1	carbohydrazide; monomethoxybenzene	environmental contaminant; insecticide; xenobiotic
sorbic acid	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid; sorbic acid
riboflavin	[no description available]	medium	7	0	flavin; vitamin B2	anti-inflammatory agent; antioxidant; cofactor; Escherichia coli metabolite; food colouring; fundamental metabolite; human urinary metabolite; mouse metabolite; photosensitizing agent; plant metabolite
l 451167	[no description available]	medium	1	0
2-aminopurine	[no description available]	medium	1	0	2-aminopurines; nucleobase analogue	antimetabolite
mastoparan	[no description available]	medium	3	0	mastoparans; peptidyl amide	antimicrobial agent
(all-e) phytoene	[no description available]	medium	1	0	phytoene	plant metabolite
docosanol	[no description available]	medium	1	0	docosanol; long-chain primary fatty alcohol	antiviral drug; plant metabolite
acyclovir	[no description available]	medium	4	0	2-aminopurines; oxopurine	antimetabolite; antiviral drug
zalcitabine	[no description available]	medium	2	0	pyrimidine 2',3'-dideoxyribonucleoside	antimetabolite; antiviral drug; HIV-1 reverse transcriptase inhibitor
deoxycytidine monophosphate	[no description available]	medium	1	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
thymidine monophosphate	[no description available]	medium	4	0	thymidine 5'-monophosphate	fundamental metabolite
galactose	[no description available]	medium	9	0	D-galactose; galactopyranose	Escherichia coli metabolite; mouse metabolite
4,6-diamino-5-n-formamidopyrimidine	[no description available]	medium	1	0	aminopyrimidine; formamidopyrimidine
4-nitrophenylphosphate	[no description available]	medium	6	0	aryl phosphate	mouse metabolite
nitrophenols	[no description available]	medium	34	0
2'-deoxyguanosine 5'-phosphate	[no description available]	medium	2	0	deoxyguanosine phosphate; guanyl deoxyribonucleotide; purine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; mouse metabolite
8-oxodeoxyguanosine triphosphate	[no description available]	medium	1	0	purine 2'-deoxyribonucleoside 5'-triphosphate	mutagen
8-oxoguanosine 2'-phosphate	[no description available]	medium	1	0
paclitaxel	[no description available]	medium	3	0	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
prisma-fil	[no description available]	medium	1	0
vibriobactin	[no description available]	medium	1	0	1,3-oxazoles; secondary carboxamide	siderophore
taxane	[no description available]	medium	1	0	diterpene; terpenoid fundamental parent
chlormequat	[no description available]	medium	1	0	quaternary ammonium ion	plant growth retardant
mevastatin	[no description available]	medium	1	0	2-pyranones; carboxylic ester; hexahydronaphthalenes; polyketide; statin (naturally occurring)	antifungal agent; apoptosis inducer; EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor; fungal metabolite; Penicillium metabolite
lovastatin	[no description available]	medium	1	0	delta-lactone; fatty acid ester; hexahydronaphthalenes; polyketide; statin (naturally occurring)	anticholesteremic drug; antineoplastic agent; Aspergillus metabolite; prodrug
glyceraldehyde	[no description available]	medium	7	0	aldotriose	fundamental metabolite
malathion	[no description available]	medium	3	0	diester; ethyl ester; organic thiophosphate
2',3'-dideoxyadenosine 5'-phosphate	[no description available]	medium	2	0
3'-azido-3'-deoxythymidine 5'phosphate	[no description available]	medium	3	0
phosphatidylbutanol	[no description available]	medium	1	0
chitotetrose	[no description available]	medium	1	0
deoxyuridine triphosphate	[no description available]	medium	2	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-triphosphate	Arabidopsis thaliana metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite
calcium phosphate, dibasic, anhydrous	[no description available]	medium	22	2	calcium phosphate
calcium phosphate, monobasic, anhydrous	[no description available]	medium	22	2	calcium phosphate	fertilizer
calcium pyrophosphate	[no description available]	medium	22	2
octamethyl pyrophosphoramide	[no description available]	medium	8	0	phosphorodiamide
atropine	[no description available]	medium	23	0
pentaerythritol	[no description available]	medium	1	0	primary alcohol; tetrol	flame retardant; laxative
isopentaquine	[no description available]	medium	1	0
quinine	[no description available]	medium	2	0	cinchona alkaloid	antimalarial; muscle relaxant; non-narcotic analgesic
vitamin k semiquinone radical	[no description available]	medium	15	0
parathion	[no description available]	medium	18	0	C-nitro compound; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite
galactose	[no description available]	medium	12	0
4-butyrolactone	[no description available]	medium	2	0	butan-4-olide	metabolite; neurotoxin
butenolide	[no description available]	medium	1	0	butenolide
allopurinol	[no description available]	medium	26	0	nucleobase analogue; organic heterobicyclic compound	antimetabolite; EC 1.17.3.2 (xanthine oxidase) inhibitor; gout suppressant; radical scavenger
phosphoramide	[no description available]	medium	3	0
pyridostigmine bromide	[no description available]	medium	1	0	pyridinium salt
ribose 1-phosphate	[no description available]	medium	2	0	D-ribose 1-phosphate	Escherichia coli metabolite
sedoheptulose	[no description available]	medium	5	0	ketoheptose
ribulose	[no description available]	medium	6	0	ribulose	Escherichia coli metabolite; human metabolite
glyceric acid	[no description available]	medium	1	0	trionic acid	fundamental metabolite
shikimic acid	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid; cyclohexenecarboxylic acid; hydroxy monocarboxylic acid	Escherichia coli metabolite; plant metabolite; Saccharomyces cerevisiae metabolite
glyceraldehyde 3-phosphate	[no description available]	medium	4	0	glyceraldehyde 3-phosphate	mouse metabolite
monothiopyrophosphoric acid	[no description available]	medium	11	0
tetraethyl pyrophosphate	[no description available]	medium	15	0	organic diphosphate
neostigmine	[no description available]	medium	9	0	quaternary ammonium ion	antidote to curare poisoning; EC 3.1.1.7 (acetylcholinesterase) inhibitor
physostigmine	[no description available]	medium	15	0	carbamate ester; indole alkaloid	antidote to curare poisoning; EC 3.1.1.8 (cholinesterase) inhibitor; miotic
isoflurophate	[no description available]	medium	25	0	dialkyl phosphate
pralidoxime	[no description available]	medium	4	0	pyridinium ion	antidote to organophosphate poisoning; antidote to sarin poisoning; cholinergic drug; cholinesterase reactivator
paraoxon	[no description available]	medium	3	0	aryl dialkyl phosphate; organophosphate insecticide	EC 3.1.1.7 (acetylcholinesterase) inhibitor; mouse metabolite
vitamin b 12	[no description available]	medium	4	0
dipin	[no description available]	medium	1	0
chlorine	[no description available]	medium	5	0	diatomic chlorine; gas molecular entity	bleaching agent
barium	[no description available]	medium	5	0	alkaline earth metal atom; elemental barium
menadiol	[no description available]	medium	9	0	methylnaphthalenes; naphthalenediols; naphthohydroquinone
quinolinic acid	[no description available]	medium	1	0	pyridinedicarboxylic acid	Escherichia coli metabolite; human metabolite; mouse metabolite; NMDA receptor agonist
methacholine chloride	[no description available]	medium	1	0	quaternary ammonium salt
ribose-5-phosphate	[no description available]	medium	3	0	D-ribose 5-phosphate
3-hydroxyanthranilic acid	[no description available]	medium	1	0	aminobenzoic acid; monohydroxybenzoic acid	human metabolite; mouse metabolite
hexachlorocyclohexane	[no description available]	medium	1	0	chlorocyclohexane
1,1,1-trichloroethane	[no description available]	medium	1	0	chloroethanes	polar solvent
ddt	[no description available]	medium	2	0	benzenoid aromatic compound; chlorophenylethane; monochlorobenzenes; organochlorine insecticide	bridged diphenyl acaricide; carcinogenic agent; endocrine disruptor; persistent organic pollutant
glutaminase	[no description available]	medium	3	0
1-methylpyridinium	[no description available]	medium	1	0	methylpyridines
methanesulfonic acid	[no description available]	medium	1	0	alkanesulfonic acid; one-carbon compound	Escherichia coli metabolite
purine	[no description available]	medium	7	0	purine
kanamycin a	[no description available]	medium	1	0	kanamycins	bacterial metabolite
sodium glutamate	[no description available]	medium	1	0	monosodium glutamate	flavouring agent
azauridine	[no description available]	medium	2	0	N-glycosyl-1,2,4-triazine	antimetabolite; antineoplastic agent; drug metabolite
phosphocreatine	[no description available]	medium	15	1	phosphagen; phosphoamino acid	human metabolite; mouse metabolite
digitoxin	[no description available]	medium	1	0	cardenolide glycoside	EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
diethylstilbestrol	[no description available]	medium	4	0	olefinic compound; polyphenol	antifungal agent; antineoplastic agent; autophagy inducer; calcium channel blocker; carcinogenic agent; EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; endocrine disruptor; xenoestrogen
fosfestrol	[no description available]	medium	2	0	aryl phosphate
oxythiamine	[no description available]	medium	2	0	1,3-thiazolium cation	antimetabolite; vitamin B1 antagonist
hydroxyethylthiamine	[no description available]	medium	1	0
acetaldehyde	[no description available]	medium	6	0	aldehyde	carcinogenic agent; EC 3.5.1.4 (amidase) inhibitor; electron acceptor; Escherichia coli metabolite; human metabolite; mouse metabolite; mutagen; oxidising agent; Saccharomyces cerevisiae metabolite; teratogenic agent
erythrose	[no description available]	medium	2	0	erythrose	plant metabolite
alloxan	[no description available]	medium	1	0	pyrimidone	hyperglycemic agent; metabolite
morin	[no description available]	medium	1	0	7-hydroxyflavonol; pentahydroxyflavone	angiogenesis modulating agent; anti-inflammatory agent; antibacterial agent; antihypertensive agent; antineoplastic agent; antioxidant; EC 5.99.1.2 (DNA topoisomerase) inhibitor; hepatoprotective agent; metabolite; neuroprotective agent
creatine	[no description available]	medium	5	0	glycine derivative; guanidines; zwitterion	geroprotector; human metabolite; mouse metabolite; neuroprotective agent; nutraceutical
mannose	[no description available]	medium	15	0	D-aldohexose; D-mannose; mannopyranose	metabolite
cobinamide	[no description available]	medium	1	0
thioinosine	[no description available]	medium	1	0
mercaptopurine	[no description available]	medium	9	0	aryl thiol; purines; thiocarbonyl compound	anticoronaviral agent; antimetabolite; antineoplastic agent
lycopene	[no description available]	medium	1	0	acyclic carotene	antioxidant; plant metabolite
p-chloromercuribenzoic acid	[no description available]	medium	2	0	chlorine molecular entity; mercuribenzoic acid
dactinomycin	[no description available]	medium	22	0	actinomycin	mutagen
alanylglycine	[no description available]	medium	1	0
pseudouridine	[no description available]	medium	3	0	pseudouridines	fundamental metabolite
2-aminoadipic acid	[no description available]	medium	1	0	amino dicarboxylic acid; dicarboxylic fatty acid; non-proteinogenic alpha-amino acid	Caenorhabditis elegans metabolite; mammalian metabolite
adipic acid	[no description available]	medium	1	0	alpha,omega-dicarboxylic acid; dicarboxylic fatty acid	food acidity regulator; human xenobiotic metabolite
oxyquinoline	[no description available]	medium	4	0	monohydroxyquinoline	antibacterial agent; antifungal agrochemical; antiseptic drug; iron chelator
procaine	[no description available]	medium	3	0	benzoate ester; substituted aniline; tertiary amino compound	central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug
trihexyphenidyl	[no description available]	medium	2	0	amine
tubocurarine	[no description available]	medium	5	0	bisbenzylisoquinoline alkaloid	drug allergen; muscle relaxant; nicotinic antagonist
cortisone	[no description available]	medium	2	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	human metabolite; mouse metabolite
pentylenetetrazole	[no description available]	medium	1	0	organic heterobicyclic compound; organonitrogen heterocyclic compound
gallamine triethiodide	[no description available]	medium	1	0
chloralose	[no description available]	medium	1	0
bemegride	[no description available]	medium	1	0	piperidones
picrotoxin	[no description available]	medium	1	0
nicotine	[no description available]	medium	7	0	3-(1-methylpyrrolidin-2-yl)pyridine	anxiolytic drug; biomarker; immunomodulator; mitogen; neurotoxin; nicotinic acetylcholine receptor agonist; peripheral nervous system drug; phytogenic insecticide; plant metabolite; psychotropic drug; teratogenic agent; xenobiotic
pentobarbital	[no description available]	medium	4	0	barbiturates	GABAA receptor agonist
strychnine	[no description available]	medium	3	0	monoterpenoid indole alkaloid; organic heteroheptacyclic compound	avicide; cholinergic antagonist; glycine receptor antagonist; neurotransmitter agent; rodenticide
erythrulose	[no description available]	medium	1	0	ketotetrose; primary alpha-hydroxy ketone; secondary alpha-hydroxy ketone
stearic acid	[no description available]	medium	1	0	long-chain fatty acid; saturated fatty acid; straight-chain saturated fatty acid	algal metabolite; Daphnia magna metabolite; human metabolite; plant metabolite
linoleic acid	[no description available]	medium	3	0	octadecadienoic acid; omega-6 fatty acid	algal metabolite; Daphnia galeata metabolite; plant metabolite
uric acid	[no description available]	medium	90	1	uric acid	Escherichia coli metabolite; human metabolite; mouse metabolite
formaldehyde	[no description available]	medium	6	0	aldehyde; one-carbon compound	allergen; carcinogenic agent; disinfectant; EC 3.5.1.4 (amidase) inhibitor; environmental contaminant; Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
thromboplastin	[no description available]	medium	1	0
hydroxyproline	[no description available]	medium	21	0	4-hydroxyproline; L-alpha-amino acid zwitterion	human metabolite; mouse metabolite; plant metabolite
proline	[no description available]	medium	24	0	amino acid zwitterion; glutamine family amino acid; L-alpha-amino acid; proline; proteinogenic amino acid	algal metabolite; compatible osmolytes; Escherichia coli metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
diphenyl	[no description available]	medium	1	0	aromatic fungicide; benzenes; biphenyls	antifungal agrochemical; antimicrobial food preservative
dimercaprol	[no description available]	medium	2	0	dithiol; primary alcohol	chelator
folic acid	[no description available]	medium	8	0	folic acids; N-acyl-amino acid	human metabolite; mouse metabolite; nutrient
formic acid	[no description available]	medium	2	0	monocarboxylic acid	antibacterial agent; astringent; metabolite; protic solvent; solvent
palladium chloride	[no description available]	medium	1	0	palladium coordination entity	catalyst
pheniprazine	[no description available]	medium	1	0	amphetamines
iproniazid	[no description available]	medium	1	0	carbohydrazide; pyridines
amphetamine	[no description available]	medium	2	0	primary amine
dextroamphetamine	[no description available]	medium	1	0	1-phenylpropan-2-amine	adrenergic agent; adrenergic uptake inhibitor; dopamine uptake inhibitor; dopaminergic agent; neurotoxin; sympathomimetic agent
hexobarbital	[no description available]	medium	5	0	barbiturates
perphenazine	[no description available]	medium	1	0	N-(2-hydroxyethyl)piperazine; N-alkylpiperazine; organochlorine compound; phenothiazines	antiemetic; dopaminergic antagonist; phenothiazine antipsychotic drug
2'-deoxycytidine diphosphate	[no description available]	medium	1	0	2'-deoxycytidine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-diphosphate	Escherichia coli metabolite; human metabolite; mouse metabolite; Mycoplasma genitalium metabolite
2,4-dinitrophenol	[no description available]	medium	1	0	dinitrophenol	allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor
gramicidin a	[no description available]	medium	4	0
tyrocidine	[no description available]	medium	2	0	homodetic cyclic peptide; macrocycle; peptide antibiotic	antibacterial agent; bacterial metabolite
glutamine	[no description available]	medium	27	0	amino acid zwitterion; glutamine family amino acid; glutamine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid	EC 1.14.13.39 (nitric oxide synthase) inhibitor; Escherichia coli metabolite; human metabolite; metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite
spermine	[no description available]	medium	16	0	polyazaalkane; tetramine	antioxidant; fundamental metabolite; immunosuppressive agent
diiodotyrosine	[no description available]	medium	1	0	diiodotyrosine; L-tyrosine derivative; non-proteinogenic L-alpha-amino acid	human metabolite; mouse metabolite
thyroxine	[no description available]	medium	6	0	2-halophenol; iodophenol; L-phenylalanine derivative; non-proteinogenic L-alpha-amino acid; thyroxine zwitterion; thyroxine	antithyroid drug; human metabolite; mouse metabolite; thyroid hormone
triiodothyronine	[no description available]	medium	3	0	2-halophenol; amino acid zwitterion; iodophenol; iodothyronine	human metabolite; mouse metabolite; thyroid hormone
thyronines	[no description available]	medium	1	0	thyronine
phenylbutazone	[no description available]	medium	5	0	pyrazolidines	antirheumatic drug; EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor; metabolite; non-narcotic analgesic; non-steroidal anti-inflammatory drug; peripheral nervous system drug
uranium	[no description available]	medium	3	0	actinoid atom; f-block element atom; monoatomic uranium
pyridine-2-aldoxime	[no description available]	medium	1	0
thymine	[no description available]	medium	7	0	pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite
3'-deoxyadenosine 5'-triphosphate	[no description available]	medium	1	0	purine ribonucleoside 5'-triphosphate	antifungal agent; antimetabolite; antineoplastic agent; antiviral agent
methylene blue	[no description available]	medium	13	0	organic chloride salt	acid-base indicator; antidepressant; antimalarial; antimicrobial agent; antioxidant; cardioprotective agent; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; EC 4.6.1.2 (guanylate cyclase) inhibitor; fluorochrome; histological dye; neuroprotective agent; physical tracer
1-propanol	[no description available]	medium	3	0	propan-1-ols; short-chain primary fatty alcohol	metabolite; protic solvent
niacin	[no description available]	medium	5	0	pyridine alkaloid; pyridinemonocarboxylic acid; vitamin B3	antidote; antilipemic drug; EC 3.5.1.19 (nicotinamidase) inhibitor; Escherichia coli metabolite; human urinary metabolite; metabolite; mouse metabolite; plant metabolite; vasodilator agent
mercaptoethanol	[no description available]	medium	26	0	alkanethiol; primary alcohol	geroprotector
cobamamide	[no description available]	medium	1	0
trichloroacetic acid	[no description available]	medium	4	0	monocarboxylic acid; organochlorine compound	carcinogenic agent; metabolite; mouse metabolite
cycloheximide	[no description available]	medium	9	0	antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol	anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor
chlortetracycline	[no description available]	medium	2	0
urethane	[no description available]	medium	2	0	carbamate ester	fungal metabolite; mutagen
caffeine	[no description available]	medium	8	0	purine alkaloid; trimethylxanthine	adenosine A2A receptor antagonist; adenosine receptor antagonist; adjuvant; central nervous system stimulant; diuretic; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; environmental contaminant; food additive; fungal metabolite; geroprotector; human blood serum metabolite; mouse metabolite; mutagen; plant metabolite; psychotropic drug; ryanodine receptor agonist; xenobiotic
cytosine	[no description available]	medium	4	0	aminopyrimidine; pyrimidine nucleobase; pyrimidone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
kynurenine	[no description available]	medium	1	0	aromatic ketone; non-proteinogenic alpha-amino acid; substituted aniline	human metabolite
pyridoxine	[no description available]	medium	3	0	hydroxymethylpyridine; methylpyridines; monohydroxypyridine; vitamin B6	cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
pyridoxamine	[no description available]	medium	1	0	aminoalkylpyridine; hydroxymethylpyridine; monohydroxypyridine; vitamin B6	Escherichia coli metabolite; human metabolite; iron chelator; mouse metabolite; nephroprotective agent; plant metabolite; Saccharomyces cerevisiae metabolite
azaguanine	[no description available]	medium	4	0	nucleobase analogue; triazolopyrimidines	antimetabolite; antineoplastic agent; EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
thioguanine anhydrous	[no description available]	medium	1	0	2-aminopurines	anticoronaviral agent; antimetabolite; antineoplastic agent
uridine diphosphate glucose	[no description available]	medium	13	0	UDP-D-glucose	fundamental metabolite
bromine	[no description available]	medium	5	0	diatomic bromine
rifamycin sv	[no description available]	medium	1	0	acetate ester; cyclic ketal; lactam; macrocycle; organic heterotetracyclic compound; polyphenol; rifamycins	antimicrobial agent; antitubercular agent; bacterial metabolite
rifamycins	[no description available]	medium	2	0
meprobamate	[no description available]	medium	2	0	organic molecular entity
carisoprodol	[no description available]	medium	2	0	carbamate ester	muscle relaxant
ouabain	[no description available]	medium	2	0	11alpha-hydroxy steroid; 14beta-hydroxy steroid; 5beta-hydroxy steroid; alpha-L-rhamnoside; cardenolide glycoside; steroid hormone	anti-arrhythmia drug; cardiotonic drug; EC 2.3.3.1 [citrate (Si)-synthase] inhibitor; EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; ion transport inhibitor; plant metabolite
oxytetracycline, anhydrous	[no description available]	medium	2	0
cordycepin	[no description available]	medium	1	0	3'-deoxyribonucleoside; adenosines	antimetabolite; nucleoside antibiotic
azauracil	[no description available]	medium	3	0	1,2,4-triazines; nucleobase analogue	antimetabolite
thioctic acid	[no description available]	medium	4	0	dithiolanes; heterocyclic fatty acid; thia fatty acid	fundamental metabolite; geroprotector
ammonium chloride	[no description available]	medium	14	0	ammonium salt; inorganic chloride	ferroptosis inhibitor
thiophenes	[no description available]	medium	2	0	mancude organic heteromonocyclic parent; monocyclic heteroarene; thiophenes; volatile organic compound	non-polar solvent
cytidine monophosphate	[no description available]	medium	5	0	cytidine 5'-phosphate; pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
demeclocycline	[no description available]	medium	2	0
sulfadiazine	[no description available]	medium	1	0	pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
streptomycin	[no description available]	medium	9	0	antibiotic antifungal drug; antibiotic fungicide; streptomycins	antibacterial drug; antifungal agrochemical; antimicrobial agent; antimicrobial drug; bacterial metabolite; protein synthesis inhibitor
xanthosine	[no description available]	medium	1	0	purines D-ribonucleoside; xanthosines	Escherichia coli metabolite; human metabolite; mouse metabolite
succinylcholine	[no description available]	medium	4	0	quaternary ammonium ion; succinate ester	drug allergen; muscle relaxant; neuromuscular agent
ornithine	[no description available]	medium	10	0	non-proteinogenic L-alpha-amino acid; ornithine	algal metabolite; hepatoprotective agent; mouse metabolite
potassium permanganate	[no description available]	medium	6	0
ipomeamarone	[no description available]	medium	1	0
proadifen	[no description available]	medium	2	0	diarylmethane
beta-ionone	[no description available]	medium	1	0	ionone	antioxidant; fragrance
vitamin d 2	[no description available]	medium	2	0	hydroxy seco-steroid; seco-ergostane; vitamin D	bone density conservation agent; nutraceutical; plant metabolite; rodenticide
diphenhydramine	[no description available]	medium	1	0	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
scopolamine hydrobromide	[no description available]	medium	4	0
ephedrine	[no description available]	medium	1	0	phenethylamine alkaloid; phenylethanolamines	bacterial metabolite; environmental contaminant; nasal decongestant; plant metabolite; sympathomimetic agent; vasoconstrictor agent; xenobiotic
pilocarpine	[no description available]	medium	3	0	pilocarpine	antiglaucoma drug
phenylephrine	[no description available]	medium	3	0	phenols; phenylethanolamines; secondary amino compound	alpha-adrenergic agonist; cardiotonic drug; mydriatic agent; nasal decongestant; protective agent; sympathomimetic agent; vasoconstrictor agent
guanosine diphosphate mannose	[no description available]	medium	4	0	GDP-D-mannose	Escherichia coli metabolite; human metabolite; mouse metabolite; plant metabolite
tromethamine	[no description available]	medium	13	0	primary amino compound; triol	buffer
glucuronic acid	[no description available]	medium	1	0	D-glucuronic acid	algal metabolite
chlorcyclizine	[no description available]	medium	1	0	diarylmethane
methyl chloride	[no description available]	medium	1	0	chloromethanes; methyl halides	marine metabolite; mutagen; refrigerant
reserpine	[no description available]	medium	3	0	alkaloid ester; methyl ester; yohimban alkaloid	adrenergic uptake inhibitor; antihypertensive agent; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; environmental contaminant; first generation antipsychotic; plant metabolite; xenobiotic
phenoxybenzamine	[no description available]	medium	2	0	aromatic amine
4-phenylenediamine	[no description available]	medium	1	0	phenylenediamine	allergen; dye; hapten; reagent
rotenone	[no description available]	medium	2	0	organic heteropentacyclic compound; rotenones	antineoplastic agent; metabolite; mitochondrial NADH:ubiquinone reductase inhibitor; phytogenic insecticide; piscicide; toxin
amobarbital	[no description available]	medium	2	0	barbiturates
antimycin a	[no description available]	medium	14	0	amidobenzoic acid
oligomycins	[no description available]	medium	23	0
rubidium	[no description available]	medium	10	0	alkali metal atom
colchicine	[no description available]	medium	18	0	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
tin	[no description available]	medium	62	1	carbon group element atom; elemental tin; metal atom	micronutrient
isobutyl alcohol	[no description available]	medium	1	0	alkyl alcohol; primary alcohol	Saccharomyces cerevisiae metabolite
carnitine	[no description available]	medium	1	0	amino-acid betaine	human metabolite; mouse metabolite
quinacrine	[no description available]	medium	3	0	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
benzimidazole	[no description available]	medium	1	0	benzimidazole; polycyclic heteroarene
magnesium sulfate	[no description available]	medium	4	0	magnesium salt; metal sulfate; organic magnesium salt	anaesthetic; analgesic; anti-arrhythmia drug; anticonvulsant; calcium channel blocker; cardiovascular drug; fertilizer; tocolytic agent
aminopterin	[no description available]	medium	3	0	dicarboxylic acid	EC 1.5.1.3 (dihydrofolate reductase) inhibitor; mutagen
histamine	[no description available]	medium	2	0	aralkylamino compound; imidazoles	human metabolite; mouse metabolite; neurotransmitter
chalcone	[no description available]	medium	2	0	chalcone	EC 3.2.1.1 (alpha-amylase) inhibitor
sodium azide	[no description available]	medium	2	0	inorganic sodium salt	antibacterial agent; explosive; mitochondrial respiratory-chain inhibitor; mutagen
aminosalicylic acid	[no description available]	medium	1	0	aminobenzoic acid; phenols	antitubercular agent
thiouridine	[no description available]	medium	5	0	nucleoside analogue; thiouridine	affinity label; antimetabolite
hydroquinone	[no description available]	medium	1	0	benzenediol; hydroquinones	antioxidant; carcinogenic agent; cofactor; Escherichia coli metabolite; human xenobiotic metabolite; mouse metabolite; skin lightening agent
gulonic acid	[no description available]	medium	1	0	gulonic acid
provitamin c	[no description available]	medium	1	0	hexose
nitrilotriacetic acid	[no description available]	medium	3	0	NTA; tricarboxylic acid	carcinogenic agent; nephrotoxic agent
n-(hydroxyethyl)ethylenediaminetriacetic acid	[no description available]	medium	1	0
iminodiacetic acid	[no description available]	medium	2	0	amino dicarboxylic acid; glycine derivative; non-proteinogenic alpha-amino acid	chelator
(ethylenedinitrilo)-tetramethylenephosphonic acid	[no description available]	medium	1	0
edda	[no description available]	medium	2	0	amino dicarboxylic acid; ethylenediamine derivative; glycine derivative; polyamino carboxylic acid	bacterial xenobiotic metabolite; chelator
phenylphosphate	[no description available]	medium	1	0	aryl phosphate	mouse metabolite
n(6),n(6)-dimethyladenine	[no description available]	medium	1	1	tertiary amine
sodium bromide	[no description available]	medium	1	0	bromide salt; inorganic sodium salt
haloperidol	[no description available]	medium	1	1	aromatic ketone; hydroxypiperidine; monochlorobenzenes; organofluorine compound; tertiary alcohol	antidyskinesia agent; antiemetic; dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist
methacrylic acid	[no description available]	medium	1	0	alpha,beta-unsaturated monocarboxylic acid
3-(trimethoxysilyl)propyl methacrylate	[no description available]	medium	1	0
glycero-alpha-manno-heptopyranose	[no description available]	medium	2	0	aldoheptose
phosphoramidite	[no description available]	medium	1	0
1,1-diphenyl-2-picrylhydrazyl	[no description available]	medium	1	0
ureidosuccinic acid	[no description available]	medium	1	0	aspartic acid derivative; C4-dicarboxylic acid; N-carbamoyl-amino acid	Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
uridine monophosphate	[no description available]	medium	9	0	pyrimidine ribonucleoside 5'-monophosphate; uridine 5'-phosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
maleic acid	[no description available]	medium	6	2	butenedioic acid	algal metabolite; mouse metabolite; plant metabolite
1-deoxy-d-xylulose 5-phosphate	[no description available]	medium	1	0	xylulose phosphate	Escherichia coli metabolite
6-hydroxymethyl-7,8-dihydropterin	[no description available]	medium	1	0	dihydropterin	Saccharomyces cerevisiae metabolite
ferrous citrate	[no description available]	medium	2	0
mersalyl	[no description available]	medium	1	0
phosphoramidic acid	[no description available]	medium	2	0	phosphoric acid derivative
fura-2	[no description available]	medium	1	0
bafilomycin a1	[no description available]	medium	1	0	cyclic hemiketal; macrolide antibiotic; oxanes	apoptosis inducer; autophagy inhibitor; bacterial metabolite; EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor; EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor; ferroptosis inhibitor; fungicide; potassium ionophore; toxin
nigericin	[no description available]	medium	1	0	polycyclic ether	antibacterial agent; antimicrobial agent; bacterial metabolite; potassium ionophore
digitonin	[no description available]	medium	5	0
pyrrolysine	[no description available]	medium	1	0	amino acid zwitterion; N(6)-acyl-L-lysine; proteinogenic amino acid; pyrrolysine
iodoacetamide	[no description available]	medium	5	0
endothelin-1	[no description available]	medium	1	0
angiotensin i	[no description available]	medium	1	0	angiotensin; peptide zwitterion	human metabolite; neurotransmitter agent
methylmercaptan	[no description available]	medium	1	0	alkanethiol	human metabolite; Saccharomyces cerevisiae metabolite
tetrahydrofuran	[no description available]	medium	1	0	cyclic ether; oxolanes; saturated organic heteromonocyclic parent; volatile organic compound	polar aprotic solvent
molybdenum cofactor	[no description available]	medium	1	0	Mo-molybdopterin cofactor; organophosphate oxoanion
pteridines	[no description available]	medium	6	0	azaarene; mancude organic heterobicyclic parent; ortho-fused heteroarene; pteridines
undecaprenyl pyrophosphate	[no description available]	medium	1	0	all-trans-polyprenyl diphosphate; undecaprenyl diphosphate; undecaprenyl phosphate
tretinoin	[no description available]	medium	2	0	retinoic acid; vitamin A	anti-inflammatory agent; antineoplastic agent; antioxidant; AP-1 antagonist; human metabolite; keratolytic drug; retinoic acid receptor agonist; retinoid X receptor agonist; signalling molecule
alizarin red s	[no description available]	medium	3	0	organic sodium salt; organosulfonate salt	histological dye
thiourea	[no description available]	medium	2	0	one-carbon compound; thioureas; ureas	antioxidant; chromophore
dihydroneopterin triphosphate	[no description available]	medium	1	0	dihydropterin; neopterins; pterin phosphate	Escherichia coli metabolite; mouse metabolite
neopterin	[no description available]	medium	1	0
epidermal growth factor	[no description available]	medium	3	0
3'-(methylanthraniloyl)-2'-deoxy-guanosine diphosphate	[no description available]	medium	1	0
2',3'-o-(2,4,6-trinitrocyclohexadienylidene)guanosine 5'-triphosphate	[no description available]	medium	1	0
wortmannin	[no description available]	medium	1	0	acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound	anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent
menthol	[no description available]	medium	1	0	p-menthane monoterpenoid; secondary alcohol	volatile oil component
carbachol	[no description available]	medium	2	0	ammonium salt; carbamate ester	cardiotonic drug; miotic; muscarinic agonist; nicotinic acetylcholine receptor agonist; non-narcotic analgesic
glycerophosphoinositol 4,5-bisphosphate	[no description available]	medium	2	0
malonic acid	[no description available]	medium	3	0	alpha,omega-dicarboxylic acid	human metabolite
tetradecanoylphorbol acetate	[no description available]	medium	1	0	acetate ester; diester; phorbol ester; tertiary alpha-hydroxy ketone; tetradecanoate ester	antineoplastic agent; apoptosis inducer; carcinogenic agent; mitogen; plant metabolite; protein kinase C agonist; reactive oxygen species generator
sphingosine	[no description available]	medium	3	0	sphing-4-enine	human metabolite; mouse metabolite
sphingosine 1-phosphate	[no description available]	medium	2	0	sphingoid 1-phosphate	mouse metabolite; signalling molecule; sphingosine-1-phosphate receptor agonist; T-cell proliferation inhibitor; vasodilator agent
framycetin	[no description available]	medium	4	0	aminoglycoside	allergen; antibacterial drug; Escherichia coli metabolite
5-methylcytosine	[no description available]	medium	1	0	methylcytosine; pyrimidines	human metabolite
isoguanine	[no description available]	medium	1	0	oxopurine
methylacetylphosphonate	[no description available]	medium	1	0
3-methyl-3,4-epoxybutyl diphosphate	[no description available]	medium	1	0
2,3-diphosphoglycerate	[no description available]	medium	5	0	bisphosphoglyceric acid; tetronic acid derivative	human metabolite
cidofovir anhydrous	[no description available]	medium	1	0	phosphonic acids; pyrimidone	anti-HIV agent; antineoplastic agent; antiviral drug; photosensitizing agent
beta-glucono-1,5-lactone	[no description available]	medium	1	0	aldono-1,5-lactone; gluconolactone	animal metabolite; mouse metabolite
ammonium hydroxide	[no description available]	medium	1	0	inorganic hydroxy compound	food acidity regulator
decaprenyl phosphate	[no description available]	medium	1	0	polyprenol phosphate
arabinose	[no description available]	medium	4	0	L-arabinose	Escherichia coli metabolite; mouse metabolite
arabinofuranose	[no description available]	medium	1	0	L-arabinose
araban	[no description available]	medium	1	0
pitavastatin	[no description available]	medium	1	0	cyclopropanes; dihydroxy monocarboxylic acid; monofluorobenzenes; quinolines; statin (synthetic)	antioxidant
eosine i bluish	[no description available]	medium	1	0	organic sodium salt	fluorescent dye; histological dye
glycerate 1,3-biphosphate	[no description available]	medium	1	0	2,3-bisphosphoglyceric acid; acyl monophosphate	Escherichia coli metabolite; mouse metabolite
phosphorus pentoxide	[no description available]	medium	1	0
carbonyl sulfide	[no description available]	medium	1	0	one-carbon compound; organosulfur compound
ketotifen	[no description available]	medium	1	0	cyclic ketone; olefinic compound; organic heterotricyclic compound; organosulfur heterocyclic compound; piperidines; tertiary amino compound	anti-asthmatic drug; H1-receptor antagonist
acrylamide	[no description available]	medium	2	0	acrylamides; N-acylammonia; primary carboxamide	alkylating agent; carcinogenic agent; Maillard reaction product; mutagen; neurotoxin
spermidine	[no description available]	medium	10	0	polyazaalkane; triamine	autophagy inducer; fundamental metabolite; geroprotector
struvite	[no description available]	medium	2	0	hydrate; phosphate mineral	fertilizer
lutein	[no description available]	medium	2	0	carotenol	food colouring; plant metabolite
felodipine	[no description available]	medium	1	0	dichlorobenzene; dihydropyridine; ethyl ester; methyl ester	anti-arrhythmia drug; antihypertensive agent; calcium channel blocker; vasodilator agent
nifedipine	[no description available]	medium	1	0	C-nitro compound; dihydropyridine; methyl ester	calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent
methylcellulose	[no description available]	medium	1	0
olivine	[no description available]	medium	1	0
ferric phosphate	[no description available]	medium	1	0	inorganic phosphate salt; inorganic phosphate; iron molecular entity
ferrous phosphate	[no description available]	medium	1	0
fluspirilene	[no description available]	medium	1	0	diarylmethane
pimozide	[no description available]	medium	2	0	benzimidazoles; heteroarylpiperidine; organofluorine compound	antidyskinesia agent; dopaminergic antagonist; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist
glutaral	[no description available]	medium	3	1	dialdehyde	cross-linking reagent; disinfectant; fixative
gluma	[no description available]	medium	1	1
coenzyme q10	[no description available]	medium	1	0	ubiquinones	antioxidant; ferroptosis inhibitor; human metabolite
solanesyl pyrophosphate	[no description available]	medium	2	0	all-trans-polyprenyl diphosphate; nonaprenyl diphosphate
ubiquinone 9	[no description available]	medium	1	0	ubiquinones	antioxidant; human metabolite
isoprocarb	[no description available]	medium	1	0	carbamate ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
bpmc	[no description available]	medium	1	0	carbamate ester	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; herbicide; insecticide
2-diethylaminoethanol	[no description available]	medium	1	0	ethanolamines; primary alcohol; tertiary amino compound
chlorhexidine	[no description available]	medium	6	4	biguanides; monochlorobenzenes	antibacterial agent; antiinfective agent
4-thiouridine triphosphate	[no description available]	medium	1	0
cystamine	[no description available]	medium	3	0	organic disulfide; primary amino compound	EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor
cadaverine	[no description available]	medium	4	0	alkane-alpha,omega-diamine	Daphnia magna metabolite; Escherichia coli metabolite; mouse metabolite; plant metabolite
monodansylcadaverine	[no description available]	medium	2	0	aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound	EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent
cyanates	[no description available]	medium	4	0
oxazolidin-2-one	[no description available]	medium	1	0	carbamate ester; oxazolidinone	metabolite
acridines	[no description available]	medium	2	0	acridines; mancude organic heterotricyclic parent; polycyclic heteroarene	genotoxin
quinoxalines	[no description available]	medium	1	0	mancude organic heterobicyclic parent; naphthyridine; ortho-fused heteroarene
lanthanum	[no description available]	medium	5	0	f-block element atom; lanthanoid atom; scandium group element atom
gentamicin	[no description available]	medium	3	0
cetyltrimethylammonium ion	[no description available]	medium	1	0	quaternary ammonium ion
trehazolin	[no description available]	medium	1	0
arsenic acid	[no description available]	medium	3	0	arsenic oxoacid	Escherichia coli metabolite
oenothein b	[no description available]	medium	1	0
3-aminobenzamide	[no description available]	medium	1	0	benzamides; substituted aniline	EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
methylnitronitrosoguanidine	[no description available]	medium	2	0	nitroso compound	alkylating agent
osteoprotegerin	[no description available]	medium	2	0	long-chain fatty acid
2'-c-methylcytidine	[no description available]	medium	1	0
2-phosphoglycerate	[no description available]	medium	1	0	monophosphoglyceric acid; tetronic acid derivative
o-ethyl o-4-nitrophenyl phosphoramidate	[no description available]	medium	1	0
sirolimus	[no description available]	medium	1	0	antibiotic antifungal drug; cyclic acetal; cyclic ketone; ether; macrolide lactam; organic heterotricyclic compound; secondary alcohol	antibacterial drug; anticoronaviral agent; antineoplastic agent; bacterial metabolite; geroprotector; immunosuppressive agent; mTOR inhibitor
uridine diphosphate glucuronic acid	[no description available]	medium	1	0	UDP-D-glucuronic acid	Escherichia coli metabolite; human metabolite; mouse metabolite
triphenylphosphine	[no description available]	medium	2	0	benzenes; tertiary phosphine	NMR chemical shift reference compound; reducing agent
glycosides	[no description available]	medium	4	0
ubiquinol	[no description available]	medium	1	0	polyprenylhydroquinone; ubiquinol	biomarker; metabolite
dolichols	[no description available]	medium	6	0	polyterpene
mycothiol	[no description available]	medium	1	0
orotidylic acid	[no description available]	medium	4	0	pyrimidine ribonucleoside 5'-monophosphate	Escherichia coli metabolite; human metabolite; mouse metabolite
subtilin	[no description available]	medium	1	0
lanthionine	[no description available]	medium	1	0	alanine derivative; non-proteinogenic alpha-amino acid; organic sulfide	bacterial metabolite
6-carboxyfluorescein	[no description available]	medium	1	0	monocarboxylic acid
1,2-dioleoyl-sn-glycero-3-phosphoglycerol	[no description available]	medium	1	0	1,2-diacyl-sn-glycero-3-phospho-(1'-sn-glycerol)
4-chloro-7-nitrobenzofurazan	[no description available]	medium	2	0	benzoxadiazole; C-nitro compound; organochlorine compound	EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome
evans blue	[no description available]	medium	1	0	organic sodium salt	fluorochrome; histological dye; sodium channel blocker; teratogenic agent
1-carboxyglutamic acid	[no description available]	medium	1	0
gs-9148	[no description available]	medium	1	0
gs-9131	[no description available]	medium	1	0
sulfanilamide	[no description available]	medium	1	0	substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor
glucose-1,6-bisphosphate	[no description available]	medium	2	0	D-glucose 1,6-bisphosphate	Escherichia coli metabolite; human metabolite
mesoporphyrin ix	[no description available]	medium	1	0
carbon monoxide	[no description available]	medium	3	0	carbon oxide; gas molecular entity; one-carbon compound	biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent
2,4,6-tripyridyl-s-triazine	[no description available]	medium	1	0
potassium sulfate	[no description available]	medium	2	0	inorganic potassium salt; potassium salt
cacodylic acid	[no description available]	medium	1	0	organoarsenic compound	xenobiotic metabolite
hexylresorcinol	[no description available]	medium	1	0	resorcinols
2'-deoxyadenosine 5'-o-(1-thiotriphosphate)	[no description available]	medium	2	0
succimer	[no description available]	medium	3	0	dicarboxylic acid; dithiol; sulfur-containing carboxylic acid	chelator
technetium tc 99m pentetate	[no description available]	medium	9	0
technetium tc 99m lidofenin	[no description available]	medium	1	0
technetium tc 99m dimercaptosuccinic acid	[no description available]	medium	2	0
strontium radioisotopes	[no description available]	medium	36	0
hydroxyurea	[no description available]	medium	2	0	one-carbon compound; ureas	antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent
fluorouracil	[no description available]	medium	4	0	nucleobase analogue; organofluorine compound	antimetabolite; antineoplastic agent; environmental contaminant; immunosuppressive agent; radiosensitizing agent; xenobiotic
thallium	[no description available]	medium	101	0	boron group element atom
triamcinolone acetonide	[no description available]	medium	5	1	11beta-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; cyclic ketal; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone	anti-allergic agent; anti-inflammatory drug
diatrizoate meglumine	[no description available]	medium	4	0	monocarboxylic acid anion	radioopaque medium
scandium	[no description available]	medium	1	0	d-block element atom; rare earth metal atom; scandium group element atom
urografin 76	[no description available]	medium	2	0
diatrizoic acid	[no description available]	medium	3	0	acetamides; benzoic acids; organoiodine compound	environmental contaminant; radioopaque medium; xenobiotic
furosemide	[no description available]	medium	3	0	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
iodohippuric acid	[no description available]	medium	2	0	benzamides; N-acylglycine; organoiodine compound
carbonyl cyanide m-chlorophenyl hydrazone	[no description available]	medium	2	0	hydrazone; monochlorobenzenes; nitrile	antibacterial agent; geroprotector; ionophore
isosorbide dinitrate	[no description available]	medium	1	0	glucitol derivative; nitrate ester	nitric oxide donor; vasodilator agent
nitroglycerin	[no description available]	medium	3	0	nitroglycerol	explosive; muscle relaxant; nitric oxide donor; prodrug; tocolytic agent; vasodilator agent; xenobiotic
pyridoxal(5')diphospho(1)-glucose	[no description available]	medium	1	0
1-deoxygluco-heptulose 2-phosphate	[no description available]	medium	1	0
dobutamine	[no description available]	medium	1	0	catecholamine; secondary amine	beta-adrenergic agonist; cardiotonic drug; sympathomimetic agent
phenylphosphonic acid	[no description available]	medium	4	0	benzenes
bromodeoxyuridine	[no description available]	medium	1	0	pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent
idoxuridine	[no description available]	medium	2	0	organoiodine compound; pyrimidine 2'-deoxyribonucleoside	antiviral drug; DNA synthesis inhibitor
brivudine	[no description available]	medium	1	0
sodium pertechnetate tc 99m	[no description available]	medium	31	0
butylscopolammonium bromide	[no description available]	medium	1	0
alpha,beta-methyleneadenosine 5'-triphosphate	[no description available]	medium	3	0	nucleoside triphosphate analogue
potassium nitrate	[no description available]	medium	7	3	inorganic nitrate salt; potassium salt	fertilizer
triamcinolone hexacetonide	[no description available]	medium	1	1	corticosteroid hormone
yttrium radioisotopes	[no description available]	medium	1	1
dithiothreitol	[no description available]	medium	16	0	1,4-dimercaptobutane-2,3-diol; butanediols; dithiol; glycol; thiol	chelator; human metabolite; reducing agent
dicyclohexylcarbodiimide	[no description available]	medium	6	0	carbodiimide	ATP synthase inhibitor; cross-linking reagent; peptide coupling reagent
phosphorylethanolamine	[no description available]	medium	7	0	phosphoethanolamine; primary amino compound	algal metabolite; human metabolite; mouse metabolite
nalidixic acid	[no description available]	medium	1	0	1,8-naphthyridine derivative; monocarboxylic acid; quinolone antibiotic	antibacterial drug; antimicrobial agent; DNA synthesis inhibitor
chondroitin sulfates	[no description available]	medium	14	0
3-hydroxy-3-methylglutaryl-coenzyme a	[no description available]	medium	1	0	3-hydroxy-3-methylglutaryl-CoA; 3-hydroxy fatty acyl-CoA	human metabolite; mouse metabolite
meglutol	[no description available]	medium	1	0	3-hydroxy carboxylic acid; dicarboxylic acid; tertiary alcohol	anticholesteremic drug; antimetabolite; EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor; human metabolite; plant metabolite
captan	[no description available]	medium	1	0	isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide	antifungal agrochemical
4-nitroquinoline-1-oxide	[no description available]	medium	1	0	C-nitro compound; quinoline N-oxide	carcinogenic agent
hydroxyacetylaminofluorene	[no description available]	medium	1	0	2-acetamidofluorenes
dicumarol	[no description available]	medium	2	0	hydroxycoumarin	anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor; Hsp90 inhibitor; vitamin K antagonist
selenaproline	[no description available]	medium	1	0
chondroitin	[no description available]	medium	6	0
technetium tc 99m hydroxymethylene diphosphonate	[no description available]	medium	6	0
technetium tc 99m gluceptate	[no description available]	medium	2	0
xenon radioisotopes	[no description available]	medium	8	0
technetium tc 99m etidronate	[no description available]	medium	7	0
tetramethylammonium	[no description available]	medium	1	0	quaternary ammonium ion
thallium chloride	[no description available]	medium	11	0	inorganic chloride; thallium molecular entity
krypton	[no description available]	medium	3	0	monoatomic krypton; noble gas atom; p-block element atom
hymecromone	[no description available]	medium	1	0	hydroxycoumarin	antineoplastic agent; hyaluronic acid synthesis inhibitor
mupirocin	[no description available]	medium	1	0	alpha,beta-unsaturated carboxylic ester; epoxide; monocarboxylic acid; oxanes; secondary alcohol; triol	antibacterial drug; bacterial metabolite; protein synthesis inhibitor
estramustine	[no description available]	medium	1	0	17beta-hydroxy steroid; carbamate ester; organochlorine compound	alkylating agent; antineoplastic agent; radiation protective agent
technetium tc 99m sulfur colloid	[no description available]	medium	6	0
2,5-dihydroxybenzoic acid	[no description available]	medium	1	0	dihydroxybenzoic acid	EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; fungal metabolite; human metabolite; MALDI matrix material; mouse metabolite
technetium tc 99m diphosphonate	[no description available]	medium	15	1
tryptophyl adenylate	[no description available]	medium	1	0	adenosine 5'-phosphate; alpha-amino acid ester; L-tryptophan derivative; purine ribonucleoside 5'-monophosphate	Mycoplasma genitalium metabolite
desoxycorticosterone	[no description available]	medium	1	0	20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; mineralocorticoid; primary alpha-hydroxy ketone	human metabolite; mouse metabolite
cholecalciferol	[no description available]	medium	7	0	D3 vitamins; hydroxy seco-steroid; seco-cholestane; secondary alcohol; steroid hormone	geroprotector; human metabolite
dipyridamole	[no description available]	medium	3	0	piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol	adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent
verapamil	[no description available]	medium	1	0	aromatic ether; nitrile; polyether; tertiary amino compound
bathophenanthroline disulfonic acid	[no description available]	medium	2	0
bathophenanthroline	[no description available]	medium	1	0	benzenes; phenanthrolines	chelator
iron(iii)-deuteroporphyrin	[no description available]	medium	1	0
paraquat	[no description available]	medium	2	0	organic cation	geroprotector; herbicide
carbon tetrachloride	[no description available]	medium	3	0	chlorocarbon; chloromethanes	hepatotoxic agent; refrigerant
cumene hydroperoxide	[no description available]	medium	2	0	peroxol	environmental contaminant; Mycoplasma genitalium metabolite; oxidising agent
cytochalasin b	[no description available]	medium	4	0	cytochalasin; lactam; lactone; organic heterotricyclic compound	actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor
monoammonium molybdate	[no description available]	medium	2	0	ammonium salt	poison
potassium fluoride	[no description available]	medium	2	0	fluoride salt; potassium salt	NMR chemical shift reference compound; poison
dihydrotachysterol	[no description available]	medium	3	1
oxalic acid	[no description available]	medium	5	0	alpha,omega-dicarboxylic acid	algal metabolite; human metabolite; plant metabolite
carbonyl cyanide p-trifluoromethoxyphenylhydrazone	[no description available]	medium	5	0	aromatic ether; hydrazone; nitrile; organofluorine compound	ATP synthase inhibitor; geroprotector; ionophore
flavin semiquinone	[no description available]	medium	1	0
technetium tc 99m gluconate	[no description available]	medium	7	0
daunorubicin	[no description available]	medium	4	0	aminoglycoside antibiotic; anthracycline; p-quinones; tetracenequinones	antineoplastic agent; bacterial metabolite
formycins	[no description available]	medium	1	0
formycin triphosphate	[no description available]	medium	1	0
enterobactin	[no description available]	medium	4	0	catechols; crown compound; macrotriolide; polyphenol	bacterial metabolite; siderophore
aerobactin	[no description available]	medium	1	0	L-lysine derivative	Escherichia coli metabolite; siderophore; virulence factor
tyloxapol	[no description available]	medium	1	0
methylene chloride	[no description available]	medium	2	0	chloromethanes; volatile organic compound	carcinogenic agent; polar aprotic solvent; refrigerant
clodronic acid	[no description available]	medium	4	0	1,1-bis(phosphonic acid); one-carbon compound; organochlorine compound	antineoplastic agent; bone density conservation agent
agmatine	[no description available]	medium	1	0	guanidines; primary amino compound	Escherichia coli metabolite; mouse metabolite
triphenyltetrazolium	[no description available]	medium	3	0	organic cation
heliomycin	[no description available]	medium	1	0
diadenosine tetraphosphate	[no description available]	medium	6	0	diadenosyl tetraphosphate	Escherichia coli metabolite; mouse metabolite
peracetic acid	[no description available]	medium	2	0	a peroxy acid	disinfectant; oxidising agent
persteril	[no description available]	medium	1	0
deoxyglucose	[no description available]	medium	5	0
n-sulfo-2-aminotricarballylate	[no description available]	medium	1	0
phosphocitrate	[no description available]	medium	2	0
adenosine diphosphate glucose	[no description available]	medium	4	0	NDP-alpha-D-glucose(2-); ribonucleoside 5'-diphosphate-alpha-D-glucose(2-)	human metabolite
hippuric acid	[no description available]	medium	1	0	N-acylglycine	human blood serum metabolite; uremic toxin
adosterol	[no description available]	medium	1	0
lysine hydroxamate	[no description available]	medium	1	0
dibromothymoquinone	[no description available]	medium	1	0	1,4-benzoquinones	cytochrome-b6f complex inhibitor
technetium tc 99m n-(methylamino)methylene diphosphonate	[no description available]	medium	1	0
tyrosinol	[no description available]	medium	1	0
phosphoryl chloride	[no description available]	medium	1	0	phosphorus coordination entity
chiniofon	[no description available]	medium	1	0
indium oxine	[no description available]	medium	2	0
lysergic acid	[no description available]	medium	1	0
adenosine 5'-phosphoroimidazolide	[no description available]	medium	1	0
bucladesine	[no description available]	medium	3	0	3',5'-cyclic purine nucleotide
calcimycin	[no description available]	medium	4	0	benzoxazole
guanosine 5'-o-(3-thiotriphosphate)	[no description available]	medium	1	0	nucleoside triphosphate analogue
dolichol monophosphate	[no description available]	medium	1	0
dideoxyadenosine	[no description available]	medium	1	0	adenosines; purine 2',3'-dideoxyribonucleoside	EC 3.5.4.4 (adenosine deaminase) inhibitor; EC 4.6.1.1 (adenylate cyclase) inhibitor
1-methyl-3-isobutylxanthine	[no description available]	medium	1	0	3-isobutyl-1-methylxanthine
4-nitrophenyl sulfate	[no description available]	medium	1	0	aryl sulfate; C-nitro compound	human metabolite
tyramine	[no description available]	medium	1	0	monoamine molecular messenger; primary amino compound; tyramines	EC 3.1.1.8 (cholinesterase) inhibitor; Escherichia coli metabolite; human metabolite; mouse metabolite; neurotransmitter
pentachlorophenol	[no description available]	medium	3	0	aromatic fungicide; chlorophenol; organochlorine pesticide; pentachlorobenzenes	human xenobiotic metabolite
4-amino-4-deoxyarabinose	[no description available]	medium	1	0
ethanolamine	[no description available]	medium	1	0	ethanolamines; primary alcohol; primary amine	Escherichia coli metabolite; human metabolite; mouse metabolite
aminoarabinose	[no description available]	medium	1	0
dithionitrobenzoic acid	[no description available]	medium	5	0	nitrobenzoic acid; organic disulfide	indicator
phosphorylcholine	[no description available]	medium	1	0	phosphocholines	allergen; epitope; hapten; human metabolite; mouse metabolite
glycerophosphoethanolamine	[no description available]	medium	1	0	phosphoethanolamine; sn-glycerol 3-phosphates
beryllium	[no description available]	medium	3	0	alkaline earth metal atom; elemental beryllium; metal allergen	adjuvant; carcinogenic agent; epitope
beryllium fluoride	[no description available]	medium	2	0	beryllium molecular entity; fluoride salt
1-(5-isoquinolinesulfonyl)-2-methylpiperazine	[no description available]	medium	1	0	isoquinolines; N-sulfonylpiperazine	EC 2.7.11.13 (protein kinase C) inhibitor
staurosporine	[no description available]	medium	1	0	ammonium ion derivative
ucn 1028 c	[no description available]	medium	1	0
mannitol	[no description available]	medium	7	1	mannitol	allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent
amanitins	[no description available]	medium	3	0
metaperiodate	[no description available]	medium	15	0	iodine oxoacid
metaperiodate	[no description available]	medium	1	0	iodine oxoanion; monovalent inorganic anion
potassium cyanide	[no description available]	medium	1	0	cyanide salt; one-carbon compound; potassium salt	EC 1.15.1.1 (superoxide dismutase) inhibitor; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; neurotoxin
potassium thiocyanate	[no description available]	medium	2	0	potassium salt
losartan potassium	[no description available]	medium	2	2
2,2-bis(bromomethyl)-1,3-propanediol	[no description available]	medium	2	0	primary alcohol
7-methylguanosine-5'-monophosphate	[no description available]	medium	1	0	organophosphate oxoanion
8-azidoadenosine 5'-triphosphate	[no description available]	medium	2	0
vecuronium bromide	[no description available]	medium	1	0	organic bromide salt; quaternary ammonium salt	muscle relaxant; neuromuscular agent; nicotinic antagonist
enflurane	[no description available]	medium	1	0	ether; organochlorine compound; organofluorine compound	anaesthetic
ether	[no description available]	medium	1	0	ether; volatile organic compound	inhalation anaesthetic; non-polar solvent; refrigerant
dantrolene	[no description available]	medium	2	0	hydrazone; imidazolidine-2,4-dione	muscle relaxant; neuroprotective agent; ryanodine receptor antagonist
halothane	[no description available]	medium	3	0	haloalkane; organobromine compound; organochlorine compound; organofluorine compound	inhalation anaesthetic
fentanyl	[no description available]	medium	1	0	anilide; monocarboxylic acid amide; piperidines	adjuvant; anaesthesia adjuvant; anaesthetic; intravenous anaesthetic; mu-opioid receptor agonist; opioid analgesic
2-(n-morpholino)ethanesulfonic acid	[no description available]	medium	2	0	MES; organosulfonic acid; zwitterion
sym-trinitrobenzene	[no description available]	medium	2	0	trinitrobenzene	explosive
1,2-dipalmitoyl-3-phosphatidylethanolamine	[no description available]	medium	1	0
lysophosphatidylcholines	[no description available]	medium	2	0	1-O-acyl-sn-glycero-3-phosphocholine
1-stearoyl-2-arachidonylphosphatidylcholine	[no description available]	medium	1	0
beta-alanine	[no description available]	medium	1	0	amino acid zwitterion; beta-amino acid	agonist; fundamental metabolite; human metabolite; inhibitor; neurotransmitter
bafilomycin a	[no description available]	medium	2	0
cantharidin	[no description available]	medium	1	0	cyclic dicarboxylic anhydride; monoterpenoid	EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide
endothall	[no description available]	medium	1	0
maleimide	[no description available]	medium	1	0	dicarboximide; maleimides	EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
adp beta s	[no description available]	medium	1	0
chlorophyll	[no description available]	medium	1	0
antimycin	[no description available]	medium	2	0
phytic acid	[no description available]	medium	1	0	inositol phosphate
trinitrobenzenesulfonic acid	[no description available]	medium	7	0	arenesulfonic acid; C-nitro compound	epitope; explosive; reagent
isocitric acid	[no description available]	medium	1	0	secondary alcohol; tricarboxylic acid	fundamental metabolite
sanguinarine	[no description available]	medium	1	0	alkaloid antibiotic; benzophenanthridine alkaloid; botanical anti-fungal agent
tetraphenylphosphonium	[no description available]	medium	1	0	heteroorganic entity; phosphorus molecular entity; polyatomic cation
ranitidine	[no description available]	medium	1	0	C-nitro compound; furans; organic sulfide; tertiary amino compound	anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic
cyclosporine	[no description available]	medium	2	0
5'-(4-fluorosulfonylbenzoyl)adenosine	[no description available]	medium	4	0
8-bromocyclic gmp	[no description available]	medium	1	0	3',5'-cyclic purine nucleotide; organobromine compound	muscle relaxant; protein kinase G agonist
8-bromo cyclic adenosine monophosphate	[no description available]	medium	1	0	3',5'-cyclic purine nucleotide; adenyl ribonucleotide; organobromine compound	antidepressant; protein kinase agonist
4-chlorobenzoic acid	[no description available]	medium	1	0	monochlorobenzoic acid	bacterial xenobiotic metabolite
n-bromoacetylethanolamine phosphate	[no description available]	medium	2	0
6-mercapto-7-methylguanosine	[no description available]	medium	1	0
deoxyuridine	[no description available]	medium	3	0	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
aminoacetonitrile	[no description available]	medium	1	0
nikkomycin	[no description available]	medium	1	0
papulacandin b	[no description available]	medium	1	0
glyphosphine	[no description available]	medium	1	0	glycine derivative; phosphonic acids; tertiary amino compound	plant growth retardant
glyburide	[no description available]	medium	1	0	monochlorobenzenes; N-sulfonylurea	anti-arrhythmia drug; EC 2.7.1.33 (pantothenate kinase) inhibitor; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor; hypoglycemic agent
methylnitrosourea	[no description available]	medium	1	0	N-nitrosoureas	alkylating agent; carcinogenic agent; mutagen; teratogenic agent
chromium	[no description available]	medium	7	0	chromium group element atom; metal allergen	micronutrient
4-nitrophenol	[no description available]	medium	1	0	4-nitrophenols	human xenobiotic metabolite; mouse metabolite
phosphotyrosine	[no description available]	medium	2	0	L-tyrosine derivative; non-proteinogenic L-alpha-amino acid; O(4)-phosphotyrosine	Escherichia coli metabolite; immunogen
2',3'-dideoxythymidine triphosphate	[no description available]	medium	2	0	pyrimidine 2',3'-dideoxyribonucleoside 5'-triphosphate; thymidine phosphate
nicotinate mononucleotide	[no description available]	medium	2	0	organophosphate oxoanion	human metabolite; Saccharomyces cerevisiae metabolite
theophylline	[no description available]	medium	15	0	dimethylxanthine	adenosine receptor antagonist; anti-asthmatic drug; anti-inflammatory agent; bronchodilator agent; drug metabolite; EC 3.1.4.* (phosphoric diester hydrolase) inhibitor; fungal metabolite; human blood serum metabolite; immunomodulator; muscle relaxant; vasodilator agent
olivetolic acid	[no description available]	medium	1	0	benzoic acids; monocarboxylic acid; polyketide; resorcinols	metabolite
olivetol	[no description available]	medium	1	0	resorcinols	lichen metabolite
dronabinol	[no description available]	medium	1	0	benzochromene; diterpenoid; phytocannabinoid; polyketide	cannabinoid receptor agonist; epitope; hallucinogen; metabolite; non-narcotic analgesic
cannabigerolic acid	[no description available]	medium	1	0	dihydroxybenzoic acid; diterpenoid; phytocannabinoid; polyketide; resorcinols
salicylates	[no description available]	medium	8	0	monohydroxybenzoate	plant metabolite
genistein	[no description available]	medium	2	0	7-hydroxyisoflavones	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; geroprotector; human urinary metabolite; phytoestrogen; plant metabolite; tyrosine kinase inhibitor
2,2'-azobis(2-amidinopropane)	[no description available]	medium	1	0	monoazo compound
pyrazines	[no description available]	medium	2	0	diazine; pyrazines	Daphnia magna metabolite
2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one	[no description available]	medium	1	0
methanopterin	[no description available]	medium	1	0	methanopterins
n(delta)-(phosphonoacetyl)-l-ornithine	[no description available]	medium	1	0
2'-deoxy-3'-adenosine monophosphate	[no description available]	medium	1	0	2'-deoxyadenosine phosphate; purine 2'-deoxyribonucleoside 3'-monophosphate
arginine vasopressin	[no description available]	medium	1	0	vasopressin	cardiovascular drug; hematologic agent; mitogen
enkephalin, leucine	[no description available]	medium	2	0	pentapeptide; peptide zwitterion	analgesic; delta-opioid receptor agonist; human metabolite; mu-opioid receptor agonist; neurotransmitter; rat metabolite
tyrosyl-arginyl-phenylalanyl-lysinamide	[no description available]	medium	2	0
guanethidine	[no description available]	medium	1	0	azocanes; guanidines	adrenergic antagonist; antihypertensive agent; sympatholytic agent
enkephalin, ala(2)-mephe(4)-gly(5)-	[no description available]	medium	2	0
4-chloromercuribenzenesulfonate	[no description available]	medium	1	0	arenesulfonic acid; arylmercury compound
immucillin g	[no description available]	medium	3	0	dihydroxypyrrolidine; pyrrolopyrimidine
forodesine	[no description available]	medium	1	0	dihydroxypyrrolidine; pyrrolopyrimidine
pyrimidinones	[no description available]	medium	3	0
adenosine 3'-phosphate 5'-diphosphate	[no description available]	medium	1	0
fibrin	[no description available]	medium	3	0	peptide
2',3'-dideoxyadenosine triphosphate	[no description available]	medium	1	0	purine deoxyribonucleoside triphosphate
xanthosine 5'-triphosphate	[no description available]	medium	1	0	purine ribonucleoside 5'-monophosphate; xanthosine 5'-phosphate	Escherichia coli metabolite; metabolite; mouse metabolite
xanthine	[no description available]	medium	1	0	xanthine	Saccharomyces cerevisiae metabolite
pyochelin	[no description available]	medium	1	0	monocarboxylic acid; phenols; thiazolidines	metabolite; siderophore
phosphopantothenic acid	[no description available]	medium	1	0	amidoalkyl phosphate	Escherichia coli metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1,4-dihydropyridine	[no description available]	medium	1	0
dihydropyridines	[no description available]	medium	1	0
ganciclovir	[no description available]	medium	1	0	2-aminopurines; oxopurine	antiinfective agent; antiviral drug
2'-deoxyuridylic acid	[no description available]	medium	1	0	deoxyuridine phosphate; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate	Escherichia coli metabolite; metabolite; mouse metabolite
yersiniabactin	[no description available]	medium	2	0	monocarboxylic acid; phenols; secondary alcohol; thiazolidines	bacterial metabolite; siderophore
surfactin peptide	[no description available]	medium	1	0
salicylic acid	[no description available]	medium	1	0	monohydroxybenzoic acid	algal metabolite; antifungal agent; antiinfective agent; EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor; keratolytic drug; plant hormone; plant metabolite
4'-phosphopantetheine	[no description available]	medium	1	0	pantetheine 4'-phosphate	prosthetic group
tosyllysine chloromethyl ketone	[no description available]	medium	1	0	sulfonic acid derivative
ferric nitrilotriacetate	[no description available]	medium	1	0	iron chelate	carcinogenic agent; mutagen
ciprofloxacin	[no description available]	medium	1	0	aminoquinoline; cyclopropanes; fluoroquinolone antibiotic; N-arylpiperazine; quinolinemonocarboxylic acid; quinolone antibiotic; quinolone; zwitterion	antibacterial drug; antiinfective agent; antimicrobial agent; DNA synthesis inhibitor; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; environmental contaminant; topoisomerase IV inhibitor; xenobiotic
cycloprodigiosin	[no description available]	medium	1	0
6-hydroxymethylpterin	[no description available]	medium	1	0
dapsone	[no description available]	medium	1	0	substituted aniline; sulfone	anti-inflammatory drug; antiinfective agent; antimalarial; leprostatic drug
magnesium fluoride	[no description available]	medium	1	0
phenylazide	[no description available]	medium	1	0
xylulose	[no description available]	medium	1	0	xylulose	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1-deoxy-2-pentulose	[no description available]	medium	1	0	deoxypentose	Escherichia coli metabolite
ammonium nitrate	[no description available]	medium	1	0	ammonium salt; inorganic molecular entity; inorganic nitrate salt	explosive; fertilizer; oxidising agent
mobic	[no description available]	medium	1	0	1,3-thiazoles; benzothiazine; monocarboxylic acid amide	analgesic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
beta carotene	[no description available]	medium	1	0	carotenoid beta-end derivative; cyclic carotene	antioxidant; biological pigment; cofactor; ferroptosis inhibitor; human metabolite; mouse metabolite; plant metabolite; provitamin A
risedronic acid	[no description available]	medium	1	0	pyridines
angiogenin	[no description available]	medium	2	0
calcium peroxide	[no description available]	medium	1	1	calcium oxides
cyanoginosin lr	[no description available]	medium	1	0	microcystin	bacterial metabolite; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; environmental contaminant; xenobiotic
potassium hydroxide	[no description available]	medium	2	0	alkali metal hydroxide
pantolactone	[no description available]	medium	1	0	butan-4-olide	Saccharomyces cerevisiae metabolite
methenamine	[no description available]	medium	1	0	polyazaalkane; polycyclic cage; tetramine	antibacterial drug
cyanogen	[no description available]	medium	1	0	dinitrile; pseudohalogen
acetic anhydride	[no description available]	medium	1	0	acyclic carboxylic anhydride	metabolite; reagent
trimetaphosphoric acid	[no description available]	medium	1	0	cyclic phosphorus acid anhydride; inorganic heterocyclic compound; phosphorus oxoacid
maleic anhydride	[no description available]	medium	6	1	cyclic dicarboxylic anhydride; furans	allergen
guanosine 5'-phospho-2-methylimidazolide	[no description available]	medium	2	0
cytidine 5'-phospho-2-methylimidazolide	[no description available]	medium	1	0
zeatin	[no description available]	medium	1	0	zeatin	plant metabolite
2,4-dichlorophenoxyacetic acid	[no description available]	medium	1	0	chlorophenoxyacetic acid; dichlorobenzene	agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin
indoleacetic acid	[no description available]	medium	1	0	indole-3-acetic acids; monocarboxylic acid	auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite
1-o-indol-3-ylacetylglucose	[no description available]	medium	1	0	indoleacetic acid ester conjugate; indolyl carbohydrate
2,2'-dipyridyl disulfide	[no description available]	medium	1	0	organic disulfide; pyridines	oxidising agent
procion brilliant red h8-bs	[no description available]	medium	1	1
rhenium	[no description available]	medium	1	0	manganese group element atom
tetragastrin	[no description available]	medium	1	0	peptidyl amide; tetrapeptide	anxiogenic; human metabolite
sodium borohydride	[no description available]	medium	1	0	inorganic sodium salt; metal tetrahydridoborate
cystine	[no description available]	medium	4	0
silicon carbide	[no description available]	medium	1	0	organosilicon compound
diazoxide	[no description available]	medium	1	0	benzothiadiazine; organochlorine compound; sulfone	antihypertensive agent; beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; diuretic; K-ATP channel agonist; sodium channel blocker; sympathomimetic agent; vasodilator agent
tolbutamide	[no description available]	medium	2	0	N-sulfonylurea	human metabolite; hypoglycemic agent; insulin secretagogue; potassium channel blocker
beta-farnesene	[no description available]	medium	1	0	beta-farnesene
laminaran	[no description available]	medium	1	0
epiglucan	[no description available]	medium	1	0
coelenterazine	[no description available]	medium	1	0
bromosuccinimide	[no description available]	medium	1	0	dicarboximide; organobromine compound; pyrrolidinone	reagent
papaverine	[no description available]	medium	1	0	benzylisoquinoline alkaloid; dimethoxybenzene; isoquinolines	antispasmodic drug; vasodilator agent
phenylmethylsulfonyl fluoride	[no description available]	medium	1	0	acyl fluoride	serine proteinase inhibitor
2,6-dichloroindophenol	[no description available]	medium	1	0	dichlorobenzene; quinone imine
aminopyrine	[no description available]	medium	2	0	pyrazolone; tertiary amino compound	antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
ethidium	[no description available]	medium	6	0	phenanthridines	fluorochrome; intercalator
carnosine	[no description available]	medium	1	0	amino acid zwitterion; dipeptide	anticonvulsant; antineoplastic agent; antioxidant; Daphnia magna metabolite; geroprotector; human metabolite; mouse metabolite; neuroprotective agent
aminomalonic acid	[no description available]	medium	1	0	amino dicarboxylic acid	Daphnia magna metabolite; human metabolite
glycolipids	[no description available]	medium	4	0
nitroblue tetrazolium	[no description available]	medium	4	0	organic cation
penicillamine	[no description available]	medium	3	0	non-proteinogenic alpha-amino acid; penicillamine	antirheumatic drug; chelator; copper chelator; drug allergen
phenobarbital	[no description available]	medium	5	0	barbiturates	anticonvulsant; drug allergen; excitatory amino acid antagonist; sedative
dithionite	[no description available]	medium	2	0	sulfur oxide; sulfur oxoanion
betamethasone	[no description available]	medium	2	0	11beta-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-asthmatic agent; anti-inflammatory drug; immunosuppressive agent
indomethacin	[no description available]	medium	6	0	aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole	analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic
puromycin	[no description available]	medium	5	0	puromycins	antiinfective agent; antimicrobial agent; antineoplastic agent; EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor; EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor; nucleoside antibiotic; protein synthesis inhibitor
mercury	[no description available]	medium	13	0	elemental mercury; zinc group element atom	neurotoxin
glucagon	[no description available]	medium	14	0	peptide hormone
isoproterenol	[no description available]	medium	9	0	catechols; secondary alcohol; secondary amino compound	beta-adrenergic agonist; bronchodilator agent; cardiotonic drug; sympathomimetic agent
putrescine	[no description available]	medium	3	0	alkane-alpha,omega-diamine	antioxidant; fundamental metabolite
aminopropionitrile	[no description available]	medium	1	0	aminopropionitrile	antineoplastic agent; antirheumatic drug; collagen cross-linking inhibitor; plant metabolite
chlorambucil	[no description available]	medium	2	0	aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
3-methylcholanthrene	[no description available]	medium	3	0	ortho- and peri-fused polycyclic arene	aryl hydrocarbon receptor agonist; carcinogenic agent
cholestyramine resin	[no description available]	medium	1	0
triamcinolone	[no description available]	medium	1	0	11beta-hydroxy steroid; 16alpha-hydroxy steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(4) steroid; C21-steroid hormone; fluorinated steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	anti-allergic agent; anti-inflammatory drug
methylprednisolone	[no description available]	medium	2	0	6-methylprednisolone; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antiemetic; environmental contaminant; neuroprotective agent; xenobiotic
2-hydroxy-5-nitrobenzyl bromide	[no description available]	medium	1	0
pituitrin	[no description available]	medium	4	0
diazooxonorleucine	[no description available]	medium	2	0	amino acid zwitterion; diazo compound; ketone; non-proteinogenic L-alpha-amino acid	analgesic; antibacterial agent; antimetabolite; antineoplastic agent; antiviral agent; apoptosis inducer; bacterial metabolite; EC 2.4.2.14 (amidophosphoribosyltransferase) inhibitor; EC 3.5.1.2 (glutaminase) inhibitor; EC 6.3.4.2 [CTP synthase (glutamine hydrolyzing)] inhibitor; EC 6.3.5.1 [NAD(+) synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.2 [GMP synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.3 (phosphoribosylformylglycinamidine synthase) inhibitor; EC 6.3.5.4 [asparagine synthase (glutamine-hydrolysing)] inhibitor; EC 6.3.5.5 [carbamoyl-phosphate synthase (glutamine-hydrolysing)] inhibitor; glutamine antagonist
deoxycholic acid	[no description available]	medium	4	0	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human blood serum metabolite
lidocaine	[no description available]	medium	1	0	benzenes; monocarboxylic acid amide; tertiary amino compound	anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic
prednisone	[no description available]	medium	2	0	11-oxo steroid; 17alpha-hydroxy steroid; 20-oxo steroid; 21-hydroxy steroid; 3-oxo-Delta(1),Delta(4)-steroid; C21-steroid; glucocorticoid; primary alpha-hydroxy ketone; tertiary alpha-hydroxy ketone	adrenergic agent; anti-inflammatory drug; antineoplastic agent; immunosuppressive agent; prodrug
phalloidine	[no description available]	medium	1	0	homodetic cyclic peptide
tiletamine hydrochloride	[no description available]	medium	2	0
aminoimidazole carboxamide	[no description available]	medium	1	0	aminoimidazole; monocarboxylic acid amide	mouse metabolite
barium sulfate	[no description available]	medium	2	0	barium salt; inorganic barium salt; metal sulfate	radioopaque medium
chlormerodrin	[no description available]	medium	2	1	organomercury compound; ureas	diagnostic agent; diuretic
sarcosine	[no description available]	medium	3	0	N-alkylglycine zwitterion; N-alkylglycine; N-methyl-amino acid; N-methylglycines	Escherichia coli metabolite; glycine receptor agonist; glycine transporter 1 inhibitor; human metabolite; mouse metabolite
whewellite	[no description available]	medium	1	0
hydracrylonitrile	[no description available]	medium	1	0
acrylonitrile	[no description available]	medium	1	0	aliphatic nitrile; volatile organic compound	antifungal agent; carcinogenic agent; fungal metabolite; mutagen; polar aprotic solvent
delphinidin	[no description available]	medium	1	0	anthocyanidin chloride
dolichol monophosphate mannose	[no description available]	medium	1	0
technetium tc 99m stannous pyrophosphate	[no description available]	medium	2	0
orabase	[no description available]	medium	1	0
n-formylmethionine	[no description available]	medium	1	0	L-methionine derivative; N-formyl amino acid; proteinogenic amino acid	metabolite
ytterbium	[no description available]	medium	1	0	f-block element atom; lanthanoid atom
mannans	[no description available]	medium	1	0
cyanogen bromide	[no description available]	medium	4	0
guanylyl imidodiphosphate	[no description available]	medium	4	0	nucleoside triphosphate analogue
chloral hydrate	[no description available]	medium	2	0	aldehyde hydrate; ethanediol; organochlorine compound	general anaesthetic; mouse metabolite; sedative; xenobiotic
2-fluoro-araatp	[no description available]	medium	1	0
2-methyl-butan-1,2,3,4-tetraol-2,4-cyclopyrophosphate	[no description available]	medium	1	0
octacalcium phosphate	[no description available]	medium	2	0
phytanic acid	[no description available]	medium	1	0	branched-chain saturated fatty acid; long-chain fatty acid; methyl-branched fatty acid
triethanolamine	[no description available]	medium	1	0	amino alcohol; tertiary amino compound; triol	buffer; surfactant
diclofenac	[no description available]	medium	1	1	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
dihydroxyacetone phosphate	[no description available]	medium	1	0	glycerone phosphates; primary alpha-hydroxy ketone	Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
1-cyclohexyl-3-(2-(4-morpholinyl)ethyl)carbodiimide	[no description available]	medium	1	0	carbodiimide; morpholines	cross-linking reagent
ethyldimethylaminopropyl carbodiimide	[no description available]	medium	2	0
cme-carbodiimide	[no description available]	medium	1	0
carbodiimides	[no description available]	medium	2	0	carbodiimide
2,3-dihydroxybenzoylserine	[no description available]	medium	1	0	L-serine derivative	Escherichia coli metabolite
benzoic acid	[no description available]	medium	1	0	benzoic acids	algal metabolite; antimicrobial food preservative; drug allergen; EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor; human xenobiotic metabolite; plant metabolite
quin2	[no description available]	medium	1	0
fluorocitrate	[no description available]	medium	1	0	carbonyl compound
phenylbenzoquinone	[no description available]	medium	1	0
diuron	[no description available]	medium	1	0	3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene	environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic
methylphenazonium methosulfate	[no description available]	medium	1	0	azaheterocycle sulfate salt; phenazines
transforming growth factor alpha	[no description available]	medium	1	0
riopan	[no description available]	medium	1	0
aluminum hydroxide, magnesium hydroxide, drug combination	[no description available]	medium	2	0
aluminum fluoride	[no description available]	medium	1	0	aluminium coordination entity
monensin	[no description available]	medium	2	0	cyclic hemiketal; monocarboxylic acid; polyether antibiotic; spiroketal	antifungal agent; coccidiostat; ionophore
keratan sulfate	[no description available]	medium	1	0
potassium iodide	[no description available]	medium	2	0	potassium salt	expectorant; radical scavenger
iloprost	[no description available]	medium	1	0	carbobicyclic compound; monocarboxylic acid; secondary alcohol	platelet aggregation inhibitor; vasodilator agent
mevalonolactone	[no description available]	medium	1	0	4-hydroxy-4-methyloxan-2-one	fungal metabolite; plant metabolite
glucaric acid	[no description available]	medium	1	0	glucaric acid	antineoplastic agent
propionaldehyde	[no description available]	medium	1	0	alpha-CH2-containing aldehyde; propanals	Escherichia coli metabolite
dodecanol	[no description available]	medium	1	0	dodecanol; primary alcohol	bacterial metabolite; cosmetic; insect attractant; insecticide; pheromone; plant metabolite
estrone sulfate	[no description available]	medium	1	0	17-oxo steroid; steroid sulfate	human metabolite; mouse metabolite
dehydroepiandrosterone sulfate	[no description available]	medium	1	0	17-oxo steroid; steroid sulfate	EC 2.7.1.33 (pantothenate kinase) inhibitor; human metabolite; mouse metabolite
dehydroepiandrosterone	[no description available]	medium	1	0	17-oxo steroid; 3beta-hydroxy-Delta(5)-steroid; androstanoid	androgen; human metabolite; mouse metabolite
estrone	[no description available]	medium	1	0	17-oxo steroid; 3-hydroxy steroid; phenolic steroid; phenols	antineoplastic agent; bone density conservation agent; estrogen; human metabolite; mouse metabolite
ethylene	[no description available]	medium	2	2	alkene; gas molecular entity	plant hormone; refrigerant
atrial natriuretic factor	[no description available]	medium	1	0	polypeptide
diethylcarbamazine	[no description available]	medium	1	0	N-carbamoylpiperazine; N-methylpiperazine
trypan blue	[no description available]	medium	1	0
pyoverdin	[no description available]	medium	1	0
digoxin	[no description available]	medium	1	0	cardenolide glycoside; steroid saponin	anti-arrhythmia drug; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; epitope
okadaic acid	[no description available]	medium	1	0	ketal
(nitrilotris(methylene))triphosphonic acid	[no description available]	medium	1	0	phosphonoacetic acid
trifluoperazine	[no description available]	medium	2	0	N-alkylpiperazine; N-methylpiperazine; organofluorine compound; phenothiazines	antiemetic; calmodulin antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor; phenothiazine antipsychotic drug
aminacrine	[no description available]	medium	1	0	aminoacridines; primary amino compound	acid-base indicator; antiinfective agent; antiseptic drug; fluorescent dye; MALDI matrix material; mutagen
tetracaine	[no description available]	medium	1	0	benzoate ester; tertiary amino compound	local anaesthetic
sudan iii	[no description available]	medium	1	0	azobenzenes; bis(azo) compound; naphthols	carcinogenic agent; fluorochrome; histological dye
lanthanum chloride	[no description available]	medium	1	0
equisetin	[no description available]	medium	1	0	enol; octahydronaphthalenes; primary alcohol; tetramic acids	antibacterial agent; fungal metabolite; HIV-1 integrase inhibitor; quorum sensing inhibitor
1,2-cyclohexanedione	[no description available]	medium	1	0	cyclohexanedione
farnesyl monophosphate	[no description available]	medium	1	0
diacetyl	[no description available]	medium	1	0	alpha-diketone	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
phenylglyoxal	[no description available]	medium	1	0	phenylacetaldehydes
n-acetylimidazole	[no description available]	medium	1	0	N-acylimidazole
ethylene glycol	[no description available]	medium	2	0	ethanediol; glycol	metabolite; mouse metabolite; solvent; toxin
beta-endorphin	[no description available]	medium	1	0
fenitrothion	[no description available]	medium	1	0	C-nitro compound; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
alizarin	[no description available]	medium	1	0	dihydroxyanthraquinone	chromophore; dye; plant metabolite
bumetanide	[no description available]	medium	1	0	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
4-bromotetramisole	[no description available]	medium	2	0
tetramisole	[no description available]	medium	2	0	imidazothiazole	environmental contaminant; xenobiotic
s-2-aminoethyl cysteine	[no description available]	medium	1	0	L-cysteine thioether; non-proteinogenic L-alpha-amino acid	EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor; metabolite; protein synthesis inhibitor
carboxyatractyloside	[no description available]	medium	1	0
butyric acid	[no description available]	medium	2	0	fatty acid 4:0; straight-chain saturated fatty acid	human urinary metabolite; Mycoplasma genitalium metabolite
atractyloside	[no description available]	medium	1	0
deoxyribose	[no description available]	medium	1	0	deoxypentose	human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite
lithium bromide	[no description available]	medium	1	0	bromide salt; lithium salt
p(1),p(5)-di(adenosine-5'-)pentaphosphate	[no description available]	medium	1	0	organophosphate oxoanion
3,3',4',5-tetrachlorosalicylanilide	[no description available]	medium	1	0	dichlorobenzene; salicylanilides	drug allergen
methyl coenzyme m	[no description available]	medium	1	0	S-substituted coenzyme M
mesna	[no description available]	medium	1	0	organosulfonic acid
ferric chloride	[no description available]	medium	1	0	iron coordination entity	astringent; Lewis acid
technetium tc 99m sestamibi	[no description available]	medium	2	0
glycine amide	[no description available]	medium	1	0	amino acid amide; glycine derivative
phenylalanine amide	[no description available]	medium	1	0	amino acid amide; phenylalanine derivative
sodium nitrate	[no description available]	medium	1	0	inorganic nitrate salt; inorganic sodium salt	fertilizer; NMR chemical shift reference compound
diltiazem	[no description available]	medium	1	0	5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate	antihypertensive agent; calcium channel blocker; vasodilator agent
sepharose	[no description available]	medium	1	0
2-azidoadenosine 5'-triphosphate	[no description available]	medium	1	0
2-keto-4-methylthiobutyric acid	[no description available]	medium	1	0	omega-(methylthio)-2-oxocarboxylic acid
magnesium gtp	[no description available]	medium	1	0
thiopental	[no description available]	medium	1	0	barbiturates	anticonvulsant; drug allergen; environmental contaminant; intravenous anaesthetic; sedative; xenobiotic
palmitoyl coenzyme a	[no description available]	medium	1	0	11,12-saturated fatty acyl-CoA; 3-substituted propionyl-CoA; long-chain fatty acyl-CoA; palmitoyl bioconjugate	Escherichia coli metabolite; mouse metabolite
bromodeoxyuridine triphosphate	[no description available]	medium	1	0
sodium molybdate(vi)	[no description available]	medium	1	0	inorganic sodium salt	poison
sulfosalicylic acid	[no description available]	medium	1	0	arenesulfonic acid; benzoic acids; phenols	metabolite
aphidicolin	[no description available]	medium	1	0	tetracyclic diterpenoid	antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite
lactoferrin	[no description available]	medium	1	0
2'-deoxy-6-thioguanosine 5'-triphosphate	[no description available]	medium	1	0
rhodanine	[no description available]	medium	1	0	thiazolidinone
quercetin	[no description available]	medium	1	0	7-hydroxyflavonol; pentahydroxyflavone	antibacterial agent; antineoplastic agent; antioxidant; Aurora kinase inhibitor; chelator; EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor; geroprotector; phytoestrogen; plant metabolite; protein kinase inhibitor; radical scavenger
phosphothreonine	[no description available]	medium	1	0	L-threonine derivative; non-proteinogenic L-alpha-amino acid; O-phosphoamino acid	Escherichia coli metabolite
5-fluorouridine 5'-phosphate	[no description available]	medium	1	0	organofluorine compound; pyrimidine ribonucleoside 5'-monophosphate	drug metabolite
chlorothiazide	[no description available]	medium	1	0	benzothiadiazine	antihypertensive agent; diuretic
propranolol	[no description available]	medium	3	1	naphthalenes; propanolamine; secondary amine	anti-arrhythmia drug; antihypertensive agent; anxiolytic drug; beta-adrenergic antagonist; environmental contaminant; human blood serum metabolite; vasodilator agent; xenobiotic
vidarabine	[no description available]	medium	1	0	beta-D-arabinoside; purine nucleoside	antineoplastic agent; bacterial metabolite; nucleoside antibiotic
leukotriene b4	[no description available]	medium	1	0	dihydroxy monocarboxylic acid; hydroxy polyunsaturated fatty acid; leukotriene; long-chain fatty acid	human metabolite; mouse metabolite; plant metabolite; vasoconstrictor agent
inositol hexasulfate	[no description available]	medium	1	0
rhodium	[no description available]	medium	1	0	cobalt group element atom
2-deoxyribose 1-phosphate, (alpha-d-erythro)-isomer	[no description available]	medium	1	0	2-deoxy-D-ribofuranose 1-phosphate
chromomycins	[no description available]	medium	1	0
thorium dioxide	[no description available]	medium	1	0	thorium molecular entity
indophenol	[no description available]	medium	2	0	quinone imine	dye
chlordan	[no description available]	medium	1	0	cyclodiene organochlorine insecticide	GABA-gated chloride channel antagonist; persistent organic pollutant
dieldrin	[no description available]	medium	1	0	epoxide; organochlorine compound; organochlorine insecticide	carcinogenic agent; xenobiotic
phenformin	[no description available]	medium	1	0	biguanides	antineoplastic agent; geroprotector; hypoglycemic agent
lobeline	[no description available]	medium	1	0
ethionine	[no description available]	medium	2	0	S-ethylhomocysteine	antimetabolite; carcinogenic agent
triflupromazine	[no description available]	medium	1	0	organofluorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; first generation antipsychotic
zoxazolamine	[no description available]	medium	1	0	benzoxazole
triolein	[no description available]	medium	3	0	triglyceride	Caenorhabditis elegans metabolite; plant metabolite
glutethimide	[no description available]	medium	1	0	piperidines
chlorpromazine	[no description available]	medium	3	0	organochlorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug
acetylene	[no description available]	medium	1	0	alkyne; gas molecular entity; terminal acetylenic compound
azaserine	[no description available]	medium	2	0	carboxylic ester; diazo compound; L-serine derivative; non-proteinogenic L-alpha-amino acid	antifungal agent; antimetabolite; antimicrobial agent; antineoplastic agent; glutamine antagonist; immunosuppressive agent; metabolite
chloroform	[no description available]	medium	2	0	chloromethanes; one-carbon compound	carcinogenic agent; central nervous system drug; inhalation anaesthetic; non-polar solvent; refrigerant
quinuclidines	[no description available]	medium	1	0	quinuclidines; saturated organic heterobicyclic parent
floxuridine	[no description available]	medium	2	0	nucleoside analogue; organofluorine compound; pyrimidine 2'-deoxyribonucleoside	antimetabolite; antineoplastic agent; antiviral drug; radiosensitizing agent
neodymium	[no description available]	medium	2	0	f-block element atom; lanthanoid atom
valerates	[no description available]	medium	3	0	short-chain fatty acid anion; straight-chain saturated fatty acid anion	plant metabolite
dehydrocholic acid	[no description available]	medium	1	0	12-oxo steroid; 3-oxo-5beta-steroid; 7-oxo steroid; oxo-5beta-cholanic acid	gastrointestinal drug
agar	[no description available]	medium	2	0
caprylates	[no description available]	medium	1	0	fatty acid anion 8:0; straight-chain saturated fatty acid anion	human metabolite; Saccharomyces cerevisiae metabolite
ambenonium chloride	[no description available]	medium	1	0	organic chloride salt; quaternary ammonium salt	EC 3.1.1.8 (cholinesterase) inhibitor; neurotransmitter agent
methionine sulfoximine	[no description available]	medium	1	0	methionine derivative; non-proteinogenic alpha-amino acid; sulfoximide
rifampin	[no description available]	medium	5	0	cyclic ketal; hydrazone; N-iminopiperazine; N-methylpiperazine; rifamycins; semisynthetic derivative; zwitterion	angiogenesis inhibitor; antiamoebic agent; antineoplastic agent; antitubercular agent; DNA synthesis inhibitor; EC 2.7.7.6 (RNA polymerase) inhibitor; Escherichia coli metabolite; geroprotector; leprostatic drug; neuroprotective agent; pregnane X receptor agonist; protein synthesis inhibitor
betaine	[no description available]	medium	1	0	amino-acid betaine; glycine derivative	fundamental metabolite
clofibrate	[no description available]	medium	1	0	aromatic ether; ethyl ester; monochlorobenzenes	anticholesteremic drug; antilipemic drug; geroprotector; PPARalpha agonist
taurine	[no description available]	medium	1	0	amino sulfonic acid; zwitterion	antioxidant; Escherichia coli metabolite; glycine receptor agonist; human metabolite; mouse metabolite; nutrient; radical scavenger; Saccharomyces cerevisiae metabolite
cesium	[no description available]	medium	2	0	alkali metal atom
colistin	[no description available]	medium	1	0
canavanine	[no description available]	medium	2	0	amino acid zwitterion; non-proteinogenic L-alpha-amino acid	phytogenic insecticide; plant metabolite
tungsten	[no description available]	medium	1	0	chromium group element atom	micronutrient
chromates	[no description available]	medium	3	0	chromium oxoanion; divalent inorganic anion	oxidising agent
lactose	[no description available]	medium	1	0	lactose
hemicholinium 3	[no description available]	medium	1	0
morphine	[no description available]	medium	1	0	morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound	anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic
amitriptyline	[no description available]	medium	1	0	carbotricyclic compound; tertiary amine	adrenergic uptake inhibitor; antidepressant; environmental contaminant; tropomyosin-related kinase B receptor agonist; xenobiotic
orphenadrine	[no description available]	medium	1	0	ether; tertiary amino compound	antidyskinesia agent; antiparkinson drug; H1-receptor antagonist; muscarinic antagonist; muscle relaxant; NMDA receptor antagonist; parasympatholytic
toluene	[no description available]	medium	1	0	methylbenzene; toluenes; volatile organic compound	cholinergic antagonist; fuel additive; neurotoxin; non-polar solvent
bilirubin	[no description available]	medium	1	0	biladienes; dicarboxylic acid	antioxidant; human metabolite; mouse metabolite
ecdysone	[no description available]	medium	1	0	14alpha-hydroxy steroid; 22-hydroxy steroid; 25-hydroxy steroid; 2beta-hydroxy steroid; 3beta-sterol; 6-oxo steroid; ecdysteroid	prohormone
2-bromoacetamide-4-nitrophenol	[no description available]	medium	1	0
p-methoxy-n-methylphenethylamine	[no description available]	medium	1	0	aromatic ether; secondary amino compound	metabolite
homoserine	[no description available]	medium	1	0	amino acid zwitterion; homoserine	algal metabolite; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite
osmium	[no description available]	medium	1	0	iron group element atom; platinum group metal atom
nitrosoguanidines	[no description available]	medium	3	0
gentian violet	[no description available]	medium	1	0	organic chloride salt	anthelminthic drug; antibacterial agent; antifungal agent; antiseptic drug; histological dye
hydrochlorothiazide	[no description available]	medium	1	0	benzothiadiazine; organochlorine compound; sulfonamide	antihypertensive agent; diuretic; environmental contaminant; xenobiotic
taurocholic acid	[no description available]	medium	1	0	amino sulfonic acid; bile acid taurine conjugate	human metabolite
valinomycin	[no description available]	medium	3	0	cyclodepsipeptide; macrocycle	antimicrobial agent; antiviral agent; bacterial metabolite; potassium ionophore
cycloserine	[no description available]	medium	1	0	4-amino-1,2-oxazolidin-3-one; organonitrogen heterocyclic antibiotic; organooxygen heterocyclic antibiotic; zwitterion	antiinfective agent; antimetabolite; antitubercular agent; metabolite; NMDA receptor agonist
sulfinpyrazone	[no description available]	medium	1	0	pyrazolidines; sulfoxide	uricosuric drug
aminophylline	[no description available]	medium	2	0	mixture	bronchodilator agent; cardiotonic drug
galactosamine	[no description available]	medium	1	0	D-galactosamine; primary amino compound	toxin
rhamnose	[no description available]	medium	1	0	L-rhamnose
glyoxal	[no description available]	medium	1	0	dialdehyde	agrochemical; allergen; pesticide; plant growth regulator
concanavalin a	[no description available]	medium	1	0
homogentisic acid	[no description available]	medium	1	0	dihydroxyphenylacetic acid; hydroquinones	human metabolite; plant metabolite
sodium hypochlorite	[no description available]	medium	1	0	inorganic sodium salt	bleaching agent; disinfectant
apomorphine	[no description available]	medium	1	0	aporphine alkaloid	alpha-adrenergic drug; antidyskinesia agent; antiparkinson drug; dopamine agonist; emetic; serotonergic drug
trazodone hydrochloride	[no description available]	medium	22	2	hydrochloride	adrenergic antagonist; antidepressant; H1-receptor antagonist; sedative; serotonin uptake inhibitor
egg white	[no description available]	medium	3	0
isomethyleugenol	[no description available]	medium	21	0	isomethyleugenol
oxybutynin	[no description available]	medium	1	0	acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound	antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic
fenoxycarb	[no description available]	medium	1	0	aromatic ether; carbamate ester	environmental contaminant; insecticide; juvenile hormone mimic; xenobiotic
glyphosate	[no description available]	medium	1	0	glycine derivative; phosphonic acid	agrochemical; EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor; herbicide
benzothiazide	[no description available]	medium	1	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
enerbol	[no description available]	medium	1	0
trolamine salicylate	[no description available]	medium	90	1
eye	[no description available]	medium	4	0
fomesafen	[no description available]	medium	3	0	aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
1-((3,5-dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone	[no description available]	medium	5	0	dichlorobenzene; differentiation-inducing factor; monomethoxybenzene; resorcinols	eukaryotic metabolite; signalling molecule
fusarium	[no description available]	medium	6	0
humulene	[no description available]	medium	1	0	alpha-humulene

Article	Year
Cytotoxicity of Human Hepatic Intrasinusoidal Gamma/Delta T Cells Depends on Phospho-antigen and NK Receptor Signaling. Anticancer research, Volume: 43, Issue: 1	2023
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study. PloS one, Volume: 17, Issue: 10	2022
Ferric pyrophosphate citrate for parenteral administration of maintenance iron: structure, mechanism of action, clinical efficacy and safety. Current medical research and opinion, Volume: 38, Issue: 8	2022
Superphosphate, biochar, and a microbial inoculum regulate phytotoxicity and humification during chicken manure composting. The Science of the total environment, Jun-10, Volume: 824	2022
Transdermal Delivery of Iron Using Soluble Microneedles: Dermal Kinetics and Safety. Journal of pharmaceutical sciences, Volume: 105, Issue: 3	2016
Differentially selective chemosensor with fluorescence off-on responses on Cu(2+) and Zn(2+) ions in aqueous media and applications in pyrophosphate sensing, live cell imaging, and cytotoxicity. Inorganic chemistry, Jul-07, Volume: 53, Issue: 13	2014
Pyrophosphate-bridged complexes with picomolar toxicity. Journal of inorganic biochemistry, Volume: 103, Issue: 9	2009
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies. Blood, May-14, Volume: 113, Issue: 20	2009
Manganese oxidation state mediates toxicity in PC12 cells. Toxicology and applied pharmacology, Jun-15, Volume: 205, Issue: 3	2005
Cytotoxicity of modern dentin adhesives--in vitro testing on gingival fibroblasts. Journal of biomedical materials research, Volume: 63, Issue: 1	2002
Monitoring of chemical fertilizers on toxicity of two carbamate insecticides to the cyanobacterium Anabaena PCC 7120. Microbios, Volume: 106, Issue: 415	2001
[Study of the toxicity of pyrophosphate (an ingredient of Olipiphat)]. Voprosy onkologii, Volume: 46, Issue: 4	2000
Safety and efficacy of a novel tartar control dentifrice containing 3.3% pyrophosphate: a controlled six-month clinical trial. The Journal of clinical dentistry, Volume: 9, Issue: 1	1998
The toxicity of organophosphorus compounds to mammals. Bulletin of the World Health Organization, Volume: 44, Issue: 1-3	1971
The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. The Biochemical journal, Volume: 114, Issue: 4	1969
Severe systemic reaction to diphosphonate bone imaging agents: skin testing to predict allergic response and a safe alternative agent. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, Volume: 27, Issue: 9	1986
Inhibition of Clostridium botulinum 52A toxicity and protease activity by sodium acid pyrophosphate in media systems. Applied and environmental microbiology, Volume: 50, Issue: 1	1985
On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase. Chemico-biological interactions, Volume: 72, Issue: 3	1989
Exacerbation of doxorubicin cardiotoxicity by digoxin administration in an experimental rabbit model. International journal of cancer, Apr-15, Volume: 45, Issue: 4	1990
Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin. Cancer chemotherapy and pharmacology, Volume: 28, Issue: 3	1991
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Calcinosis in systemic sclerosis. Current opinion in rheumatology, 11-01, Volume: 34, Issue: 6	2022
The cytotoxic effects of three different bisphosphonates in-vitro on human gingival fibroblasts, osteoblasts and osteogenic sarcoma cells. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, Volume: 40, Issue: 8	2012
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study. PloS one, Volume: 17, Issue: 10	2022
Ethnicity evaluation of ferric pyrophosphate citrate among Asian and Non-Asian populations: a population pharmacokinetics analysis. European journal of clinical pharmacology, Volume: 78, Issue: 9	2022
Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase. Drug metabolism and disposition: the biological fate of chemicals, Volume: 50, Issue: 8	2022
Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate. Journal of clinical pharmacology, Volume: 62, Issue: 5	2022
Effects of cytidine-5'-diphosphate choline on gray matter volumes in methamphetamine-dependent patients: A randomized, double-blind, placebo-controlled study. Journal of psychiatric research, Volume: 143	2021
Longitudinal Photoacoustic Imaging of the Pharmacodynamic Effect of Vascular Targeted Therapy on Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 12-15, Volume: 25, Issue: 24	2019
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis. Pediatric nephrology (Berlin, Germany), Volume: 33, Issue: 11	2018
Pharmacokinetics of Ferric Pyrophosphate Citrate, a Novel Iron Salt, Administered Intravenously to Healthy Volunteers. Journal of clinical pharmacology, Volume: 57, Issue: 3	2017
Phase I clinical and pharmacokinetic evaluation of the vascular-disrupting agent OXi4503 in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, Mar-01, Volume: 18, Issue: 5	2012
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. Investigational new drugs, Volume: 30, Issue: 1	2012
Oral delivery and clearance of antiplaque agents from Triclosan-containing dentifrices. International dental journal, Volume: 43, Issue: 4 Suppl 1	1993
Clearance of calcium pyrophosphate dihydrate crystals in vivo. III. Effects of synovial hemosiderosis. Arthritis and rheumatism, Volume: 24, Issue: 5	1981
Right ventricular infarction: identification by hemodynamic measurements before and after volume loading and correlation with noninvasive techniques. Journal of the American College of Cardiology, Volume: 4, Issue: 5	1984
Liver mitochondrial pyrophosphate concentration is increased by Ca2+ and regulates the intramitochondrial volume and adenine nucleotide content. The Biochemical journal, Sep-15, Volume: 246, Issue: 3	1987
Comparison of early myocardial technetium-99m pyrophosphate uptake to early peaking of creatine kinase and creatine kinase-MB as indicators of early reperfusion in acute myocardial infarction. The American journal of cardiology, Oct-01, Volume: 60, Issue: 10	1987
Quantitative estimation of infarct size by simultaneous dual radionuclide single photon emission computed tomography: comparison with peak serum creatine kinase activity. American heart journal, Volume: 121, Issue: 5	1991
CLearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. Arthritis and rheumatism, Volume: 22, Issue: 10	1979
Pharmacodynamics of stannous chelates administered with 99mTc-labeled chelates. Radiology, Volume: 132, Issue: 3	1979
Clearance of calcium pyrophosphate dihydrate crystals in vivo. I. Studies using 169Yb labeled triclinic crystals. Arthritis and rheumatism, Volume: 22, Issue: 7	1979
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
In Vitro and In Vivo Pharmacological Profiles of DS-1211, a Novel Potent, Selective, and Orally Bioavailable Tissue-Nonspecific Alkaline Phosphatase Inhibitor. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Volume: 37, Issue: 10	2022
Effect of superphosphate addition on heavy metals speciation and microbial communities during composting. Bioresource technology, Volume: 359	2022
Iron Bioavailability from Ferrous Ammonium Phosphate, Ferrous Sulfate, and Ferric Pyrophosphate in an Instant Milk Drink-A Stable Isotope Study in Children. Nutrients, Apr-14, Volume: 14, Issue: 8	2022
Impact of Ascorbic Acid on the In Vitro Iron Bioavailability of a Casein-Based Iron Fortificant. Nutrients, Sep-11, Volume: 12, Issue: 9	2020
Iron Absorption from Bouillon Fortified with Iron-Enriched Aspergillus oryzae Is Higher Than That Fortified with Ferric Pyrophosphate in Young Women. The Journal of nutrition, 05-01, Volume: 150, Issue: 5	2020
High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women. The Journal of nutrition, 05-01, Volume: 149, Issue: 5	2019
Effects of micronised microencapsulated ferric pyrophosphate supplementation in patients with advanced cancer and iron deficiency: a single-centre cohort pilot study. Blood transfusion = Trasfusione del sangue, Volume: 17, Issue: 3	2019
Sodium pyrophosphate enhances iron bioavailability from bouillon cubes fortified with ferric pyrophosphate. The British journal of nutrition, Volume: 116, Issue: 3	2016
Dissolution behaviour of ferric pyrophosphate and its mixtures with soluble pyrophosphates: Potential strategy for increasing iron bioavailability. Food chemistry, Oct-01, Volume: 208	2016
Immobilization of Pb and Cu in polluted soil by superphosphate, multi-walled carbon nanotube, rice straw and its derived biochar. Environmental science and pollution research international, Volume: 23, Issue: 15	2016
Cofortification of ferric pyrophosphate and citric acid/trisodium citrate into extruded rice grains doubles iron bioavailability through in situ generation of soluble ferric pyrophosphate citrate complexes. The American journal of clinical nutrition, Volume: 103, Issue: 5	2016
The effect of iron-fortified complementary food and intermittent preventive treatment of malaria on anaemia in 12- to 36-month-old children: a cluster-randomised controlled trial. Malaria journal, Sep-17, Volume: 14	2015
Fructo-oligosaccharides and iron bioavailability in anaemic rats: the effects on iron species distribution, ferroportin-1 expression, crypt bifurcation and crypt cell proliferation in the caecum. The British journal of nutrition, Oct-28, Volume: 112, Issue: 8	2014
Iron bioavailability in Wistar rats fed with fortified rice by Ultra Rice technology with or without addition of yacon flour (Smallanthus sonchifolius). Archivos latinoamericanos de nutricion, Volume: 63, Issue: 1	2013
Mn(II,III) oxidation and MnO2 mineralization by an expressed bacterial multicopper oxidase. Proceedings of the National Academy of Sciences of the United States of America, Jul-16, Volume: 110, Issue: 29	2013
[In situ immobilization of Pb and Cd in orchard soil using soil ameliorants]. Huan jing ke xue= Huanjing kexue, Volume: 33, Issue: 10	2012
Ferrous ammonium phosphate (FeNH₄PO₄) as a new food fortificant: iron bioavailability compared to ferrous sulfate and ferric pyrophosphate from an instant milk drink. European journal of nutrition, Volume: 52, Issue: 4	2013
Iron deficiency up-regulates iron absorption from ferrous sulphate but not ferric pyrophosphate and consequently food fortification with ferrous sulphate has relatively greater efficacy in iron-deficient individuals. The British journal of nutrition, Volume: 105, Issue: 8	2011
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. Investigational new drugs, Volume: 30, Issue: 1	2012
Difructose anhydride III enhances bioavailability of water-insoluble iron in anemic Vietnamese women. Journal of nutritional science and vitaminology, Volume: 56, Issue: 3	2010
Comparing soluble ferric pyrophosphate to common iron salts and chelates as sources of bioavailable iron in a Caco-2 cell culture model. Journal of agricultural and food chemistry, Jun-10, Volume: 57, Issue: 11	2009
Regular consumption of a complementary food fortified with ascorbic acid and ferrous fumarate or ferric pyrophosphate is as useful as ferrous sulfate in maintaining hemoglobin concentrations >105 g/L in young Bangladeshi children. The American journal of clinical nutrition, Volume: 89, Issue: 6	2009
Relative bioavailability of micronized, dispersible ferric pyrophosphate added to an apple juice drink. European journal of nutrition, Volume: 48, Issue: 2	2009
Does ascorbic acid supplementation affect iron bioavailability in rats fed micronized dispersible ferric pyrophosphate fortified fruit juice? European journal of nutrition, Volume: 47, Issue: 8	2008
Stabilized-solubilized ferric pyrophosphate as a new iron source for food fortification. Bioavailability studies by means of the prophylactic-preventive method in rats. Biological trace element research, Volume: 127, Issue: 2	2009
Iron absorption from meat pate fortified with ferric pyrophosphate in iron-deficient women. Nutrition (Burbank, Los Angeles County, Calif.), Volume: 25, Issue: 1	2009
A comparative study of iron bioavailability from cocoa supplemented with ferric pyrophosphate or ferrous fumarate in rats. Annals of nutrition & metabolism, Volume: 51, Issue: 3	2007
Salt dual-fortified with iodine and micronized ground ferric pyrophosphate affects iron status but not hemoglobin in children in Cote d'Ivoire. The Journal of nutrition, Volume: 136, Issue: 7	2006
Iron status and food matrix strongly affect the relative bioavailability of ferric pyrophosphate in humans. The American journal of clinical nutrition, Volume: 83, Issue: 3	2006
Effect of ascorbic acid and particle size on iron absorption from ferric pyrophosphate in adult women. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Volume: 74, Issue: 4	2004
Particle size reduction and encapsulation affect the bioavailability of ferric pyrophosphate in rats. The Journal of nutrition, Volume: 134, Issue: 12	2004
Iron absorption and bioavailability in rats of micronized dispersible ferric pyrophosphate. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition, Volume: 74, Issue: 1	2004
A micronised, dispersible ferric pyrophosphate with high relative bioavailability in man. The British journal of nutrition, Volume: 91, Issue: 1	2004
Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. The American journal of clinical nutrition, Volume: 71, Issue: 6	2000
Effect of copper speciation on whole-cell soluble methane monooxygenase activity in Methylosinus trichosporium OB3b. Applied and environmental microbiology, Volume: 66, Issue: 4	2000
In vitro and in vivo studies on salifluor/PVM/MA copolymer/NaF combination as an antiplaque agent. Journal of clinical periodontology, Volume: 23, Issue: 12	1996
Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time. Pharmaceutical research, Volume: 10, Issue: 7	1993
Potential role of in vitro iron bioavailability studies in combatting iron deficiency: a study of the effects of phosvitin on iron mobilization from pinto beans. Clinical physiology and biochemistry, Volume: 4, Issue: 1	1986
The absorption of iron as supplements in infant cereal and infant formulas. Pediatrics, Volume: 55, Issue: 5	1975
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Tenofovir-diphosphate in peripheral blood mononuclear cells during low, medium and high adherence to emtricitabine/ tenofovir alafenamide vs. emtricitabine/ tenofovir disoproxil fumarate. AIDS (London, England), 12-01, Volume: 35, Issue: 15	2021
High Bioavailability from Ferric Pyrophosphate-Fortified Bouillon Cubes in Meals is Not Increased by Sodium Pyrophosphate: a Stable Iron Isotope Study in Young Nigerian Women. The Journal of nutrition, 05-01, Volume: 149, Issue: 5	2019
Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates. PloS one, Volume: 11, Issue: 11	2016
Tenofovir diphosphate and emtricitabine triphosphate concentrations in blood cells compared with isolated peripheral blood mononuclear cells: a new measure of antiretroviral adherence? Journal of acquired immune deficiency syndromes (1999), Mar-01, Volume: 62, Issue: 3	2013
Pyrophosphate coupling with chelant-enhanced soil flushing of field contaminated soils for heavy metal extraction. Journal of hazardous materials, Jan-15, Volume: 199-200	2012
Daily peritoneal administration of sodium pyrophosphate in a dialysis solution prevents the development of vascular calcification in a mouse model of uraemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Volume: 26, Issue: 10	2011
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. Investigational new drugs, Volume: 30, Issue: 1	2012
Interactions of diorganolead(IV) with 3-(2-thienyl)-2-sulfanylpropenoic acid and/or thiamine: chemical and in vitro and in vivo toxicological results. Inorganic chemistry, Mar-01, Volume: 49, Issue: 5	2010
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic. Aging clinical and experimental research, Volume: 20, Issue: 1	2008
Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model. Journal of gastroenterology and hepatology, Volume: 23, Issue: 7 Pt 2	2008
Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcified tissue international, Volume: 78, Issue: 2	2006
Relative binding affinities of bisphosphonates for human bone and relationship to antiresorptive efficacy. Bone, Volume: 38, Issue: 5	2006
Effects of malathion plus superphosphate or urea on Najdi sheep. Veterinary and human toxicology, Volume: 45, Issue: 1	2003
Plaque regrowth effects of a triclosan/pyrophosphate dentifrice in a 4-day non-brushing model. The Journal of clinical dentistry, Volume: 11, Issue: 4	2000
The comparative efficacy of two commercial tartar control dentifrices in preventing calculus development and facilitating easier dental cleanings. The Journal of clinical dentistry, Volume: 7, Issue: 2 Spec No	1996
Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit time. Pharmaceutical research, Volume: 10, Issue: 7	1993
An in vitro model for studying the efficacy of fluoride dentifrices in preventing root caries. Caries research, Volume: 28, Issue: 5	1994
Alterations of the [59Fe]ferric citrate biodistribution in hyperferremic mice after the administration of pyrophosphate and desferrioxamine. The Journal of pharmacology and experimental therapeutics, Volume: 224, Issue: 2	1983
Determining the effective emetic dosage of tetrapotassium pyrophosphate (TKPP) in dogs. The Journal of toxicological sciences, Volume: 7, Issue: 2	1982
Secretion, subcellular localization and metabolic status of inorganic pyrophosphate in human platelets. A major constituent of the amine-storing granules. The Biochemical journal, Oct-15, Volume: 192, Issue: 1	1980
Effect of pyrophosphate and two diphosphonates on 45Ca and 32Pi uptake and mineralization by matrix vesicle-enriched fractions and by hydroxyapatite. Bone, Volume: 6, Issue: 5	1985
Effect of the diphosphonate EHDP on bone mineral metabolism during prolonged bed rest. The Journal of clinical endocrinology and metabolism, Volume: 41, Issue: 3	1975
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

pyrophosphate

Description

Cross-References

Synonyms (32)

Research Excerpts

Overview

Effects

Actions

Treatment

Drug Classes (1)

Pathways (42,211)

Protein Targets (6)

Inhibition Measurements

Biological Processes (12)

Molecular Functions (6)

Ceullar Components (6)

Bioassays (9)

Research

Studies (6,389)

Study Types

Research Highlights

Safety/Toxicity (21)

Long-term Use (2)

Pharmacokinetics (19)

Bioavailability (42)

Dosage (24)

Interactions (1)

Natural Sources (1)

Article	Year
Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy. Acta oncologica (Stockholm, Sweden), Volume: 52, Issue: 7	2013
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Direct charging of tRNA(CUA) with pyrrolysine in vitro and in vivo. Nature, Sep-16, Volume: 431, Issue: 7006	2004
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

pyrophosphate

Description

Cross-References

Synonyms (32)

Research Excerpts

Overview

Effects

Actions

Treatment

Drug Classes (1)

Pathways (42,211)

Protein Targets (6)

Inhibition Measurements

Biological Processes (12)

Molecular Functions (6)

Ceullar Components (6)

Bioassays (9)

Research

Studies (6,389)

Study Types

Related Drugs (1,559)

Related Conditions (3,712)

Research Highlights

Safety/Toxicity (21)

Long-term Use (2)

Pharmacokinetics (19)

Bioavailability (42)

Dosage (24)

Interactions (1)

Natural Sources (1)